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Abstract 
ENGLISH 
Metabolic syndrome (MetS) and type 2 diabetes (T2D) are important global health 
issues due to its high prevalence and its associated morbi-mortality.  
Among the modifiable risk factors that have been associated with the risk of MetS 
and T2D, diet plays an important role in the prevention and management of both 
conditions. It has been shown that dietary patterns are differently associated with 
the risk of MetS and T2D. Whereas the Western diet seems to increase the risk of 
these chronic diseases, plant-based diets, such as the Mediterranean Diet (MedDiet), 
seem to decrease the risk. In order to better understand the different effects on 
disease risk among dietary patterns, it is important to analyze the role that specific 
food groups play on the risk of developing MetS and T2D. 
This doctoral thesis has been conducted in the frame of the PREDIMED study, a 
parallel, multicenter, randomized clinical trial conducted in Spain between 2003 and 
2011 with the aim of evaluating the effectiveness of the MedDiet in the primary 
prevention of cardiovascular disease. 
The main aim of the present dissertation was to evaluate the association between the 
consumption of meat and dairy products with the risk of MetS or the incidence of 
some of its individual components, as well as to assess the association between 
legumes consumption and T2D development risk.  
The results showed a non-significant inverse association between total dairy 
consumption and the risk of MetS incidence. The consumption of low-fat dairy 
products, low-fat milk and yogurt (total, low-fat and whole-fat yogurt) was 
associated with a lower risk of MetS and some of its individual components. Contrary, 
the consumption of cheese was positively associated with the MetS risk. Likewise, 
total meat intake was also associated with the risk of MetS and the development of 
some of its components. The risk differed according to the type of meat consumed. 
Whereas red meat and processed red meat were associated with a higher risk of 
MetS, poultry was associated with a lower risk. When red meat and processed red 
meat were replaced with eggs, fish, poultry and legumes, a decreased risk of MetS 
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was observed. Finally, total legume consumption, particularly lentils, was associated 
with a lower risk of T2D incidence. The substitution of legumes for eggs, bread, rice, 
and baked potato was also associated with a lower risk of T2D. 
In conclusion, high consumption of low-fat dairy products and yogurt (regardless the 
fat content), together with the preference for poultry rather than red meat or 
processed red meat, and high frequency consumption of legumes, would be 
beneficial for the prevention of MetS and T2D among Mediterranean individuals at 
high CVD risk.  
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SPANISH 
El síndrome metabólico (SM) y la diabetes tipo 2 (DT2) son un importante problema 
de salud mundial debido a su alta prevalencia y su morbi-mortalidad asociada.  
Entre los factores de riesgo modificables que se han asociado con el riesgo de SM y 
DT2, la dieta juega un papel importante en la prevención y tratamiento de ambas 
condiciones. Se ha observado que los patrones dietéticos se asocian de manera 
distinta al riesgo de desarrollar SM y DT2. Mientras que la dieta occidentalizada 
parece incrementar el riesgo de estas enfermedades crónicas, dietas basadas en 
vegetales, como la Dieta Mediterránea, parecen disminuir el riesgo.  Con el objetivo 
de entender mejor los distintos efectos de los patrones dietéticos sobre el riesgo de 
desarrollar estas enfermedades, es importante analizar el papel que juegan 
determinados grupos de alimentos sobre el riesgo de desarrollar el SM y la DT2.  
Esta tesis doctoral se ha llevado a cabo en el contexto del estudio PREDIMED; un 
estudio clínico paralelo, multicéntrico, aleatorizado llevado a cabo en España entre 
2003 y 2011 con el objetivo de evaluar la efectividad de la Dieta Mediterránea en la 
prevención primaria de la enfermedad cardiovascular.  
El principal objetivo de la presente tesis ha sido evaluar la asociación entre el 
consumo de carne, productos lácteos y el riesgo de incidencia SM o alguno de sus 
componentes, así como evaluar la asociación entre el consumo de legumbres y el 
riesgo de desarrollar DT2. 
Los resultados mostraron una asociación inversa no significativa entre el consumo 
total de productos lácteos y el riesgo de incidencia de SM. El consumo de productos 
lácteos bajos en grasa, leche desnatada y yogur (total, bajo en grasa y entero) se 
asoció a un menor riesgo de SM y algunos de sus componentes. Contrariamente, el 
consumo de queso se asoció de forma positiva al riesgo de SM. Del mismo modo, el 
consumo de carne total  también se asoció con el riesgo de padecer SM y alguno de 
sus componentes. Dicho riesgo difirió en función del tipo de carne consumida. 
Mientras que la carne roja y la carne roja procesada se asociaron a un mayor riesgo 
de SM, el consumo de carne blanca se asoció a un menor riesgo. Cuando el consumo 
de carne roja y carne roja procesada se reemplazó por huevos, pescado, carne blanca 
y legumbres, se observó un menor riesgo de SM. Finalmente, el consumo de 
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legumbres totales, y en particular las lentejas, se asoció a un mejor riesgo de 
incidencia de DT2. 
En conclusión, un consumo elevado de productos lácteos bajos en grasa y yogur 
(independientemente del contenido en grasa), conjuntamente con consumo 
preferente de carnes blancas en lugar de carnes rojas o carnes rojas procesadas, y 
una alta frecuencia de legumbres, podría ser beneficioso para la prevención del SM y 
la DT2 en individuos Mediterráneos con alto riesgo cardiovascular.  
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CATALAN 
La síndrome metabòlica (SM) i la diabetis tipus 2 (DT2) són un important problema 
de salut mundial degut a la seva alta prevalença i la seva morbimortalitat associada.  
Entre els factors de risc modificables que s’han associat amb el risc de SM i DT2, la 
dieta juga un paper important en la prevenció i tractament d’ambdós condicions. S’ha 
observat que els patrons dietètics s’associen de forma diferent al risc de 
desenvolupar SM i DT2. Mentre que la dieta occidentalitzada sembla incrementar el 
risc d’aquestes malalties cròniques, les dietes basades en vegetals, com la Dieta 
Mediterrània, semblen disminuir el risc. Amb l’objectiu d’entendre millor els 
diferents efectes dels patrons dietètics sobre el risc de desenvolupar aquestes 
malalties, és important analitzar el paper que juguen determinats grups d’aliments 
sobre el risc de desenvolupar el SM i la DT2.   
Aquesta tesi doctoral s’ha dut a terme en el context de l’estudi PREDIMED; un estudi 
clínic, paral·lel, multicèntric, aleatoritzat conduit a Espanya entre 2003 i 2011 amb 
l’objectiu d’avaluar l’efectivitat de la Dieta Mediterrània en la prevenció primària de 
la malaltia cardiovascular. 
El principal objectiu de la present tesis ha estat avaluar l’associació entre el consum 
de carn, productes làctics i el risc d’incidència de SM o alguns dels seus components, 
així com avaluar l’associació entre el consum de llegums i el risc de desenvolupar 
DT2. 
Els resultats van mostrar una associació inversa no significativa entre el consum total 
de productes làctics i el risc d’incidència de SM. El consum de productes làctics baixos 
en greix, llet descremada i iogurt (total, baix en greix i sencer) es va associar a un 
menor risc de SM i algun dels seus components. De la mateixa manera, el consum de 
carn total també es va associar amb el risc de patir SM i algun dels seus components. 
Aquest risc va diferir en funció del tipus de carn consumida. Mentre que la carn 
vermella i la carn vermella processada es van associar a un menor risc de SM, el 
consum de carn blanca es va associar a un menor risc. Quan el consum de carn 
vermella i carn vermella processada es va substituir per ous, peix, carn blanca i 
llegums, es va observar un menor risc de SM. Finalment, el consum de llegums totals, 
i en particular de llenties, es va associar a un menor risc d’incidència de DT2.  
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En conclusió, un consum elevat de productes làctics baixos en greix i iogurt 
(independentment el seu contingut en greix), conjuntament amb el consum 
preferent de carn blanques en lloc de carns vermelles o carns vermelles processades, 
i una alta freqüència de llegums podria ser beneficiós per a la prevenció del SM i la 
DT2 en individus Mediterranis amb alt risc cardiovascular.  
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1. Metabolic syndrome 
1.1. DEFINITION AND DIAGNOSIS OF METABOLIC SYNDROME 
The term metabolic syndrome (MetS), traditionally also known as insulin resistance 
syndrome or syndrome X, is used to describe a cluster of different interrelated 
factors that directly increases the risk for type 2 diabetes mellitus (T2D) and 
cardiovascular disease (CVD). 
In 1988, Gerald M. Reaven1, after many years of investigation, hypothesized that 
insulin resistance (IR) was the underlying cause of a group of disorders 
characterized by impaired glucose tolerance, hyperinsulinaemia, increased levels of 
very-low-density lipoprotein (VLDL), decreased levels of high-density lipoprotein 
(HDL) and hypertension. However, despite the large investigations conducted in this 
field, in the 1990s there was no accepted international definition describing the 
features included in the syndrome. 
The first official definition was described in 1998 by the World Health Organization 
(WHO)2. Since then, several alternative definitions have been proposed, such as that 
used by the National Cholesterol Education Program-Adult Treatment Panel III 
(NCEP/ATP III)3, the International Diabetes Federation (IDF)4 or the American Heart 
Association/National Heart, Lung, and Blood Institute (AHA/NHLBI)5. However, 
these definitions differed in the components proposed as well as in their 
corresponding cut-off points used. As a consequence, in 2009 the IDF and 
AHA/NHLBI attempted to solve this divergence and proposed a common criteria for 
the diagnosis of the MetS6.   
According to both sides, abdominal obesity was not a prerequisite for its diagnosis, 
but it was included as 1 of the 5 criteria required. Table 1 shows the criteria 
proposed for the harmonized diagnosis. The presence of at least 3 of these 5 risk 
factors is needed for the clinical diagnosis of MetS.  
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Table 1. Clinical Diagnosis of the Metabolic Syndrome6 
Measurement Categorical cut-off 
Abdominal adiposity* Population and country specific 
definitions 
Elevated triglycerides or drug treatment† ≥150mg/dL (1.7 mmol/L) 
Reduced HDL-c or drug treatment† <40mg/dL (1.0 mmol/L) in man 
<50mg/dL (1.3 mmol/L) in woman 
Elevated blood pressure or drug 
treatment‡ 
Systolic ≥130 and/or diastolic ≥85 mmHg 
Elevated fasting glucose or drug 
treatment 
≥100mg/dL 
*It is recommended that the IDF cut points be used for non-Europeans and either the IDF of 
AHA/NHLBI cut points used for people of European origin until more data are available. 
†The most commonly used drugs for elevated triglycerides and reduced HDL-c are fibrates and 
nicotinic acid. Patients taking 1 of these drugs can be presumed to have high triglycerides and low 
HDL-c. High-dose ω-3 fatty acid presumes high triglycerides. 
‡Most patients with type 2 diabetes mellitus will have the metabolic syndrome by the proposed 
criteria. 
1.2. EPIDEMIOLOGY OF METABOLIC SYNDROME 
Elucidating the prevalence trends of the MetS has become a big challenge due to the 
multiple definitions existing over time, as commented above, as well as the fact that 
data is limited to certain populations. Nonetheless, different attempts to describe the 
epidemiological features of this condition in different regions of the world have been 
made in the last decade.  
In the United States, data coming from a cross-sectional sample of the National 
Health and Nutrition Examination Survey (NHANES)7 showed an overall prevalence 
of MetS of 33% among adults aged ≥20 years from 2003 to 2012. Significant 
differences were observed between women (35.6%) and men (30.3%). When trends 
from 2003-2004 to 2011-2012 were evaluated, an increased prevalence from 32.9% 
to 34.7% was found. However, it seemed that MetS prevalence from 2007-2008 to 
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2011-2012 remained stable. It is important to point out that more than 50% of adults 
aged 60 years or older had MetS7.  
In the Asia-Pacific region, a recent publication showed a prevalence of MetS ranging 
from 11.9% to 37.1%. In the majority of the countries, 1 or more of each 5 adults 
suffered from MetS8. 
In Europe, similar trends have been observed. In the Metabolic Syndrome and 
Arteries Research (MARE) consortium cohort, which included information of 34,821 
subjects from 12 different cohorts representing 10 countries, a 24.3% general 
prevalence of MetS was observed, increasing the percentage in an age-dependent 
fashion (more than 30% in subjects aged ≥ 70 years). Lithuania, Belgium, Spain, UK 
and Sardinia (Italy) had the highest prevalence, whereas Greece had the lowest9. 
Another study conducted in the Mediterranean population of Catalonia, confirmed 
this alarming data showing an increased prevalence of MetS from 18.4% in 1992-
1993 to 24.8% in 2002-200310.  
Therefore, independently of the definition used for its diagnostic, approximately 
25% of adult population suffers from MetS, which is in accordance to the IDF figure11, 
and its prevalence increases with age. To date, all studies agree that MetS is a 
condition with a clearly increasing prevalence, which makes it a critical public health 
problem worldwide. 
1.3. PHYSIOPATHOLOGY OF METABOLIC SYNDROME 
The physiopathology process underlying the MetS is an important ongoing debate. 
Although certainly all the components of the metabolic syndrome appear together at 
a higher frequency than expected, the underlying pathophysiology of the syndrome 
it is not yet clear. For many years it has been thought that MetS is caused by a single 
basic defect: the IR12,13. Nowadays, this hypothesis is questioned and it has been 
proposed that features of the MetS occur as a consequence of the abdominal 
adiposity14. However, it is impossible to discern which one of these two factors plays 
a predominant role in the pathogenesis and progression of the MetS due to their high 
interrelation.  
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Insulin resistance  
Insulin hormone is well known to be a major regulator of carbohydrates, proteins 
and lipids metabolism by activating their synthesis and storage, as well as by 
inhibiting their hydrolysis and their subsequent release to the circulation15. 
Therefore, alterations in insulin action may have important metabolic consequences. 
The concept IR is used to describe the inability of normal insulin concentrations to 
produce an insulin response in peripheral tissues16.  
The pathophysiological implications of IR in the carbohydrates metabolism will be 
discussed extensively in the diabetes section of the present doctoral thesis. In brief, 
this defect in insulin action supposes the inability of the hormone to mediate the 
glucose uptake in different tissues, as well as to diminish the liver glucose 
production, which eventually affects blood glucose levels. The association between 
IR, impaired fasting glucose and impaired glucose tolerance has been well 
documented17.  
Apart from controlling glucose metabolism, insulin is also involved in lipid 
metabolism. The lipoprotein lipase (LPL) activity in adipose tissue is predominantly 
regulated by insulin18,19. This enzyme acts on the triglycerides content from 
chylomicrons and VLDL, releasing free fatty acids that are subsequently uptaken by 
adipocytes20 for future storage. In normal conditions, insulin stimulates LPL21 while 
inhibiting lipolysis through the repression of the hormone sensitive lipase (HSL)- an 
enzyme that hydrolyzes triglycerides into free fatty acids and glycerol in the adipose 
tissue22. Under IR condition, an impaired lipid metabolism has been observed, mainly 
due to a reduced LPL activity, as well as a reduced LPL mRNA levels in adipose 
tissue23,24, hence affecting the clearance of triglycerides-rich lipoproteins in the 
circulation. Moreover, in this setting of IR, insulin cannot properly inhibit lipolysis, 
leading to a higher free fatty acids secretion into the plasma25 
Abdominal obesity 
The inclusion of waist circumference instead of body mass index (BMI) as 1 of the 5 
criteria required for the diagnosis of the MetS, illustrates the importance of 
abdominal adiposity in the pathogenesis of the syndrome. However, it is important 
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to highlight that the clinical definition of the MetS does not distinguish between 
subcutaneous and visceral adipose tissue, which may have large different metabolic 
affections.  
Traditionally, adipose tissue has been considered as a simple passive energy storage 
organ. Nowadays, this conception is obsolete and it is well known that it is a dynamic 
organ expressing and secreting bioactive components called adipokines. These 
proteins not only can act at paracrine level but also can be secreted into the 
circulation, hence acting at systemic level in the brain, liver or skeletal muscle26. 
Therefore, adipose tissue communicates with other organs and is involved in 
different processes including immune and reproductive function, energy 
metabolism, appetite and inflammatory signaling27. Considering the foregoing, an 
excess of adipose tissue, especially at visceral level, can lead to adverse metabolic 
consequences. 
In individuals with excess visceral adiposity, reduced circulating levels of 
adiponectin have been observed28–30. This protein is synthesized predominantly in 
adipose tissue and it seems to play an important role in the metabolism of 
carbohydrates and lipids. Moreover, purportedly it also has anti-atherogenic and 
anti-inflammatory properties31. Adiponectin has been inversely associated with 
some CVD risk factors such as LDL cholesterol, triglycerides and blood pressure32,33. 
As a consequence of all this, it is not surprising that adiponectin has been associated 
with the risk of CVD events34,35 and T2D36.   
 
Whereas levels of adiponectin are reduced in individuals with excess of visceral 
adipose tissue, other pro-inflammatory adipokines such as C-reactive protein (CRP), 
interleukine-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) are increased30,37,38.  
CRP is considered an inflammatory marker that could be predictive of CVD events39 
and T2D incidence40. Moreover, it has been associated with impaired endothelial 
vasoreactivity41. In regard to IL-6, it has been shown that in adipose tissue reduces 
the activity of LPL, as well as increases lipolysis42,43 and it is also a predictor of both 
T2D44 and myocardial infarction45. Finally, TNF-α exerts different actions in adipose 
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tissue among which stands out the alteration of lipid storage and oxidative capacity 
through the inhibition of lipogenesis and the activation of lipolysis46.  
Other proteins with different inflammatory, endothelial and thrombotic properties 
are also produced by adipocytes or the central adipose tissue, which contains 
infiltrated macrophages in the obesity states (Figure 1). 
Visceral adipose tissue also contributes to increase free fatty acids levels into the 
systemic circulation. In women with upper body obesity, but not with lower body 
obesity, a higher free fatty acids release from adipose tissue has been observed 
compare to non-obese postmenopausal women47. This could be explained through 
the higher lipolysis activity in visceral adipocytes compare to subcutaneous 
adipocytes, as observed in several in vivo and in vitro studies48. Elevated 
concentrations of free fatty acids can directly affect liver functions increasing hepatic 
glucose production and resulting in fasting hyperglycemia49. In fact, higher 
concentrations of free fatty acids have been associated with an increased risk of T2D 
in a large case-cohort study50.  
Therefore, an excess of adipose tissue, mainly in the visceral area, contributes to the 
physiopathology associated to MetS, through an alteration of free fatty acids 
metabolism and its endocrine function leading not only to an impaired glucose and 
lipid metabolism but also to a state of low-grade inflammation.  
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Figure 1. Contribution of white adipose tissue to metabolic and vascular complications. Adapted 
from: Gómez-Hernández et al, Int J Endocrinol. 2016; 2016: 1216783 
Dyslipidemia 
Individuals with MetS present a lipid profile characterized by a combination of low 
levels of HDL-c and high concentrations of triglycerides. As stated before, IR and 
abdominal adiposity can lead to an impaired lipid metabolism through different 
pathways. Under both conditions, lipolysis in adipocytes is enhanced and a higher 
release of free fatty acids into the liver is produced. This increased flux of free fatty 
acids promotes hepatic production of triglycerides and secretion of VLDL51. Under 
normal conditions, triglycerides from VLDL particles are hydrolyzed to be storage in 
adipose tissue. However, in individuals with MetS, an impaired activity of LPL is 
presented favoring the accumulation of lipoproteins rich in triglycerides in the 
circulation. 
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Low levels of HDL-c are highly correlated with hypertriglyceridemia and could be as 
a result of both increased production and reduced catabolism of VLDL observed in 
MetS individuals. In normal conditions, LPL hydrolyzes triglycerides from VLDL and 
chylomicrons. As pointed previously, LPL activity is reduced in individuals with MetS 
producing a reduction in the clearance of VLDL from the circulation. The large 
concentrations of these triglyceride-rich lipoproteins during a prolonged time 
produce an exchange, mediated by cholesteryl ester transfer protein (CETP), of 
cholesteryl ester and triglycerides between HDL-c and VLDL. As a results, enriched 
triglycerides HDL-c particles are generated, which are faster catabolized than normal 
HDL particles22,52. Besides, the activity of lipase hormone, responsible for the 
catalysis of HDL-c, is increased53. Taking together all the aforementioned aspects, 
irredeemably levels of circulating HDL-c are reduced. 
Hypertension 
High blood pressure is considered another feature of the MetS although its relation 
with the syndrome is complex. Both IR and abdominal adiposity have been 
associated with hypertension54–56. Although different possible mechanisms have 
been proposed, the association between these conditions is not well understood. 
The main hypothesis linking the three conditions seems to be the contribution of 
visceral adiposity and IR to the endothelial dysfunction by lowering nitric oxide 
bioavailability. In normal conditions, insulin produces vasorelaxation and increases 
capillarity in the skeletal muscle through the stimulation of endothelial nitric oxide 
production57. In the setting of IR condition, the production of nitric oxide is impaired 
and the resulting compensatory hyperinsulinemia may enhance vasoconstriction57, 
hereby contributing to the hypertension in MetS. Different studies supported this 
theory. The activity of the nitric oxide synthase, stimulated by insulin in muscle, is 
impaired in individuals with T2D58. Moreover, lower levels of adiponectin, as has 
been observed in individuals with abdominal obesity, also can contribute to the 
reduced bioavailability of nitric oxide. It seems that this adipokine directly stimulates 
its production in endothelial cells59,60.  In this line, reduced levels of adiponectin have 
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been associated with hypertension61,62, suggesting a possible role of this protein in 
the pathophysiology of hypertension in the MetS. 
Insulin also plays a role stimulating renal sodium reabsorption63,64. In fact, in IR 
conditions, the stimulated activity seems to be maintained or even enhanced. This is 
supported by a study showing an increased sodium retention in diabetics 
participants with severe IR, compared to those participants with less severe 
impaired insulin sensitivity and controls65. In consonance, individuals with MetS 
have an increased rate of proximal fractional sodium reabsorption66,67, which may be 
relevant in the pathophysiology of hypertension. 
The increased circulating levels free fatty acids observed in individuals with MetS 
also could contribute to the raise of blood pressure through the endothelial 
dysfunction, the stimulation of vascular cell growth and the increase of oxidant 
stress68.  
Finally, an increased sympathetic neuron system activity has been also observed in 
individuals with MetS69, although the mechanisms leading to an hyperactivity of 
sympathetic neuron system in the setting of MetS are not well established, it seems 
that may contribute to the initiation and progression of hypertension70. 
1.4. METABOLIC SYNDROME AS A RISK FACTOR FOR CARDIOVASCULAR 
DISEASE AND TYPE 2 DIABETES 
Each component of the MetS has been associated independently with the risk of T2D 
and CVD development. Some evidence suggests that, regardless the definition used, 
MetS is more than the sum of its individual components and it also represents an 
additional risk of T2D and CVD incidence. However, some authors suggested that 
although the MetS can predict the development of T2D or CVD, its ability is less 
effective than the Framingham risk score or the Diabetes Predicting Model, which 
are models designed specifically for this purpose71. In any case, MetS can be 
considered as a useful and simple phenotypic clinical tool for the identification of 
individuals predisposed to T2D and CVD.  
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Metabolic syndrome as a predictor of cardiovascular disease 
The main objective to create a definition for the MetS was to have a clinical tool to 
identify individuals at high risk of CVD. However, whether MetS is actually associated 
or not with the risk of developing CVD has been a subject of discussion in the last 
decade. In 2005 the American Diabetes Association jointly with the European 
Association for the Study of Diabetes stated a big concern regarding the MetS given 
that the CVD risk associated with it appeared to be not greater than the sum of its 
parts72. Since then, several different studies in large populations have been 
conducted in order to increase the knowledge in this area, despite the fact that 
differences in the Mets diagnosis represented a big limitation. In 2010, Mottillo et al. 
published a systematic review and meta-analysis evaluating the association between 
MetS, CVD risk and all-cause mortality. The 87 prospective studies included were 
published between 2002 and 2009 and used NCEP/ATPIII definition for the 
diagnosis of the MetS. The results revealed a 2-fold increased risk of total CVD 
outcomes, CVD mortality and stroke associated with the MetS73. These findings are 
in line with the IDF, which affirms that individuals with MetS are twice as likely to 
die from and three times as likely to have heart attack or stroke than those 
individuals without the syndrome11. However, although few, there are some 
exceptions to these findings. The Casale Monferrato Study74, the Prospective Study 
of Pravastatin in the Elderly at Risk (PROSPER)75 and the Strong Heart Study76 did 
not find an association between the MetS and CVD risk. It seems that the ability to 
predict CVD vary by sex and the numbers of components that are present. For 
instance, a study showed a higher relative risk (RR) of coronary heart diseases in 
women than in men even in the presence of the same number of MetS components77. 
In the same line, another study conducted in Korean participants aged 20-78 years 
observed a higher odd ratios for CVD in women (4.04; 95%CI 1.78-9.14) than men 
(1.98; 95%CI 1.30-3.03)78. Regarding the number of components of the MetS, 
according to the Beaver Dam Study, those individuals with three risk factors had an 
odd ratio for CVD of 1.95 (95%CI 0.91-4.16) whereas in those individuals with four 
risk factors it was 5.86 (95%CI 2.51-13.66)79. Similar results were observed in the 
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Framingham Heart Study, where the relative risk for CVD increased exponentially, 
regardless gender, with the number of presented risk factors80. 
The predictability of CVD incidence may differ according to the definition used81, 
however, evidence so far suggests that individuals suffering from MetS are at a higher 
risk of CVD development. Nonetheless, it is important to point out that to date no 
study has evaluated the association between the MetS, diagnosed with the 
harmonized criteria, and the risk of CVD development. Therefore, although criteria 
included in the definition did not vary a lot from the previous definitions, further 
studies are needed to confirm the ability of the new clinical tool to identify 
individuals at high CVD risk and to elucidate the mechanisms by which MetS may 
increase the risk. 
Metabolic syndrome as a predictor of type 2 diabetes 
One of the gold standard methods in research to identify individuals at increased risk 
of T2D is the oral glucose tolerance test (OGTT). However, because of its cost, it is 
not widely used in clinical practice. For this reason, is important to identify new tools 
to predict the risk of T2D. In this field, the MetS has been proposed as a useful and 
good predictor instrument of T2D. 
The evidence supporting the ability of the MetS to predict T2D is well recognized. 
According to the IDF individuals with MetS have a 5-fold increased risk of T2D 
development11. Different studies conducted in large populations support this 
statement. In 2008 a meta-analysis of 16 prospective studies of several different 
populations showed a strong positive association between MetS, independently of 
the definition used, and the risk of T2D incidence82. Nonetheless, because impaired 
fasting glucose levels is one component of the MetS, is not surprising to observe a 
higher risk of T2D associated to this condition. It is noteworthy that in the Kuopio 
Ischemic Heart Disease Risk Factor Study, the sensitivity for the prediction of T2D 
incidence decreased after excluding impaired fasting glycaemia from the definitions 
of the MetS, especially for the NCEP definition83. In the same line, in another 
longitudinal study conducted in Korean population, the ability of MetS to predict T2D 
decreased dramatically after controlling the analysis for fasting plasma glucose78. 
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Different studies have also analyzed the association between the number of MetS 
components and the risk of T2D. In the comparisons, the risk associated rose in 
proportion with the number of MetS features present. In the British Regional Heart 
Study84 the risk of T2D increases from 4.56 (95%CI 2-48-8,78), in those individuals 
with 3 or 4 criteria, to 10.88 (95%CI 5.77-20.50) in those participants with 5. Results 
were in the same line in the West of Scotland Coronary Prevention study85 and the 
Beaver Dam study79. 
As with CVD, to date no previous studies have analyzed the association between the 
MetS defined by the harmonized criteria and the risk of T2D. Therefore, although 
strong evidence has shown an increased risk, studies using the new clinical criteria 
are warranted to corroborate these findings. 
2. Diabetes 
2.1. DEFINITION, CLASSIFICATION AND DIAGNOSTIC OF DIABETES 
Diabetes is considered, rather than an isolated pathological entity, a group of 
metabolic diseases whose main common characteristic is a hyperglycemic status 
resulting from defects in insulin action, secretion, or a combination of both. High 
levels of sustained plasma glucose are associated with several harmful effects, 
dysfunction and failure of distinct organs such as kidneys, nerves, eyes, heart and 
blood vessels86. People with diabetes have a higher risk of developing several health 
problems than people without diabetes. In fact, different long-term macrovascular 
(coronary artery disease, stroke and peripheral arterial disease) and microvascular 
complications (diabetic nephropathy, neuropathy and retinopathy) have been 
associated with the disease87.  
Diabetes is classified in 4 different categories according to the American Diabetes 
Association88: 
Type 1 diabetes (T1D): This form is presented only in 5-10% of all the individuals 
with diabetes. It is characterized by an autoimmune destruction of the pancreatic 
β-cells leading to absolute insulin deficiency. Although it is mainly presented in 
childhood or adolescence, it can also occur at any age. People with T1D need 
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insulin administration every day to control their levels of glucose and survive. 
Type 2 diabetes: This is the most frequent type of diabetes accounting for 
approximately 90-95% of all diabetes cases. It is characterized by the presence of 
IR and usually by a relative (not absolute as in T1D) insulin deficiency. Although 
not all, the vast majority of patients with T2D are obese or overweight, and they 
have a greater accumulation of body fat at the abdominal level. This form of 
diabetes can be undiagnosed for many years because the hyperglycemia status is 
gradually developed, and at early stages, patients do not have any of the classic 
symptoms of the disease. In these patients, the secretion of insulin is defective 
and insufficient to compensate for IR status. Importantly, although it usually 
occurs in adults, nowadays its prevalence is increasing in children and 
adolescents. Unlike people with T1D, most of patients with T2D do not require 
the administration of daily insulin to survive. However, if blood glucose levels 
continue rising despite using oral antidiabetic medication, insulin administration 
may be prescribed. Obesity, increased age, and lack of physical activity are 
considered as the main risk factors for developing T2D.  
Specific types of diabetes due to other causes: For instance, diseases of the 
exocrine pancreas (cystic fibrosis), monogenic diabetes syndromes (neonatal 
diabetes and maturity-onset diabetes of the young), drug or chemical induced 
diabetes (such as after organ transplantation or use of drugs for the treatment of 
HIV/AIDS), and diabetes secondary to metabolic stress. 
Gestational diabetes mellitus: Diabetes that appears for the first time during the 
second or third trimester of pregnancy, but only when it is clear that T1D or T2D 
were not preexisting. 
Diabetes diagnosis is based on plasma glucose levels measured by either fasting 
plasma glucose (FPG) or the 2-h plasma glucose concentrations (2-h PG) after a 
75g OGTT86, or glycosylated hemoglobin (A1C) levels89. Table 2 summarizes the 
criteria proposed by the American Diabetes Association according to the method 
used. 
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 NGSP, National Glycohemoglobin Standardization Program; DCCT, Diabetes Control and 
Complications Trial 
*In the absence of unequivocal hyperglycemia, results should be confirmed by repeat testing. 
It is important to highlight that although FPG, OGTT and A1C are similarly adequate 
for the diagnosis of diabetes, the concordance between these tests is imperfect, and 
more people with diabetes have been diagnosed with 2-h plasma glucose levels than 
with FPG or A1C.  
A1C has certain advantages over FPG and OGTT. For instance, fasting is not required 
for its analysis, it has a higher stability, and it is less susceptible to disturbances 
under stress and illness conditions. Nonetheless, it also has some disadvantages, 
such as a greater cost or a limited availability of A1C testing in certain areas of the 
developing word. Moreover, it cannot be ignored that A1C is an indirect 
measurement of plasma glucose levels88. 
Unless the diagnosis of diabetes is totally clear, such as in the case of patients 
presenting classic symptoms of hyperglycemia, a second test using the same 
methodology should be repeated during the 3-4 months following the first test in 
order to confirm the diagnosis and minimize possible analytic bias from laboratories.  
Table 2. Criteria for the diagnosis of diabetes88 
FPG ≥126 mg/dL (7.0 mmol/L) 
Fasting is defined as no caloric intake for at least 8 h* 
OR 
2-h PG ≥200 mg/dL (11.1 mmol/L) during an OGTT. The test should be performed as 
described by the WHO, using a glucose load containing the equivalent of 75 g anhydrous 
glucose dissolved in water* 
OR 
A1C ≥6.5% (48 mmol/mol). The test should be performed in a laboratory using a method 
that is NGSP certified and standardized to the DCCT assay* 
 OR  
In a patient with classic symptoms of hyperglycemia or hyperglycemic crisis, a random 
plasma glucose ≥200 mg/dL (11.1 mmol/L). 
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2.2. EPIDEMIOLOGY OF DIABETES 
T2D is an important health problem worldwide. According to the IDF is one of the 
largest health emergencies of the 21st century.  
In 2015, the IDF published the seventh edition of the diabetes atlas, where 
worldwide prevalence of diabetes in 2015 were described (Figure 2). After 
analyzing data from 220 countries, results revealed that 415 million adults aged 20-
79 years suffered from diabetes, which represents an 8.8% of this total adult 
population. More alarming is the figure estimated for 2040. It is expected that the 
number of individuals with diabetes will be continue growing to 642 million people, 
which is the same as one adult in ten90. It is noteworthy that IDF has estimated that 
nearly 46.5% of all individuals with diabetes (193 million people) are unaware of 
their disease. 
The prevalence of diabetes varies by age, gender and urban and rural environments. 
320.5 million people aged 20-64 suffered from diabetes, whereas 94.2 million adults 
aged 65-79 presented the disease. Although differences are small, a higher 
prevalence has also been observed in men (215.2 million) than in women (199.5 
million). According to the area of residence, the prevalence of diabetes was almost 
double in urban (269.7 million) than in rural areas (145 million). Following the 
increased estimation of worldwide diabetes prevalence by 2040, the number of 
individuals with the disease is also expected to be higher in both areas (477.9 and 
163.9 million people in urban and rural areas, respectively). 
UNIVERSITAT ROVIRA I VIRGILI 
DIETARY FACTORS ASSOCIATED WITH METABOLIC SYNDROME AND TYPE 2 DIABETES RISK 
Nerea Becerra Tomás 
Figure 2. Estimated number of people with diabetes worldwide and per region in 2015 and 2040 
in adults aged 20-79 years old. International Diabetes Federation. IDF Diabetes, 7 ed. Brussels, 
Belgium: International Diabetes Federation, 2015. http://www.diabetesatlas.org 
Regarding different regions in the world, the highest prevalence (11.5%) of diabetes 
was observed in the North America and Caribbean Region whereas the lowest was 
observed in the Africa Region (3.8%). Europe is the second region with the lowest 
age-adjusted prevalence of diabetes with 59.8 million people suffering from the 
disease (approximately 7.3% of the population aged 20-79). However, Europe has 
the highest prevalence of T1D in children.  
Spain is one of the 47 countries that reported information about diabetes to the IDF. 
According to the seventh atlas edition, there were over 3.5 million cases of diabetes 
in Spain in 2015, which represents a 10.4% of the total adult population. Figure 3 
represents the prevalence of diabetes in Spanish adults by age. It is important to note 
that as age increases, the prevalence of diabetes in Spain is higher than that reported 
in Europe or worldwide. 
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Figure 3. Prevalence of diabetes 
in adults by age, Spain 2015. 
Figure describes which age 
groups in the population have the 
highest proportions of diabetes. 
The dotted line is the distribution 
of diabetes prevalence by age for 
the world; the black line is the 
distribution for the Europe 
region; and the Spain distribution 
is plotted in the red line91.  
 
 
As the IDF figures have shown, diabetes is an important health issue whose 
prevalence is increasing dramatically worldwide, being T2D the most common type. 
Therefore, it is important to develop efficient prevention strategies to slow its 
progression. 
2.3. PHYSIOPATHOLOGY OF TYPE 2 DIABETES 
There is widespread agreement that both insulin resistance and β-cell dysfunction 
are main responsible factors for the hyperglycemic status presented in T2D. Genetics 
and environmental elements are thought to be the main causes of these alterations92. 
In order to understand all cellular and molecular mechanisms implicated in the 
development of T2D, it is imperative to contextualize the picture frame under which 
glycaemia is controlled.  
Pancreas is the organ responsible for maintaining glucose levels constant. Its 
endocrine cells represent a 1% of the total pancreas mass and are grouped into 
populations of 1000-3000 cells forming what is known as islets of Langerhans. These 
cells are responsible for the production and secretion of insulin (β-cells) and 
glucagon (α-cells), which are implicated in the regulation of glucose homeostasis.  
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Under normal physiological conditions, the release of insulin from pancreatic β-cells, 
after meal consumption, maintains glucose levels within a narrow physiological 
range through different pathways. On the one hand, insulin increases glucose 
transport and the rate of glycolysis in muscle and adipose tissue by the activation of 
hexokinase and 6-phosphofructokinase enzymes. On the other hand, it inhibits the 
production and release of glucose in the liver. Moreover, insulin also reduces HSL 
activity in adipocytes inhibiting lipolysis93,94.  
Insulin exerts its metabolic effects by binding to the insulin receptor with tyrosine 
kinase activity, which stimulates its autophosporylation and, consequently, its 
activation. This process leads to phosporilation on tyrosine residues of different 
proteins, including members of the insulin substrate family (IRS), starting the 
insulin-signaling cascade. This process ends up promoting the translocation of 
glucose transporter 4 (from intracellular vesicles to the plasma membrane), the 
synthesis of glycogen, protein, mRNAs and DNA, affecting eventually cell 
proliferation and survival93,95. 
Insulin resistance 
As has been commented in the MetS section of the present doctoral thesis, IR is 
considered as a condition where normal levels of insulin are not capable to produce 
a normal insulin response in its target tissues such as adipose, muscle and liver. Thus, 
insulin-mediated glucose uptake by adipose and muscle tissues is reduced and the 
suppression of glucose production in liver is insufficient. Under this condition, levels 
of glucose cannot be maintained within the normal range and hyperglycaemic status 
appears (Figure 4)95. 
The molecular mechanisms of IR in humans are currently not well understood, but 
changes in insulin receptor isoform expression and defects in the signalling cascade 
may play an important role in its development. The increased action of different 
phosphatases and the enhanced production of several inflammatory molecules (i.e. 
IL-6 and TNF-α) play an important role in the negative regulation of insulin 
signalling93,95. 
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Although mechanisms implicated in insulin resistance are not well elucidated, it 
seems that insulin sensitivity is influenced by several factors, such as exercise96, 
genetics, dietary components97–99 and obesity100, being body fat distribution101–103 
one of the main determinants.  
Figure 4. Pathophysiology of hyperglycemia in type 2 diabetes95. 
Beta-cells dysfunction 
β-cells play a crucial role ensuring that glucose levels are maintained within narrow 
physiological range in healthy subjects. The amount of insulin release by β-cells 
varies according to different factors, such as the nature, quantity and administration 
route of the stimulus, and the prevailing glucose concentration104. 
In healthy individuals, there is a feedback loop between insulin sensitivity and 
insulin release. Therefore, in order to maintain glucose levels constant when there is 
a change in insulin sensitivity, an equivalent and complementary variation in insulin 
release takes place. A failure in this process leads to glucose abnormal levels and 
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underlies diabetes development104,105. 
It is well known that β-cells dysfunction is present at a time of T2D diagnosis. 
However, the hypothesis that this dysfunction exists many years before its 
development106 is gaining support. A major effort has been made to understand the 
pathogenesis of β-cell dysfunction in T2D, but the mechanism remains unclear and 
current evidence appoints towards a multifactorial cause. It could be because of a β-
cell exhaustion as consequence of a higher demand of insulin secretion due to IR107, 
glucotoxicity due to a chronic hyperglycemic status108, lipotoxicity109 and a reduction 
in β-cell mass possibly due to the deposition of amyloid110. 
In the presence of both β-cells dysfunction and IR, glucose levels cannot be 
maintained within a physiological range because release of insulin is insufficient to 
compensate for IR status observed in its target tissues (Figure 4). 
2.4. TYPE 2 DIABETES AS A RISK FACTOR FOR CARDIOVASCULAR DISEASE 
CVD is the first cause mortality worldwide accounting for a 31% of all global deaths 
in 2012111. The WHO global report on diabetes stated that heart attack and stroke 
are among one of the many complications associated with diabetes112. In fact, 
evidence so far shows that diabetes is a well-established risk factor for CVD. 
According to the Task Force on diabetes, pre-diabetes, and cardiovascular diseases 
of the European Society of Cardiology (ESC) and he European Association for the 
Study of Diabetes (EASD), more than a half of the mortality and morbidity in patients 
with diabetes is related to CVD113. 
In 2010, it was published a collaborative meta-analysis of 97 prospective studies 
analyzing the associations between diabetes and fatal or non-fatal ischemic vascular 
disease. In total, data from 592,830 participants was analyzed114. The study revealed 
that, in comparison with participants without diabetes, individuals with the disease 
had a higher risk of coronary heart disease (HRs: 2,00; 95%CI 1.83-2.19), ischemic 
stroke (HRs: 2,27; 95%CI 1.95-2.65), hemorrhagic stroke (HRs: 1.56; 95%CI 1.19-
2.05), unclassified stroke (HRs: 1.84; 95%CI 1.59-2.13) and vascular death (HRs: 
1.73; 95%CI 1.51-1.98). Moreover, it is important to highlight that sex differences 
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were observed. Compared to those without diabetes, the risk of coronary heart 
disease and ischemic stroke disease was higher in women with diabetes than in 
diabetic men. The main limitation of this meta-analysis was the lack of information 
about the prevalence of T1D or T2D in their populations, although the age 
distribution suggested that the vast majority of participants would have T2D.  
This gender differences in the impact of T2D on coronary heart disease risk were 
also observed in another study including individuals aged 45-64 years without CVD 
at baseline. After adjusting for different CVD risk factors, the risk of coronary heart 
disease was higher in diabetic women than in diabetic men (HRs: 2.8; 95%CI 2.0–3.7 
and HRs: 9.5; 95%CI 5.5–16.9, respectively) compared with their counterparts 
without the disease115. 
More recently, in 2015, a cohort study including 1.9 million people also observed 
similar trends in the risk of different CVD events associated with the risk of T2D. The 
study included 1,887,062 individuals without diabetes and 34,198 individuals with 
T2D. After a median follow-up of 5.5 years, 6,137 new CVD events were developed 
among participants with T2D, being peripheral arterial disease and heart failure the 
most common events. The analysis showed a higher risk of peripheral arterial 
disease, ischemic stroke, stable angina, heart failure and non-fatal myocardial 
infarction in those individuals with T2D compared to those without this condition.  
UNIVERSITAT ROVIRA I VIRGILI 
DIETARY FACTORS ASSOCIATED WITH METABOLIC SYNDROME AND TYPE 2 DIABETES RISK 
Nerea Becerra Tomás 
3. Risk factors for metabolic syndrome and type 2 
diabetes  
MetS and T2D are considered as multifactorial diseases resulting from a complex 
interplay between genetics and environmental elements92,116. Due to their etiology, 
factors that increase the risk of MetS also increase the risk of T2D. Different risk 
factors, namely modifiable and non-modifiable risk factors, have been identified and 
associated with MetS and T2D risk. In the following section of the present doctoral 
thesis, a detailed description of both types of risk factors will be carried out. 
3.1. NON-MODIFIABLE RISK FACTORS 
3.1.1 RACE AND GENETIC FACTORS 
It is well known that T2D and MetS are, in part, inherited. Evidence from family and 
twin-based studies supports the role of genetic factors in the development of both 
diseases in conjunction with modifying effects of the environment.  
Family history of T2D has been associated with a higher risk to develop this condition 
in comparison with individuals without family history of the disease. The risk of T2D 
incidence in those individuals with an affected parent or sibling, compared to the 
general population, is approximately 3 times greater, whereas, if both parents are 
affected this risk increases up to 6117. It has also been observed that the concordance 
rate of T2D in monozygotic twins is significantly higher than those for dizygotic 
twins118,119. Regarding MetS,  the vast majority of genetic studies have assessed the 
individual components or different combinations of those, rather than the MetS as 
an entity itself120–122. The few studies focused on evaluating MetS heritability, have 
reported that this is around 25-30%. In the Northern Manhattan Family study the 
heritability was 24%123 and in the Linosa Study was 29.9%124. Similarly to those 
studies with T2D, data from twin studies assessing MetS have shown a concordance 
of 31.6% in monozygotic twins compared to 6.3% in dizygotic twins for the 
combination of 3 components of the Mets (hypertension, obesity and diabetes)125. 
Since 2007, thanks to the genome-wide association studies (GWAS), different genetic 
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variants have been associated with T2D and MetS. In the case of T2D, approximately 
88 genetic loci have been associated with its incidence risk126. It is important to 
highlight that most of these loci are mainly associated with β-cell function and insulin 
release, rather than insulin resistance. This could be probably because obesity and 
insulin resistance shares genetic variants and it is difficult to dissect out their role127. 
In the case of MetS, few studies using the condition as binary trait or pairs of its 
components have been published. All of them agreed that gene variants are mostly 
linked to genes that play a role in lipid metabolism or are associated with lipid 
levels127,128. Regarding MetS components, beyond the loci associated with T2D, 56 
loci have been associated with obesity, 157 with lipids and approximately 90 with 
hypertension128. 
In the last years, a growing body of evidence suggested that, beyond genetic variants 
itself, epigenetic mechanisms may play an important role in the pathogenesis of T2D 
and MetS128,129. Epigenetic modifications change gene expression through DNA 
methylation, histones modification or activation of microRNAs, yet DNA sequence 
remains unchanged130. Although it is too early to elucidate their degree of 
involvement in the physiopathology of both diseases, epigenetic changes should also 
be considered. 
It is noteworthy that there are differences between ethnicity in the MetS and T2D 
prevalence and/or incidence, which emphasize the role of genetic in its 
physiopathology. In a random sample of medicare fee-for-service beneficiaries, the 
lowest prevalence of T2D was observed among Whites (184 cases per 1000 
individuals), whereas Hispanics (334 cases/1000 individuals), Blacks (296 
cases/1000 individuals) and Asians (243 cases/1000 individuals) had the highest 
prevalence131. In the same line, higher incidence of T2D has been observed in African 
American women (about 2.4-fold greater) and men (about 1.5-fold greater) than 
their White counterparts. These results are confirmed by the Nurses’ Health Study, 
where after 20 years of follow-up, a higher risk of T2D was observed among Asian, 
Hispanic and Black women than Whites even after adjusting for differences in BMI132. 
Whereas in T2D seems that Black individuals present a higher risk of suffer the 
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disease, paradoxically for MetS appears to be the opposite. In spite of the fact that 
Blacks have higher prevalence of insulin resistance or T2D, a lower prevalence of 
MetS has been observed in this group133–135. It has been hypothesized that the low 
rates of dyslipidemia observed among blacks could be responsible for this ethnic 
differences134,135. However, it is important to point out that further studies are 
needed in this field due to some inconsistencies between published results.  
3.1.2. SEX 
Data from epidemiological studies have shown that sex-differences may play a role 
in the epidemiology and pathophysiology of T2D and MetS, suggesting that, the risk 
of suffering from these diseases could be different depending on the sex. In the 7 th 
edition of the IDF atlas, slightly differences between women and men were observed 
in diabetes prevalence in 2015 and the estimated prevalence for 2040. Nearly, there 
were 15.6 million more men with diabetes than women in 2015. But this difference 
is expected to be reduced to 15.1 million by 204090. However, it is noteworthy that 
others studies have shown that T2D affects women disproportionately. Furthermore, 
in general, they also have worse glycemic control and more difficulties to reach the 
goals for A1C than men136,137.  
As stated in the MetS section of the present doctoral thesis, it is difficult to elucidate 
trends in MetS due to the existence of several definitions over time. However, studies 
agreed that the prevalence of the MetS is increasing year-by-year. In a study 
including individuals from Member States of the Gulf Cooperative Council (GCC; 
Bahrain, Kuwait, Oman, Qatar, Saudi Arabia and the United Arab Emirates) a higher 
prevalence of MetS in women (ranging from 32.1 to 45,9%) than men (ranging from 
20.7 to 37.2%) was observed, regardless of the definition used (NCEP/ATP III or 
IDF)138. This figure was also observed in the NHANES sample, where prevalence of 
MetS differed between women and men, being the highest percentage in women7. 
Nevertheless, in this cross-sectional study, data showed that prevalence of MetS 
remained stable in men from 2007-2008 to 2011-2012, whereas decreased in 
women from 39.4% to 36.6% during the same period.  
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Despite all of these figures suggest that sex-differences in the risk of T2D and MetS 
maybe exist, it is certainly that there is a lack of knowledge on the true impact of 
gender in the pathophysiology of both diseases. There is a great need for large 
prospective studies designed specifically to evaluate, if any, the impact of sex in T2D 
and MetS risk. 
3.1.3. AGE 
Controversies exist about the fact that advanced age may confer higher risk of T2D 
and MetS. Different epidemiological studies support this notion. The 2015 
prevalence of T2D was higher as the age increased in men and women (Figure 5). 
Moreover, in the first national study conducted in Spain to examine the prevalence 
of diabetes, a significant increase in the percentage of individuals suffering from this 
disease was observed with age139. 
Evidence surrounding the MetS is on the same line. A cross-sectional analysis carried 
out on more than 10,000 participants in the Nord-Trøndelag Health Study observed 
an increased prevalence of MetS in men from 11.0% in those aged between 20-29 
years to 47.22% in those aged between 80-89 years. Regarding women, the 
percentage increased from 9.2% to 64.4% in the corresponding age ranges140. 
Similar results were reported in the NHANES study.  Among those individuals aged 
20-39, the prevalence of the MetS was 18.3%, increasing to 46.7% among those 
individuals aged 60 years or above7. 
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Figure 5. Worldwide prevalence of diabetes stratified by sex and age in 2015. Adapted from: 
International Diabetes Federation. IDF Diabetes, 7 ed. Brussels, Belgium: International Diabetes 
Federation, 2015. http://www.diabetesatlas.org 
3.2. MODIFIABLE RISK FACTORS 
3.2.1. SMOKING HABIT 
The fact that active smoking increases the risk of T2D and MetS is well documented. 
A meta-analysis including 88 prospective cohorts studies with 5,898,795 
participants, reported 37% higher risk of T2D in current smokers compared with 
nonsmokers. The risk was also higher when former smokers were compared with 
never smokers (HRs: 1.14; 95%CI: 1.10-1.18). Importantly, authors also reported a 
dose-response relationship between smoking and T2Drisk. The highest risk (57%) 
was reported for heavy smokers compared with never smokers, whereas moderate 
smokers had a 34% risk and light smokers a 21% risk141. Another important aspect 
to highlight is that, compared to never smokers with no passive smoke exposure, 
passive smokers had a 22% higher risk of T2D. Finally, the risk of T2D was also high 
in new quitters, but it decreases as the time since quitting increases. 
Another meta-analysis also explored the association between smoking and MetS 
risk142. After analyzed data from 13 prospective cohort studies involving 56,691 
participants, a 26% higher risk of MetS was observed in active smokers. In the dose 
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response analysis, results followed the same line as in the T2D meta-analysis. The 
risk of MetS was stronger in heavy smokers (RR: 1.42; 95%CI: 1.27-1.59) than in light 
smokers (RR: 1.10; 95%CI: 0.90-1.35). 
Different mechanisms have been proposed to explain the association between 
smoking and T2D and MetS. Tobacco consumption has been associated with IR, 
higher triglycerides and lower HDL levels. This could be partly explained by cigarette 
smoking stimulation of sympathetic nervous system and the increase of different 
hormones with insulin antagonistic activity such as cortisol and growth hormone. 
Moreover, smoking has also been associated with endothelial dysfunction143. 
3.2.2. OVERWEIGHT AND OBESITY 
Obesity is defined as an excess of body fat. In clinical practice, BMI as determined by 
weight in kilograms divided by height squared in meters, is used as a tool to identify 
overweight and obese individuals. Briefly, BMI ranging 25-29 kg/m2 indicates 
overweight and BMI ≥ 30kg/m2 indicates obesity144. It has been observed a 
worldwide increase in BMI by 0.4 kg/m2 per decade in men and 0.5kg/m2 per decade 
in women from 1980 to 2008145. Data reported from the WHO state that 
approximately 1.9 billion adults worldwide were overweight in 2014, and more than 
600 million were obese144. Nowadays, as all of the aforementioned figures 
corroborate, obesity can be considered as an epidemic condition and, importantly, it 
has important implications in the development of numerous chronic diseases, 
including T2D and MetS. 
In US adults the prevalence of T2D increased parallel to an increment in obesity 
prevalence from 1990 to 2001146. A meta-analysis including 18 prospective cohort 
studies showed that overweight and obesity were associated with a higher risk of 
T2D development. Specifically, obese and overweight participants had nearly 7-fold 
and 3-fold higher risk of T2D, respectively, in comparison with their normal weight 
counterparts147. Obesity itself can increase the risk of T2D even when other 
metabolic alterations are not present. In fact, in a recent published study, although 
those metabolically unhealthy obese presented more than 3-fold high risk of T2D 
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compared with those metabolically healthy normal weight participants, those 
metabolically healthy obese still had a higher risk of T2D (OR: 2.96;95%CI: 1.07-
8.24) followed by the metabolically unhealthy overweight (OR: 2.75; 95% CI: 1.17-
6.4) and the metabolically unhealthy normal weight individuals (OR: 1.79; 95% CI: 
0.71-4.49)148. 
Results regarding MetS risk are in the same direction. A study conducted in Finland 
showed that the risk of MetS was lower in those obese adults who were not obese in 
their childhood than those obese adults who had also been obese as children. 
Nevertheless, the risk of MetS development was lower in non-obese subjects, 
independent of the childhood obesity than those obese individuals149. In this line, a 
recent systematic review and meta-analysis has reported a higher risk of MetS in 
adults, associated with overweight or obesity in Asian and European children aged 
from birth to 6 years150. Another recent study has shown that higher baseline BMI 
was associated with a higher risk of MetS development or with a higher risk to 
develop more MetS features during aging in the PIVUS and ULSAM cohorts. 
Importantly, in the PIVUS study, the risk of MetS was also high in those individuals 
who gained weight during the follow-up151.   
Despite the fact that overweight and obesity, defined using BMI, have been 
associated with a higher risk of T2D and MetS, it is important to point out that BMI 
does not consider body fat distribution. Excessive fat accumulation within visceral 
depots may not be associated with high BMI, whereas it has been associated with 
different metabolic disturbances. As evidence from different studies suggests, 
abdominal obesity measured with waist circumference would be a better predictor 
of T2D and MetS development than BMI152–154. 
3.2.3. PHYSICAL ACTIVITY AND SEDENTARY LIFESTYLE 
In the last decades numerous changes in our life behaviors, e.g. changes of 
occupations, emergence of new technologies, accelerated pace of life in urban areas, 
have resulted in the acquisition of more sedentary work and less energy expenditure. 
Moreover, leisure-time activities have also undergone a shift from outdoor games to 
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indoor entertainment, including specially playing video games, watching television 
and using computer. 
In order to maintain general health, public health guidelines recommend at least 150 
minutes of moderate to vigorous physical activity or 75 minutes of vigorous physical 
activity per week155,156. However, some epidemiological data suggests that, 
worldwide, a 30% of adults do not meet these targets157.  
Several prospective cohort studies and clinical trials have analyzed the association 
between physical activity and the risk of T2D and MetS. In the last decade an effort 
to summarize the evidence between physical activity and the risk of T2D have 
resulted in the publication of 3 meta-analyses158–160. All of them agreed that high 
levels of total physical activity or leisure-time physical activity (including activities 
such as sport, exercise or recreational activity excluding occupational activity) are 
associated with a lower risk of T2D development when compared with low-levels of 
physical activity158,159. Regarding the type of physical activity, results showed that 
not only vigorous activity (RR: 0.61; 95%CI 0.51–0.74) was associated with a lower 
risk of T2D incidence, but also moderate activity (RR: 0.68; 95%CI 0.52–0.90), low 
intensity activity (RR: 0.66; 95%CI 0.47–0.94) and walking (RR: 0.85; 95%CI 0.79–
0.91) when high versus low activity categories were compared in each physical 
activity type160. Another meta-analysis including 17 prospective cohort studies with 
more than 64,000 individuals and 11,271 new cases of MetS showed a 20% lower 
risk of MetS development when compared high versus low levels of leisure time 
physical activity. The protection was weakly when moderate versus low levels were 
compared (RR:0.95; 95%CI 0.91-1.00)161. 
Therefore, all these findings points physical activity as one of the main modifiable 
risk factors associated with the risk of T2D and MetS development. Strategies 
focused on incrementing the time devoted to physical activity are needed in order to 
prevent greater incidence rates of both diseases.  
UNIVERSITAT ROVIRA I VIRGILI 
DIETARY FACTORS ASSOCIATED WITH METABOLIC SYNDROME AND TYPE 2 DIABETES RISK 
Nerea Becerra Tomás 
3.2.4. DIET 
In the last decades, important changes in dietary patterns have been observed, 
mainly due to the globalization process. As a result of this phenomenon, also known 
as nutritional transition, an impairment of the nutritional and health status of the 
general population has been detected. Some of the important observed changes 
across the globe includes an increase in the consumption of sugar, salt, highly 
processed grains and animal food sources, whereas the consumption of legumes, 
vegetables and fruits has been reduced162,163. These patterns usually are 
accompanied by long time spent in sedentary behaviors. The combination of both 
diet and physical inactivity have largely promoted the so-called non-communicable 
diseases, such as T2D, hypertension, MetS, obesity and cancer. 
There is increasing scientific evidence that supports the important role of nutrition 
on population health, showing both positive and negative effects. The importance lies 
in the fact that diet not only influence current health, but can also help preventing 
multiple diseases, including T2D and MetS164,165. As a consequence, diet is considered 
as an important modifiable risk factor.  
In 2002, the joint WHO/FAO expert consultation on diet, nutrition and the 
prevention of chronic diseases took place in Geneva. The main objective was to 
review and update international recommendations on diet, nutrition and the 
prevention of chronic diseases. Different nutrient intake goals were derived in order 
to establish scientific basis to develop and implement strategies to improve 
population health. Hereby, this consultation highlights again the importance that diet 
plays in the preservation of the overall health166.  
Although data from epidemiological studies have shown shifting in dietary patterns 
associated with an increased development of chronic diseases, results of a recent 
study invite us to be optimistic. After analyze trends in dietary quality of individuals 
from 187 countries between 1990-2010, a consumption improved of healthy items 
was observed, whereas the consumption of unhealthy items worsened across the 
globe167. These results suggest that international, national and regional strategies 
focused on diet changes are effective.  
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In conclusion, diet plays an important role in the prevention of several chronic 
diseases including T2D and MetS. In the next section of the present doctoral thesis, 
the scientific evidence regarding nutrients, foods, and dietary patterns associated 
with T2D and MetS risk will be described in more detail. 
4. Dietary components affecting metabolic syndrome 
and type 2 diabetes  
This section comprises an extended literature review on T2D and MetS risk factors 
related to dietary components. All these factors have been associated to an increased 
or decreased risk of T2D and MetS development and it can be modified by intensive 
lifestyle changes. 
4.1 NUTRIENTS 
4.1.1 MACRONUTRIENTS 
From a traditional point of view, science has been focused on the total amount of 
macronutrients consumed (carbohydrates, proteins and fats) and their associations 
with T2D and MetS risk. Nevertheless, recent evidence has shown different effects 
on the risk of both metabolic conditions depending on the type of macronutrient 
consumed, suggesting that the quality itself would be more important than the 
quantity consumed.  
4.1.1.1 CARBOHYDRATES 
Carbohydrates are the dietary components that have the highest influence on 
postprandial blood glucose, as they rise considerably glucose levels with the 
consequence stimulation of insulin release. As has been discussed throughout the 
present doctoral thesis, sustained hyperglycemia for long time has detrimental 
effects on human health, thus leading to an increased risk of T2D and MetS 
development. Therefore, different studies aimed to analyze whether higher amounts 
of carbohydrates consumption predispose individuals to develop T2D and MetS. 
Some controversy surrounds in this field, especially because the metabolic effects of 
carbohydrates consumption not only depend on their quantity but also on their 
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quality. In this regard, it has been shown that the increase of blood glucose levels 
after a certain amount of carbohydrates consumption depends on the food sources. 
From this observation appeared as the so-called glycemic index 168. This concept is 
defined as the incremental area under the blood glucose response curve after the 
ingestion of 50g of carbohydrates of a test food expressed as a % of the response 
obtained after the ingestion of 50gr of glucose or bread in the same subject. Glycemic 
index is a characteristic of the food and it is considered a valid marker of 
carbohydrate quality169. This index only takes into account the type of carbohydrates 
of the food based on an equal amount of available carbohydrate, and therefore, not 
the total quantity of carbohydrates consumed. Because the amounts of total available 
carbohydrates can vary in a food or in the overall diet, another concept, the glycemic 
load, was developed in order to easily overcome this issue. The glycemic load is 
calculated as the product of glycemic index and the total available carbohydrates in 
a given amounts of foods170. Since the development of both concepts, a grown body 
of evidence has been published in relation of its association with T2D and MetS risk. 
However, its utility and validity have been extensively criticized, arguing that the 
total whole grain and fiber content are best markers of carbohydrate quality. 
Carbohydrates and T2D 
Some evidence supports the notion that high amounts of carbohydrate consumption 
increase the risk of T2D171–174. However, other studies could not observe any 
significant association between high amounts of total carbohydrates consumption 
and T2D incidence170,175,176. In 2012 a meta-analysis evaluating the association 
between different macronutrients intake and the risk of T2D observed a positive 
association between total carbohydrate consumption and the risk of development 
this disease173. Nevertheless, authors did not analyze the dose-response relationship. 
One year later, this issue was addressed in another meta-analysis177 where non-
linear association was observed between total carbohydrate consumption and the 
risk of T2D. Recently, a meta-analysis of observational studies reported no 
differences in the risk of T2D between those participants adhering to a high-
carbohydrate diet compared to those following a low-carbohydrate diet in the long 
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term.178. The combined results of these meta-analyses reinforce the fact that further 
research is needed in this field in order to clarify the role of total carbohydrate 
consumption on the risk of T2D. 
Prospective studies evaluating the association between carbohydrate quality and the 
risk of T2D development have also yielded inconsistent results. Although some of 
them observed a direct association between glycemic index, glycemic load and 
T2D170–172,176,179,180, others did not observe any significant association 175,181–183. 
However, whereas data for the relation between carbohydrates quality and risk of 
T2D from prospective studies has been mixed, results coming from meta-analyses 
are more consistent. All the meta-analyses published up to date suggested that diets 
with a high glycemic index or a high glycemic load were associated with an increased 
risk of T2D development177,180,184. The most recent showed a 19% higher risk of T2D 
in those individuals in the highest category of glycemic index and a 13% in those 
participants in the top category of glycemic load, compared to their counterparts in 
the lowest category180. 
Taking into account all discussed above, it seems that quality rather than quantity of 
carbohydrate consumption maybe associated with the risk of development T2D. 
Carbohydrates and MetS 
Limited evidence exists regarding carbohydrates quantity and quality consumption 
and the risk of MetS. The vast majority of studies presented a cross-sectional design 
and showed inconsistent results. Three studies, all conducted in Korea, observed a 
higher increase of MetS prevalence with increased total carbohydrate 
consumption185–187. Conversely, a non-significant association was observed in a 
study conducted in Massachusetts188. In terms of carbohydrate quality, a similar 
situation exists. While three studies did not observe any association between the 
glycemic index and/or the glycemic load of the diet and the prevalence of the 
MetS186,188,189, others observed an inverse significant association185,190,191. However, 
it is important to highlight that cross-sectional studies do not allow establishing 
cause-effect associations. To date, only one prospective study, conducted in the 
framework of the PREDIMED (PREvención con DIeta MEDiterránea) study, has 
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analyzed the association between glycemic index, glycemic load and the risk of MetS 
development. After a mean of 4.8 years of follow-up an increase in glycemic index 
was associated with a 3% higher risk of MetS development in those individuals aged 
65-74. No association was observed for the youngest and oldest age groups. 
Similarly, changes in glycemic load were only associated with a higher risk of MetS 
incidence in the middle age category (HR: 1.005; 95% CI: 1.002–1.009)192.  
Further studies are required in order to clarify the effect, if any, of carbohydrate 
quality and quantity and the risk of MetS.  
4.1.1.2 PROTEINS 
In recent years, protein-rich diets have become trendy for the treatment of obesity. 
Because obesity is one of the main modifiable risk factors for MetS and T2D, it has 
been hypothesized that a high protein consumption may also have a beneficial role 
in the prevention of both diseases. However, it is important to point out that most of 
clinical trials have evaluated the effect of high-protein diets, compared to low-
protein diets, on weight loss and metabolic disturbances in the short-term193,194 and 
these benefits seems to be not apparent in long-term trials193,195.   
Proteins and T2D 
Several prospective studies have observed a direct association between high-protein 
diets and the risk of T2D development196–201. However, some did not find any 
significant association174,202. Similar to the observations with carbohydrate 
consumption, strong evidence suggests that different protein sources have different 
impact on T2D incidence. While animal protein consumption has been associated 
with a higher risk174,196,197,199,201, a null174,196,197,201 or even an inverse association199 
has been observed with vegetable protein intake . 
In 2016, a meta-analysis of 11 prospective studies showed a modest inverse 
association between total protein consumption and the risk of T2D (HR: 1.09; 95%CI: 
1.06-1.13). In the same line, animal protein consumption was associated with a 19% 
increased risk of T2D (HR:1.19;95%CI: 1.11-1.28), whereas plant protein intake was 
not associated (HR:0.95;95%CI:0.89-1.02)201. Guo-Chong et al, attempted to 
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characterize the shape of the association regarding animal protein consumption and 
re-analyzed data from the aforementioned meta-analysis. A nonlinear relation 
between animal protein consumption and the risk of T2D was observed. Results 
showed that dietary animal protein was only associated with an increased risk when 
the percentage of energy from animal protein was up to 12%203. 
Proteins and MetS 
Several studies have analyzed the association between protein consumption and the 
incidence of different components of the MetS, such as blood pressure, HDL-c and 
triglycerides, showing a beneficial effect for plant-sourced proteins compared to 
animal-sourced proteins204. However, limited evidence is available on the 
association between protein consumption and the risk of MetS as an entity. A cross-
sectional study conducted in more than 38,000 adults observed a significant inverse 
association between total protein intake and MetS prevalence187. Similar results 
were observed only for vegetable protein consumption in another cross-sectional 
study including 149 individuals, whereas animal proteins intake was not 
associated205. To date, only one prospective study has evaluated the effect of protein 
consumption on the risk of MetS development. After a mean of 11.3 years of follow-
up, participants in the highest quartile of total and animal proteins consumption had 
a higher risk of MetS, whereas those with a higher consumption of vegetable proteins 
presented a lower risk206.  
4.1.1.3. FATTY ACIDS 
Dietary fat, especially the type of fat consumed, has become the focus of scientific 
community attention because of the important effects that exerts on human health. 
During long time, low-fat diets have been recommended in order to prevent CVD. 
Consequently, the consumption of total fat was reduced whereas the consumption of 
total carbohydrate (independently of the quality) was increased. However, this fact 
did not decrease the incidence of chronic diseases, probably because the 
consumption of healthy fats was also reduced along with the consumption of harmful 
ones. With the emergence of large nutritional clinical trials, which have 
demonstrated that the quality of the fat content of the diet is more important that the 
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amount in the prevention of several chronic diseases207,208, a shift in this paradigm 
has been occurred. 
Previous research has focused on assessing the association between the quantity and 
quality of fats and the risk of CVD development209,210. Nevertheless, little is known 
about their role in the prevention of T2D and MetS.  
Fatty acids and T2D 
While total fat intake has not been considered a risk factor for the development of 
T2D211–213, evidence for specific types of fat remains unclear. Some studies have 
observed a reduced risk of T2D associated to a higher consumption of extra virgin 
olive oil214, which is an important food source of monounsaturated fatty acids 
(MUFAs). However, prospective cohort studies have not reported any association 
between MUFAs intake and the risk of T2D development211,212,215. Findings from 
polyunsaturated fatty acids (PUFAs) are also contradictory. Whereas some studies 
observed an increased risk with higher intakes of PUFAs215, other studies observed 
a decreased risk211 or non-association with T2D212.  PUFAs are fats seeming to have 
different effect on T2D depending on the type215. However, previous meta-analyses 
have observed non-harmful/beneficial associations between different types of 
PUFAs (ω-6 or ω-3 fatty acids and its different subtypes) and the risk of T2D173,216. It 
is important to remark that all the analyses yielded evident heterogeneity between 
studies (I-squared >50% in all of them) and the majority of the analysis included less 
than 10 studies making difficult the exploration of heterogeneity sources.  
Saturated fatty acids (SFAs) are another subtype of fat that have received especial 
attention in the last years. It has been suggested that the replacement of SFA with 
MUFAs or PUFAs has beneficial effects on insulin sensitivity217. However, a recent 
meta-analysis concluded that SFAs are not associated with the risk of T2D with the 
limitation of high heterogeneity between studies218. Different SFAs exist, according 
to the chain lengths (ranging from 6 to more than 22 carbon atoms), therefore their 
biological effects are expected to be different219. For instance, plasma 15:0 and 17:0 
SFAs, which are considered biomarkers of fat dairy consumption, have been 
associated with lower risk of T2D development220. SFAs are present in foods along 
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with other nutritional components that may modify its health effects. Moreover, SFAs 
can be found in wide range of different foods such as red meat and processed meat, 
butter, dairy products or vegetable oils, which have been associated with different 
effects on T2D risk. 
Finally, limited evidence exists for the association of trans-unsaturated fatty acids 
with the risk of T2D.  Although a recent meta-analysis observed no association 
between its consumption and the risk of T2D, only 6 studies were included in the 
analysis and, again, substantial heterogeneity was presented, which made difficult 
the interpretation of the results218. Furthermore, trans-unsaturated fatty acids are 
also a heterogeneous group of fat, which can exerts different biological effects. 
Whereas plasma levels of t-16:1n9 and t-18:1 have positively been associated with 
the risk of T2D221, circulating levels of trans-palmitoleic (produced by ruminant 
stomach bacteria and consumed mainly through dairy and meats products) have 
been associated with a lower risk218,222. 
Fatty acids and MetS 
Several studies have been conducted in order to better understand the role of 
different fatty acids on the progression of the features of the MetS, particularly blood 
pressure and plasma lipids, suggesting that more attention should be paid not only 
to the quantity but also to the quality of dietary fatty acids intake223.  
MUFAs-rich diets seems to have health attributes, as have demonstrated in different 
research. Its consumption improves lipid profile and blood pressure224. Moreover, it 
seems not affect waist circumference, as have been observed in the Health 
Professional Study. The replacement of 2% of energy from PUFAs or carbohydrates 
with MUFAs was not associated with changes in waist circumference, whereas an 
increase was observed in the replacement with trans-unsaturated fatty acids 225. 
Similarly, in the PREDIMED study a less gain in abdominal adiposity was observed in 
those individuals following a high MUFAs Mediterranean diet compare to those 
following a low-fat control diet226. PUFAs, especially ω-3 fatty acids, have a 
considerable potential to decreased the risk of MetS because its consumption has 
been associated with beneficial effects on different components, reducing 
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triglycerides227 and blood pressure levels228,229. Trans-unsaturated fatty acids seems 
to play adversely physiological effects, beyond those affecting T2D risk, impairing 
lipid profile, producing endothelial dysfunction and increasing body weight and 
visceral adiposity 230, which is one of the main underlying causes of MetS.  However, 
all these studies have been only focused in one component of the MetS, and little it is 
known about their association with the MetS as an entity. To date, few studies have 
analyzed the association between fatty acids consumption and the risk of MetS, 
which have been included relatively small samples, have been conducted in different 
populations and have shown inconsistent results. Total fat consumption has been 
associated with a higher risk of MetS prevalence in Iranian231 and Japanese Brazilian 
232 populations, but not in Spanish adults233. MUFAs consumption have not been 
associated with MetS risk231–233. Whereas some have associated SFAs with a higher 
prevalence of MetS231, others have not been observed any association233. Regarding 
PUFAs consumption, some studies232,233, but not all 231, observed a reduced risk of 
MetS prevalence with higher intakes. The only prospective study conducted to date, 
observed a lower risk of MetS development, after 20.7 months of follow-up, with 
higher intakes of vegetable fats. However, non-association between animal, SFAs, 
PUFAs or MUFAs and MetS incidence was observed234. 
4.1.2 OTHER COMPONENTS 
4.1.2.1 ANTIOXIDANT VITAMINS AND MINERALS  
It has been postulated that an excess of reactive oxygen species may play an 
important role in the pathogenesis of T2D and MetS235,236. Vitamins and minerals 
with antioxidant capacities inhibit the oxidation of other molecules and, therefore, it 
seems biological plausible that sufficient amounts of antioxidant may prevent and 
delay the development of both diseases, as it has been proposed by different 
authors237. However, the evidence in this field is limited for supporting this 
hypothesis. 
 A meta-analysis of prospective cohort studies, published in 2007, observed an 
inverse association between vitamin E, carotenoids and T2D development, whereas 
non-significant association was observed with vitamin C238. However, the meta-
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analysis included few studies ranging from 2 to 5 in each individual antioxidant 
analysis, highlighting the need for further studies to draw conclusions. On the other 
hand, in a cohort of male smokers, no association was observed between vitamin E 
and C and the risk of T2D239. In a recent study conducted in 2 different Chinese 
cohorts, an inverse association between vitamin C consumption and the risk of T2D 
has been observed, whereas the consumption of vitamin E has not been 
associated240. Similarly, in a cross-sectional study of 22.672 Korean adults, dietary 
vitamin C has been associated with a lower risk of MetS development (OR: 0.89; 
95%CI: 0.80–0.99)241. Another cross-sectional study concluded that low vitamin C 
consumption predisposed to MetS risk, while vitamin E was not associated242. Large 
and well-conducted randomized clinical trials are needed in order to clarify the role 
of antioxidant vitamins in the prevention of MetS and T2D. 
Selenium and magnesium are two essential minerals with a recognized antioxidant 
capacity. In a meta-analysis of 22 prospective cohort studies, 100mg/day increment 
of dietary magnesium consumption was associated with a 10% lower risk of T2D 
(RR:0.90; 95%CI:0.81-0.99)243. Similarly, a recent meta-analysis of 9 studies found 
an inverse association between high dietary magnesium intake and the risk of MetS 
(OR: 0.73; 95%CI: 0.62-0.86)244. The association between selenium and T2D and 
MetS remains inconclusive. The majority of studies have been focused on serum 
selenium status rather on selenium consumption. A recent study found a negative 
correlation between selenium intake and insulin resistance at intakes below 1.6 
μg/kg/day, whereas the benefit disappeared with consumption above this value 245. 
However, results from epidemiological studies evaluating its association with T2D 
suggest a detrimental effect on this disease. Cross-sectional246 and prospective247 
studies reported an increased risk of T2D in those individuals in the highest 
categories of dietary selenium intake compared with those in the lowest categories. 
Results from randomized clinical selenium supplementation trials also corroborate 
this concern. In the Nutritional Prevention of Cancer Study Group, supplementation 
of 200 μg/d was associated with a 55% higher risk of T2D development compared to 
the placebo group248. In the Selenium and Vitamin E Cancer Prevention Trial study a 
non-significant increased risk of T2D was found in those individuals with 
UNIVERSITAT ROVIRA I VIRGILI 
DIETARY FACTORS ASSOCIATED WITH METABOLIC SYNDROME AND TYPE 2 DIABETES RISK 
Nerea Becerra Tomás 
supplementation of 200 μg/d of selenium compared with the placebo group249. Only 
one study has specifically evaluated the association between dietary selenium intake 
and the risk of MetS, showing a non-significant inverse association in those 
individuals with a higher consumption compared to those with a lower intake242.  
4.1.2.2 POLYPHENOLS  
Polyphenols are organic compounds with more than one phenol ring, which come 
from secondary metabolites of plants.  The main food sources of polyphenols are 
fruits, nuts, tea, red wine, coffee, chocolate and dry legumes250. Polyphenols have 
antioxidant properties and its consumption improves some oxidative stress related 
parameters that could be linked to different diseases251. However, although in recent 
years a lot of research has been focused on health effects of dietary polyphenols, the 
true impact of these plants metabolites on T2D and MetS needs further investigation. 
Higher consumption of polyphenol has been associated with a reduced incidence of 
T2D in several studies252–254. Recently, the association between different subtypes of 
polyphenols and T2D incidence has been evaluated in the PREDIMED study255. 
Results revealed that not only total polyphenols (HRs: 0.72; 95%CI: 0.52-0.99), but 
also total flavonoids (HRs: 0.67; 95%CI: 0.48-0.93), stilbenes (HRs: 0.57; 95%CI: 
0.38-0.84), dihyroflavonols (HRs: 0.59; 95%CI: 0.40-0.88) and flavanones (HRs: 0.69; 
95%CI: 0.49-0.97) consumption was associated with a lower risk of T2D 
development. 
High amounts of polyphenols intake may also have beneficial effects on different 
MetS components256, with the corresponding possible reduction on the risk of 
suffering this syndrome. However, analysis evaluating the association between 
polyphenol and MetS are scarce and controversial. In a cross-sectional study 
conducted in Iranian adults, only flavonoids consumption was associated with a 
lower risk of MetS prevalence, whereas total polyphenols, phenolic acid, stilbenes 
and lignans were not associated257. Contrary, in Polish adults, total polyphenols 
intake was inversely associated with a lower risk of MetS prevalence. In the subgroup 
analysis, only phenolic acids intake was associated with the MetS risk258. 
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4.2. FOOD GROUPS 
4.2.1. FRUITS AND VEGETABLES 
The consumption of high amounts of fruits and vegetables is a main characteristic of 
the most of healthy diets, such as the Mediterranean diet, vegetarian diet or DASH 
diet. This food group contains sizeable amounts of fiber, vitamins with antioxidant 
capacity (vitamin C, E), minerals (mainly potassium and magnesium) and 
polyphenols, such as flavonoids. This nutritional value may explain the protective 
effects that have been attributed to fruits and vegetables consumption. It seems that 
their capacity to reduce antioxidant stress and inflammation259, to lower blood 
pressure260 and to prevent weight gain and the risk of adiposity261 would be the 
major contributors to its healthy effects. However, their association with the risk of 
T2D and MetS it is not totally clear. 
Up to date, several prospective cohort studies have been published in relation to 
fruits and vegetables consumption and the risk of T2D incidence, which is reflected 
in the publication of several meta-analyses in this field238,262–264. In the most recent 
meta-analysis, neither fruit nor vegetable consumption was associated with the risk 
of T2D265. However, a non-linear dose response association was observed, with a 9% 
reduced risk with increasing intake up to 300gr/day of vegetables and a 10% lower 
risk increasing intake of fruits up to 200-300gr/day. The increase of the intake above 
these values showed no benefit on T2D risk.  
The evidence regarding fruits and vegetables consumption and the risk of MetS is 
scarce. Results from epidemiological studies also shown a trend toward to a lower 
risk of MetS with higher consumption of fruits and vegetables, but results are still 
inconsistent266–268. In fact, a meta-analysis of eight randomized clinical trials 
revealed that fruits and vegetables consumption reduced diastolic blood pressure, 
but had non-effect on other MetS components, such as fasting glucose, HDL-cl, waist 
circumference or triglycerides levels in individuals with MetS260. 
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4.2.2. LEGUMES 
Legumes are a food group rich in plant proteins, fiber, vitamins, minerals and 
polyphenols269. Moreover, are considered as a low glycemic index food270. This 
nutritional composition confers legumes excellent properties to improve 
cardiometabolic health. Indeed, its consumption has been associated with lower 
systolic blood pressure, body weight, fasting glucose, LDL-clevels and glycosylated 
blood proteins271. Therefore, taking into consideration these beneficial health effects, 
it would be expected that legumes intake protects against T2D and MetS. However, 
evidence to date does not support this notion, and the scarcity of epidemiological 
studies (especially regarding non-soy legumes consumption) highlight the need of 
further research in this field. 
The majority of studies published so far have analyzed the association between soy-
legumes and the risk of T2D, being scarce the studies focused on non-soy legumes 
consumption, which could exert different effects on T2D risk due to their differences 
in nutritional composition272. Five previous prospective studies have analyzed the 
association between non-soy legumes and the risk of T2D showing inconsistent 
results. Whereas some of them did not show any significant association between 
legume consumption and T2D incidence175,198,273, others have shown a reduced274 or 
an increased risk of T2D development275. 
Few studies have analyzed the association between legumes consumption and the 
risk of MetS. In a case-control study, individuals in the highest quartile of legumes 
consumption had lower odds of having MetS compared to those in the lowest 
quartile276. Studies that reported results stratified by sex, showed inconsistencies 
between them. In the Isfahan Healthy Heart Program study, compared to non-
consumption, the intake of ≥3 servings/week was associated with a lower risk MetS 
prevalence in women, but not in men277. Contrary, in the DR's EXTRA Study, the 
consumption of 10g/day of legumes plus nuts was associated with a lower risk of 
MetS prevalence in men, but not in women278.  
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4.2.3. CEREALS 
Cereals can be divided in two groups: refined or whole grains. The main difference 
between both types remains in the preservation of the bran and germ in whole 
grains279. The majority of nutrients and phytochemicals are present in the out part 
of the grain; therefore, during the refined process there is a reduction in the nutrient 
content. As consequence, whole grains contain more fiber, starch, protein, vitamins 
and minerals than refined grains279.  Due to these differences in the nutritional 
composition, whole and refined grains may play a different role in human health. 
Whereas refined grains are associated with a higher risk of developing chronic 
diseases, whole-grains seems to be protective280,281. Based on this, dietary guidelines 
recommend the consumption of whole grains as a part of healthy diets.  
In 2013, the Food and Drug Administration (FDA) concluded that limited scientific 
evidence existed for qualified a health claim for whole grains and T2D risk282. 
However, in 2015 a systematic review and meta-analysis, of 8 observational studies 
including 316,051 participants, reported that consuming 3 servings/day of whole 
grain foods would reduce the risk of T2D by a 20% compared to consuming a half 
serving/day283. More recently, another meta-analysis that included 13 studies with 
29,633 T2D cases, revealed a non-linear dose response relationship between whole 
grains consumption and the risk of T2D. More specifically, increasing the 
consumption up to 50g/day was associated with a 25% lower risk of T2D. However, 
small benefits were observed when its consumption was increase above this amount. 
It is important to note that non-significant association was observed between refined 
grains consumption and T2D risk265. 
Although dietary recommendations based on increasing the consumption of whole 
grains are generally accepted, the fact is that few studies have focused on evaluating 
the physiological effects of a diet high in whole grains on MetS. The Framingham 
Offspring Cohort reported lower odds (ORs: 0.67; 95%CI: 0.48-0.91) in those 
individuals in the highest quintile of whole grain consumption compared to those in 
the first quintile. Refined grains were not associated with the risk of MetS 
prevalence188. In the Tehran Lipids and Glucose Study, whole grains consumption 
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was also associated with a lower risk of MetS prevalence (ORs: 0.68; 95%CI: 0.60-
0.78 for highest vs. lowest quartile). Nevertheless, the consumption of refined grains 
was associated with a higher risk (ORs: 2.25; 95%CI: 1.80-2.84 for highest vs. lowest 
quartile)284. 
4.2.4. VEGETABLE OILS 
Vegetable oils can be obtained from different food sources, such as oilseeds 
(sunflower), nuts (almond, walnuts), legumes (soybean), or the flesh of fruits 
(olives). The composition of fatty acids can vary widely from one to another one. 
Although vegetable oils contain different fatty acids, always one type predominates 
over the others. For instance, the main fatty acids in olive oil are MUFAs (oleic acid), 
whereas in sunflower are PUFAs (linoleic acid) and in palm oils are SFAs (palmitic 
acid)285. The presence of fatty acids along with other minor components with 
bioactive properties (plant sterols and antioxidant vitamins) determines the 
physiological effects of vegetable oils. 
There is a big gap in current scientific knowledge on the association between 
vegetable oils per se and the risk of T2D and MetS. The majority of studies have been 
focused only on the main fatty acids effects on human health, rather than vegetable 
oils as a whole. For instance, unhealthy effects have been attributed to palm oil 
because of its high content in SFAs, mainly palmitic acid286. Therefore, it seems that 
not all vegetable oils have the same metabolically effects. A review concluded that 
high-oleic acid soybean oil consumption might improve plasma lipids when replaces 
fats and oils high in SFAs or TFAs. Moreover, authors also suggested favorable effects 
on CHD risk factors when diets high in SFAs or trans-unsaturated fatty acids are 
replaced by high-oleic acid soybean oil or vegetable oils with high PUFAs content 
(sunflower, soybean or corn oil)287. Vegetable oils are a complex alimentary matrix 
and fatty acids are only one of its components. Therefore, its effects on human health 
cannot be attributed only to their fatty acid composition. Further research is needed 
in this field in order to better understand the role that vegetable oils can play in T2D 
and MetS. 
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One of the most studied vegetable oils, maybe because is one of the major 
components of the Mediterranean diet, is olive oil. A meta-analysis of 5 prospective 
cohort studies observed a lower risk of T2D incidence when highest versus lowest 
categories of olive oil consumption were compared (RRs: 0.84; 95%CI: 0.77-0.92). 
The dose-response meta-analysis showed a 9% reduced risk for each 10g/day 
increase in olive oil consumption. However, authors reported a non-linear 
relationship. No benefits of intakes above 15-20g/day were observed214. Although 
non previous studies have directly analyze the association of olive oil consumption 
and the risk of MetS, it seems that its intake could lower the risk of suffer the 
syndrome, beyond those beneficial effects on T2D, through benefits on blood 
pressure288, plasma lipids levels and oxidative damage289. 
4.2.5. NUTS 
Nuts are considered as energy-dense food due to its low water and high fatty acids 
content. Nevertheless, they are rich in many other healthy nutrients such as 
unsaturated fatty acids, minerals, vitamins, phytosterols and polyphenols that have 
been related with an improve in human health290. For instance, nuts intake has been 
associated with benefits in lipid profile (in a dose-related manner)291, 
inflammation292 and blood pressure293. However, the effect of nuts consumption on 
T2D and MetS remains inconclusive. 
A recent meta-analysis that included eight studies with 27,016 cases of T2D 
concluded that nuts consumption is not associated with T2D risk (RRs: 0.95; 95%CI: 
0.85-1.05 for highest versus lowest categories of nuts intake). It is important no point 
out that in the subgroup analysis, an inverse association was observed in those 
studies conducted in Asian population and those with a short-term follow-up265. 
Another meta-analysis that included 49 randomized clinical trials concluded that 
tree nuts consumption produces a modest diminution in triglycerides and fasting 
blood glucose levels, while does not affect other MetS components294. Besides, nuts 
consumption has been associated to a lower risk of MetS prevalence in the 
PREDIMED study 295 and NHANES (National Health and Nutrition Examination 
Survey) study296. Similarly, in the SUN (Seguimiento Universidad de Navarra) study, 
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a lower incidence of MetS was observed in those individuals with a higher 
consumption compared to those with a lower intake297. However, a review focused 
on nuts in the prevention and treatment of MetS suggested that large clinical trials 
are needed to clarify the role of nuts on this condition298. 
4.2.6. FISH 
Fish is an important food source of unsaturated fatty acids (mainly ω-3 fatty acids), 
proteins, selenium and vitamin D, which could contribute to its positive benefits on 
human health299.  
In the last decades, several prospective studies have evaluated the association 
between fish intake and T2D risk, but findings were conflicting. A recent meta-
analysis of 16 prospective studies and 45,029 T2D cases, reported a non-significant 
association between highest versus lowest fish consumption categories (RRs: 1.04; 
95%CI: 0.95-1.13) with a high heterogeneity between studies (I2=76%)265. 
In 2014, a systematic review suggested that fish intake may play an important role 
in MetS prevention. Of the seven included studies, four studies (3 cross-sectional and 
1 prospective) observed an inverse association between fish consumption and MetS 
risk300. Recently, in the Tromsø Study 4, consumption of one serving/week of lean 
fish has been associated with decreased triglycerides and increased high-density 
lipoprotein HDL-c levels, whereas fatty fish has positively been associated with 
increased waist circumference in both sexes301.  
Further studies are required to explore the ability of fish consumption on MetS and 
T2D risk, especially because high heterogeneity have been observed in those studies 
published up to date in relation to T2D and few studies have assessed the association 
between fish intake and MetS risk as a whole. 
4.2.7. RED MEAT AND PROCESSED MEAT 
Meat is a food group with a high nutritional value due to its protein, minerals and 
vitamin (mainly B12) content. However, despite this nutritional characteristics, 
several studies have argue that plausible mechanisms exist linking its consumption, 
especially regarding red meat and processed meat, with the risk of different chronic 
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diseases302. This harmful effects could be attributed to its high SFAs, sodium, iron and 
nitrate content. It is important to point out that fat content of meats varies depending 
on the animal species303, as well as sodium and nitrite and nitrate content, which are 
higher in processed than unprocessed red meat304. Therefore, it is expected that 
different types of meat exert different health effects. 
A meta-analysis that included 15 prospective studies with 45,702 T2D cases 
observed a positive association between red meat consumption and the risk of T2D 
(RRs: 1.21; 95%CI: 1.13-1.30 for high versus low categories of red meat 
consumption). Similarly, a 27% higher risk of T2D was observed in those individuals 
in the highest category compared to those in the lowest category of processed meat 
consumption (RRs: 1.27; 95%CI: 1.20-1.35) after analyze 14 prospective cohort 
studies. In both cases a high heterogeneity was observed (I2>55%)265. 
Red meat and processed meat consumption has also been associated with other 
components of the MetS such as hypertension305,306 and abdominal obesity307. 
However, limited evidence exists in relation to its association with MetS risk and, 
importantly, findings from published studies so far are inconsistent. Whereas some 
prospective studies observed a positive association between red meat consumption 
and the risk of MetS incidence308,309, others did not observed any association310. 
Besides, few studies have analyzed the association between poultry consumption 
and the risk of MetS310,311, showing a non-significant association. Hence, these results 
suggest that meat from different animal species could exert different effects on MetS 
risk. 
4.2.8. DAIRY PRODUCTS 
Until recently, dairy products have been considered to be harmful to health because 
of its high fat content, especially in SFAs. However, recent evidence suggested that 
not all SFAs have the same health effects, as has been discussed in the macronutrient 
section of the present doctoral thesis. Moreover, dairy products are also good 
sources of vitamin D, calcium, magnesium and potassium. Therefore, this unique 
nutrient package could explain the beneficial health effects that have been associated 
with dairy products consumption in recent years312. 
UNIVERSITAT ROVIRA I VIRGILI 
DIETARY FACTORS ASSOCIATED WITH METABOLIC SYNDROME AND TYPE 2 DIABETES RISK 
Nerea Becerra Tomás 
Different meta-analyses have been published up to date evaluating the association 
between dairy products consumption and the risk of T2D265,313–315. The last dose-
response meta-analysis that analyzed the association between total dairy products, 
different subtypes and the risk of T2D development, included 22 cohort studies and 
579,832 individuals. Results revealed a lower risk of T2D per each 200g/day 
increment of total dairy consumption (RR: 0.97; 95%CI: 0.95-1.00). Yogurt and ice-
cream intake showed a non-linear association with T2D risk (RRs: 0.86; 95%CI: 0.83-
0.90 for 80g/day compared to 0g/day and RRs: 0.81; 95%CI: 0.78-0.85 for 10g/day 
compared to 0g/day, respectively). However, no incremental benefits were found at 
higher intakes. The other types of dairy products (low-fat products, high-fat 
products, milk and cheese) were not associated with T2D risk313. 
A meta-analysis of observational studies analyzed the association between dairy 
consumption and the risk of MetS. The final analyses included 15 cross-sectional 
studies, one case-control study and 7 cohort studies. Results revealed an inverse 
association between higher dairy consumption and the risk of MetS in the cross-
sectional/case-cohort studies (ORs: 0.83; 95%CI: 0.73-0.94) and prospective cohort 
studies (RRs: 0.86; 95%CI: 0.79-0.92) analyses316. However, the meta-analysis only 
evaluated the association between total dairy products consumption and did not 
report results from different dairy subtypes, which seems to have different effects on 
MetS risk depending on the type consumed317,318.  
4.2.9. ALCOHOL 
Alcohol consumption is thought to play an important role in T2D and MetS 
development. Evidence evaluating the association between alcohol consumption and 
both conditions is inconsistent and controversial, with results suggesting protective, 
detrimental or J-shape associations.  In the last years, different meta-analyses have 
attempted to solve these discrepancies. In a meta-analysis that included 38 studies 
with 1,902,605 participants and 125,926 cases of T2D, a lower risk of T2D was 
observed at alcohol intake levels <63g/day, with increasing risk above this threshold 
compared to abstainers. The highest risk reduction (18%) was observed in 
consumptions ranging 10-14g/day. The stratification analyses showed that the 
UNIVERSITAT ROVIRA I VIRGILI 
DIETARY FACTORS ASSOCIATED WITH METABOLIC SYNDROME AND TYPE 2 DIABETES RISK 
Nerea Becerra Tomás 
reduction risk may be specific only to women319. Similar results have been observed 
in another meta-analysis that has evaluated the association between alcohol 
consumption and the risk of MetS development. After including in the analyses 6 
prospective studies involving 28,862 participants and 3,305 cases of MetS, a lower 
risk of MetS was observed in light drinkers compared with non-drinkers (RRs:0.86; 
95%CI:0.75-0.99). Nevertheless, heavy drinkers showed a higher risk of MetS 
compared with non-drinkers (RRs: 1.84; 95%CI: 1.34-2.52)320.  
The results of these meta-analyses reinforce the fact that a J-shape association exists 
between alcohol consumption and T2D and MetS. 
4.3. DIETARY PATTERNS 
In the last decades, an alternative and complementary approach, the dietary pattern 
analysis, has gained strength to the detriment of the reductionist approach 
emphasizing the role of isolated nutrients or food groups on health. This new 
approach takes into account the synergy between nutrients and foods, which are 
consumed combined. The dietary approach is important not only because allows us 
to remove the confounding effects attributed to the interaction of one nutrient with 
another, but also because it facilities the interpretation of overall dietary patterns 
from a public point of view and it is easy to translate to diets321. However, it is 
important to highlight that it is crucial to explore the role of nutrients and food 
groups on health in order to establish dietary patterns and to better understand their 
possible beneficial or detrimental effects on health. 
As consequence of several analyses, different dietary patterns have been identified 
and different health effects have been attributed to each one. 
4.3.1. MEDITERRANEAN DIET 
The Mediterranean diet (MedDiet) is characterized by a higher consumption of 
vegetables, fruits, legumes, whole grains, nuts, olive oil and fish alongside with a 
moderate consumption of dairy products and wine and a low intake of red and 
processed red meats322. MedDiet differs from other healthy dietary patterns due to 
the presence of high amounts of olive oil, nuts, sauces with tomato basis, onions, 
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garlic and spices, and the consumption of moderate wine323. It has been suggested 
that the synergetic effect of different bioactive components of the MedDiet in 
conjunction with the abundance of healthy foods, beneficially influence several 
metabolic pathways that causes T2D and MetS323.  
A meta-analysis of 6 prospective cohort studies showed a 13% lower risk of T2D 
development when highest versus lowest categories of adherence to MedDiet were 
compared, showing a low heterogeneity between studies (I2=26%)324. In the same 
line, a meta-analysis including 8 cross-sectional and 4 prospective cohort studies 
showed a 19% lower risk of MetS in those individuals with a higher adherence to the 
MedDiet (RR: 0.81, 95%CI: 0.71-0.92). When the evaluation was focused on the 
individual components of the MetS, an inverse association was observed between 
MedDiet and waist circumference, blood pressure and low HDL-c levels325. 
Few randomized clinical trials have analyzed the effect of the MedDiet in the 
prevention of T2D and MetS. Results from the PREDIMED study demonstrated for 
the first time that, after a mean follow-up of 4.1 years, participants following a 
MedDiet enriched with extra virgin olive oil or nuts  had a 40% and 18% lower risk 
of T2D incidence, respectively, compared with those individuals that followed a low-
fat control diet326. The PREDIMED study did not demonstrate that a MedDiet reduces 
the risk of MetS development compared with the low-fat control group. However, 
participants in either MedDiet enriched with extra virgin oil or nuts were more likely 
to reverse the MetS during 4.8 years of follow-up (HRs: 1.35; 95%CI: 1.15-1.58 and 
HRs: 1.28; 95%CI: 1.08-1.51, for olive oil versus control group and nuts versus 
control group, respectively)327. 
4.3.2. PLANT-BASED DIETARY PATTERN 
Plant-based diets, also widely known as vegetarian diets, are defined by the absence 
of meat products, seafood or products containing those foods. To date, different 
alternative/variations exist, such as the lacto-vegetarian diets (that consider the 
inclusion of dairy products) or the lacto-ovo-vegetarian diets (that not only consider 
the inclusion of dairy products, but also eggs). As a consequence, this dietary pattern 
is characterized by the consumption of high amounts of vegetables, fruits, legumes, 
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nuts and grains. Therefore, it is not surprising that the adoption of plant-based diets 
have been associated with a lower incidence of chronic diseases328. 
In the Adventist Health Study-2, vegans, lacto-ovo-vegetarians, and semi-vegetarians 
participants had a 62%, 38% and 51% lower risk of T2D, respectively, compared to 
those non-vegetarian individuals329.  
A recent meta-analysis including 2 prospective cohort and 12 cross-sectional studies, 
evaluated the association between vegetarian diets and the risk of T2D. The results 
showed an inverse significant association between vegetarian diets and the 
incidence/prevalence of T2D (ORs: 0.73; 95%CI: 0.61-0.87) compared to the 
omnivorous diets330. According to a systematic review, eight previous observational 
studies have evaluated the association between vegetarian or vegan diets and the 
risk of MetS. Of them, only four reported a beneficial effect of vegetarian diets on 
MetS risk, whereas three did not observe any association. Only one of them reported 
a lower risk of having MetS in those participants following an omnivorous diet 
compared to those following a vegan diet331. This review highlighted that no 
randomized clinical trials have been conducted up to date evaluating the effect of 
plant-based diets on the risk of MetS development. 
 4.3.3. DIETARY APPROACHES TO STOP HYPERTENSION (DASH) DIET 
The DASH diet is characterized by a high consumption of fruits, vegetables, whole 
grains and low-fat dairy products along with a sodium restriction. This dietary 
pattern was originally developed in order to prevent hypertension332. Nowadays, 
due to its different healthy effects, it is widely recommended as a healthy dietary 
pattern. Because of its food composition, the DASH diet is rich in dietary fiber, 
unsaturated fatty acids and antioxidant components.  
A meta-analysis of controlled trials reported beneficial effects of DASH diet reducing 
fasting insulin concentration (mean difference −0.16; 95% CI, −0.23 to −0.08). 
However, non- beneficial effects on fasting blood glucose or HOMA-IR was 
observed333. Another meta-analysis, including 6 studies, has observed a reduced risk 
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of T2D (RRs: 0.82; 95%CI: 0.74-0.92) when highest versus lowest quantiles were 
compared324.  
Few studies have analyzed the association between DASH diet and MetS. Cross-
sectionally, higher adherence to DASH diet has been associated with a lower 
prevalence of MetS in Brazilian334 and Isfahan population335. Although no previous 
clinical trials have evaluated the effect of DASH diet on the prevention of MetS, a 
randomized controlled trial conducted in 116 patients with MetS, demonstrated that 
DASH diet with caloric restriction increases HDL-c levels, decreases triglycerides, 
systolic and diastolic blood pressure, as well as reduces fasting blood glucose levels 
and weight, after 6 months of intervention compared to a control diet336. 
4.3.4. WESTERN PATTERN 
Western type diets are mainly characterized by a high consumption of red meat and 
processed meat, refined grains, refined vegetable oils and refined sugar337. 
Moreover, this dietary pattern contains high amounts of SFAs and trans-unsaturated 
fatty acids. Contrary to the other types of dietary patterns described in this section, 
the wester pattern has been associated with a higher risk of several chronic diseases. 
A meta-analysis of prospective cohort studies analyzing the association between a 
pattern derived from exploratory factor and principal component analyses, 
resembling the western diet (characterized by a higher consumption of red and 
processed meat, refined grains, high-fat dairy, eggs and fried products), has shown a 
significantly positive association with T2D (RRs: 1.44;95%CI: 1.27-1.62)324. 
Studies regarding MetS present mixed results. A higher prevalence of MetS has been 
observed in Iranian female teachers338, whereas no association has been observed in 
community-dwelling older adults of Pennsylvania339 and among Korean women340. 
Prospectively, results from the ARIC study showed a higher risk of MetS incidence in 
those individuals in the highest quintile of western dietary pattern scores compared 
with those in the lowest quintile after 9 years of follow-up (HRs: 1.18; 95%CI: 1.03-
1.37)308.  
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MetS is considered a risk factor for T2D and CVD. It affects approximately a quarter 
of the adult population, increasing its prevalence rates with age. In turn, T2D is a 
major public health issue worldwide because of its high prevalence and its 
premature associated morbi-mortality. Likewise, both metabolic disorders are 
linked to a reduced quality and life expectancy. Therefore, to address this health 
problem, efficient and effective strategies focused on changes in lifestyle are critically 
required.  
It has been observed that diet plays a crucial role in the prevention and management 
of MetS and T2D. Shift in dietary patterns, characterized by adoption towards a more 
westernized diet due to the nutrition transition process, has been one of the 
responsible factors for the high prevalence of different chronic diseases, including 
MetS and T2D. Contrary, adherence to healthy dietary patterns, such as the 
Mediterranean, DASH and vegetarian diets, have been associated with lower 
incidence of these chronic age-related diseases. Current nutritional epidemiology 
has centered in analyzing dietary patterns, which describe the overall diet and take 
into account the combination and synergic effects of foods and nutrients. In order to 
understand the observed differences in disease risk among dietary patterns, it is of 
great importance to evaluate the specific role that play particular nutrients and 
foods.  
Some of the main differences between Western and plant-based dietary patterns are 
the frequency of consumption of dairy products, meat and legumes.  
Dairy consumption has been considered as harmful for health because of its high-fat 
content. However, accumulating evidence suggests that may actually protect against 
T2D. Regarding MetS, few studies have investigated its association and most of them 
have been conducted in healthy adult population without evaluating different 
subtypes of dairy products. 
Research also suggested that the consumption of meat, particularly red meat and 
processed red meat, may increase the risk of development some components of the 
MetS. However, the evidence regarding MetS as a whole entity is scarce and 
inconsistent. Previously, our research group observed a higher risk of MetS incidence 
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associated with red and processed red meat consumption in the PREDIMED Reus-
Tarragona cohort after one year of follow-up. However, this association has not been 
previously evaluated in the full cohort. 
Legumes consumption is widely recommended because of its beneficial effects on 
health, however, little it is known regarding its association with T2D risk. The 
majority of studies have been focused on evaluate the association between soy-
legumes consumption and the risk of T2D and have been conducted in Asian, 
American and north Europe populations, but not in Mediterranean populations 
where legume consumption is relatively high. 
Therefore, taking into account the big gap of knowledge regarding the consumption 
of the aforementioned foods and the risk the MetS and T2D incidence, with the 
present doctoral thesis we investigated in deeper manner the association between 
meat and dairy products consumption and the risk of MetS incidence, as well as the 
association between legume consumption and the risk of T2D using data from the 
PREDIMED trial as an observational prospective cohort. The PREDIMED study 
provides with a unique opportunity to evaluate these associations in adults at high 
CVD risk in the context of the MedDiet. 
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Hypothesis 1: A greater intake of dairy products is associated with a reduced risk of 
MetS or any of its components incidence.  
 Objective 1: To evaluate the association between total dairy products and 
its different subtypes (whole-fat dairy, low-fat dairy, yogurt, milk and 
cheese) consumption and the risk of MetS and its components incidence. 
Hypothesis 2: Higher consumption of meat, and particularly red meat and processed 
red meat, is associated with an increased risk of MetS or any of its features 
development. 
 Objective 2.1: To analyze the association between total meat and its 
different subtypes (red meat, processed meat and poultry) consumption and 
the risk of MetS and its features development. 
 Objective 2.2: To assess the replacement effects of red meat and processed 
red meat with other protein-rich foods on the risk of MetS development.   
Hypothesis 3: Higher consumption of legumes is inversely associated with the risk 
of T2D incidence. 
 Objective 3.1: To evaluate the association between total legume and its 
different subtypes consumption (lentils, chickpeas, dry beans and fresh 
peas) and the risk of T2D incidence. 
 Objective 3.2: To estimate the theoretical substitution effect of legumes for 
other protein- or carbohydrate-rich foods on the risk of T2D incidence.  
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1. PREDIMED (prevención con dieta mediterránea) 
study 
1.1. MAIN OBJECTIVES OF THE PREDIMED STUDY 
The PREDIMED study is a randomized multicenter parallel clinical trial conducted in 
Spain between 2003 and 2011 with the objective to evaluate the effectiveness of the 
MedDiet (enriched with extra virgin olive oil or nuts) in the primary prevention of 
CVD, compared to a low-fat control diet in elderly individuals at high CVD risk. 
The primary outcome comprised a composite of myocardial infarction, stroke and 
CVD mortality. Secondary endpoints included death from any cause, heart failure, 
T2D, MetS, dementia and cancer. In order to understand the role of dietary changes 
on clinical events, the study also included changes in intermediate outcomes such as 
fasting blood glucose, blood pressure, lipid profile and markers of inflammation and 
oxidation. 
The main results of the study were published in 2013 in the New England Journal 
Medicine207. 
1.2. STUDY DESIGN  
1.2.1. PARTICIPANTS SELECTION 
PREDIMED participants were recruited between October 2003 and June 2009. 
Eleven centers from 9 cities in Spain participated in the recruitment process: Sevilla, 
Málaga, Reus-Tarragona, Barcelona, Islas Baleares, Pamplona, País Vasco, Valencia 
and Gran Canaria.  
1.2.1.1. ELIGIBILITY CRITERIA 
Inclusion criteria for the PREDIMED study were as follows: men (aged 55-80 years) 
and women (aged 60-80 years) who were free from CVD at baseline (Ischemic heart 
disease including angina pectoris or heart attack; stroke and peripheral 
artheriopathy), but who were at high CVD risk. Moreover, in order to be included in 
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the study, participants had to have either T2D or at least three of the following risk 
factors: Family history of premature CVD 
 BMI ≥ 25 kg/m2 
 Current smoking (> 1 cig/day during the last month) 
 Hypertension (systolic blood pressure ≥ 140 mmHg or diastolic blood 
pressure ≥ 90 mmHg or antihypertensive medication) 
 LDL cholesterol ≥ 160 mg/dL or lipid lowering medication 
 HDL cholesterol ≤ 40 mg/dL in men or ≤ 50 mg/dL in women 
Besides, participants were excluded if they met one of the following criteria: 
 Previous history of CVD: coronary heart disease (angina, myocardial 
infarction, coronary revascularization procedures or existence of 
abnormal Q waves in the electrocardiogram, stroke (ischemic or 
hemorrhagic, including transient ischemic attacks) and peripheral artery 
disease  
 Presence of medical conditions that could impair the ability of the person 
to participate in the study or to attend visits 
 Life expectancy less than 1 year 
 Immunodeficiency or HIV-positive status 
 Illegal drug use or chronic alcoholism or total daily consumption of 50g 
of alcohol  
 BMI >40kg/m2 
 Difficulties or major inconvenience to change dietary habits 
 Impossibility to follow a Mediterranean diet due to religious reasons or 
presence of disorders that affect chewing or swallowing 
 Low predicted likelihood to change dietary habits according to 
Prochaska and Diclemente transtheoretical model (or stages of change) 
 Food allergy with hypersensitivity to any olive oil or nuts components 
 Participation in any drug trial or use of any investigational drug within 
the last year 
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Institutionalized patients for chronic care, those who lacked autonomy, 
were unable to walk, lacked a stable address or were unable to attend 
visits in the Primary Care Health Centers every 3 months 
 Illiteracy 
 Patients with an acute infection or inflammation were allowed to 
participate in the study after three months from the resolution of their 
condition 
The recruitment process started with the review of clinical records by medical 
doctors in order to extract the name of potential participants that met the eligibility 
criteria and exclude participants who met any of the exclusion criteria. After 
participants gave their consent, doctors sent to PREDIMED investigators the 
telephone number and, after a brief phone call and if they agreed, an appointment 
for a face-to face screening visit in their primary care center was scheduled. 
1.2.1.2. SCREENING VISIT 
This visit was performed at each primary care center in order to identify 
unequivocally the inclusion and exclusion criteria. At first, general characteristics 
and objectives of the study were explained and the informed consent for the trial 
participation and another for DNA collection for genetic analyses were obtained. This 
visit lasted ≈30min and encompassed an inclusion case report form and a general 
questionnaire of 26-items about medical conditions and risk factors for study 
purpose that were filled by PREDIMED investigators. Moreover, the last 
electrocardiogram available in the clinical history were revised or a new one was 
performed if the last one was not available; a validated semi-quantitative food 
frequency questionnaire (FFQ) of 137-items was administered to each participant as 
well as a validated Spanish version of the Minnesota Physical Activity questionnaire. 
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After this first screening visit, if participants met the eligibility criteria, they were 
randomized to one of the three possible intervention groups and a baseline visit was 
scheduled (see figure 6) asking to all participants to attend it after an overnight fast 
for blood extraction.  
Figure 6. Design of the PREDIMED Study 
1.2.1.3. RANDOMIZATION 
A total of 7.447 participants met the eligibility criteria and were randomized to one 
of the three possible intervention groups in a 1:1:1 rate following tables of random 
allocation according to the recruitment order in blocks of 50 participants that were 
balanced by sex and age group. These tables were centrally elaborated by a 
coordinating group (IDIBAPS), and provided a stratified random sequence of 
allocation for each field center. 
Intervention groups were as follows: 
a) Low-fat control diet following the recommendations of the American Heart 
Association 
b) Mediterranean type diet enriched with extra virgin olive oil  
c) Mediterranean type diet enriched with mixed nuts (walnuts, almonds and 
hazelnuts) 
1.2.2. INTERVENTION 
PREDIMED dietitians were the responsible for all the dietary intervention and they 
received specific training sessions before and during the trial in order to ensure a 
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good implementation of the intervention. The main aim was to promote a 
Mediterranean dietary pattern in both intervention groups of MedDiet, without 
energy restriction or modifications in the physical activity, and to promote a low-fat 
diet in the control group. The delivery for free of extra virgin olive oil and nuts to 
both intervention arms increased the compliance and the adherence to the 
intervention. Free small gifts (e.g., kitchenware, aprons or shopping bags) were also 
given to participants in the control group in order to increase their compliance. 
1.2.2.1. MEDITERRANEAN DIET GROUPS 
Participants enrolled to the MedDiet enriched with extra virgin olive oil and MedDiet 
enriched with nuts, received ≈ 1L of olive oil per week and 30g per day of mixed nuts 
(15g of walnuts, 7,5g of almonds and 7,5g of hazelnuts), respectively.  
Dietitians promoted a MedDiet giving the following specific advice to increase the 
frequency consumption of typical healthy foods of the MedDiet and to decrease the 
frequency of non-healthy foods: a) Use of extra virgin olive oil as main source of fat 
for cooking (≥ 4 tablespoon per day); b) Consumption of ≥ 2 daily servings of 
vegetables (one of them as fresh vegetables); c) Consumption of ≥ 2-3 daily servings 
of fresh fruits (including natural juices); d) Consumption of ≥ 3 servings/week of 
legumes; e) Consumption of  ≥ 3 servings/week of fish or seafood; f) Consumption of 
≥ 1 servings/week of nuts or seeds; g) Preferably consumption of poultry (without 
skin) instead of red meats or processed meat; h) Use of  ≥ 2 times/week of sofrito 
sauce (tomato, garlic and onion adding or not aromatic herbs); i) Moderate 
consumption of wine within meals (optionally, only for habitual drinkers) (≥7 
glasses/week); j) Avoid the consumption of industrial bakery products, sugar, butter, 
sugar sweetened beverages, French fries and fast food. 
A leaflet on health benefits, use and conservation of olive oil was given to those 
participants randomized to the MedDiet + extra virgin olive oil, whereas those in the 
MedDiet + nuts received a similar leaflet with information regarding nuts. 
Consumption of total fat was ad libitum as long as it was mainly from olive oil, nuts, 
vegetables and fish. A 14-item questionnaire (Table 3) was administered in order to 
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assess the adherence to the MedDiet and to personalize the intervention to achieve 
individual goals. The score ranged from 0 to 14 (high scores indicating greater 
adherence). Dietitians focused the intervention on the points that participants were 
not following. 
Table 3. 14-item questionnaire of adherence to the Mediterranean Diet 
Foods and frequency consumption Criteria for 1 point 
1. Do you use olive oil as main culinary fat? Yes 
2. How much olive oil do you consume in a given day (including 
oil use for frying, salads, out of house meals, etc.)? 
≥ 4 tablespoons 
3. How many vegetable servings do you consume per day? 
(1 serving = 200g – consider side dishes as ½ serving) 
≥ 2 (at least 1 portion 
raw or as salad) 
4. How many fruit units (including natural fruit juices) do you 
consume per day? 
≥ 3  
5. How many servings of red meat, hamburger, or meat 
products do you consume per day? (1 serving = 100-150g) 
< 1 
6. How many servings of butter, margarine, or cream do you 
consume per day? (1 serving = 12g) 
< 1 
7. How many sweet/carbonated beverages do you drink per 
day? 
< 1 
8. How much wine do you drink per week? ≥ 7 glasses 
9. How many servings of legumes do you consume per week? (1 
serving = 150) 
≥ 3  
10. How many servings of fish or shellfish do you consume per 
week? 
≥ 3  
11. How many times per week do you consume commercial 
sweets or pastries (not homemade), such as cakes, cookies, 
biscuits or custards? 
≥ 3 
12. How many servings of nuts (including peanuts) do you 
consume per week? (1 serving = 30g) 
≥ 3  
13. Do you preferentially consume chicken, turkey or rabbit 
meat instead of veal, pork, hamburger or sausage? 
Yes 
14. How many times per week do you consume vegetables, 
pasta, rice, or other dishes seasoned with sofrito (sauce made 
with tomato and onion, leek, or garlic, simmered with olive oil)? 
≥ 2  
*0 points if these criteria are not met 
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1.2.2.2. CONTROL GROUP 
Participants enrolled to the control group did not receive information about 
MedDiet. Instead, information on how to follow a low-fat control diet following the 
recommendations of the Third Report of the National Cholesterol Education 
Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood 
Cholesterol in Adults (Adults Treatment Panel III)341 was given.  
Dietitians promoted the reduction of high-fat foods consumption advising to avoid 
the intake of red meat or processed meats, sweets and pastries, fatty fish, as well as 
the use of olive oil and nuts, as long as it have high amounts of fat. On the contrary, 
dietitians encouraged the consumption of low-fat dairy products, cereals, potatoes, 
pasta, rice, fruits, vegetables and lean meats. The dietary recommendations given by 
dietitians were as follows:  
a) Consumption of ≥ 3 daily servings of low-fat dairy products 
b) Consumption of ≥ 3 daily servings of bread, potatoes, pasta and rice 
c) Consumption of ≥ 3 daily servings of fresh fruits 
d) Consumption of ≥ 2 daily servings of vegetables 
e) Consumption of ≥ 3 servings/week of lean fish and seafood 
f) Consumption of ≤ 2 daily tablespoon of vegetable oils (including olive 
oil)Consumption of ≤ 1 serving/week of commercial bakery goods, sweets 
and pastries 
g) Consumption of ≤ 1 serving/week of nuts and fried snacks 
h) Consumption of ≤ 1 serving/week of red and processed fatty meats 
i) Remove of visible fat in meats and soups 
j) Consumption of ≤ 1 serving/week of fatty fish and seafood canned in oil 
k) Consumption of ≤ 2 serving/week of sofrito 
In order to evaluate the adherence to the low-fat intervention, a 9-point score was 
used (see Table 4).  
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Table 4. 9-item questionnaire of adherence to the low-fat control diet 
Foods and frequency consumption Criteria for 1 point* 
1. How much olive oil do you consume in a given day 
(including oil used for frying, salads, out of hose meals, etc.)? 
≤ 2 tablespoons (1 
tablespoon = 10ml) 
2. Do you remove visible fat (or the skin) of chicken, duck, 
pork, lamb or veal meats before cooking and the fat of soups, 
broths and cooked meat dishes before consumption? 
Yes 
3. How many servings of fat-rich meats, hamburger, 
commercial ground meat, sausage, cold meat, cured ham, 
bacon, salami or offal do you consume per week?  
(meat serving = 100g; salami or bacon = 30g) 
≤ 1  
4. How many servings of butter, margarine, lard, mayonnaise, 
milk cream or milk-based ice-cream do you consume per 
week? 
(spread fat serving = 12g; ice-cream = 100g) 
≤ 1  
5. Do you exclusively consume low-fat dairy products? Yes (id. if no dairy 
consumption 
6. How many times per week do you prepare rice, pasta, potato 
or legume dishes by using sofrito sauce, bacon, salami or fatty 
meats such as pork or lamb ribs? 
≤ 2  
7. How many times per week do you consume fatty fish or fish 
or seafood canned in oil? 
≤ 1  
8. How many servings of commercial sweets or industrial 
bakery products (not homemade), such as cakes, cookies, 
biscuits or custard do you consume per week? 
(cake serving = 80g; 6 biscuits = 40g) 
≤ 1  
9. How many times per week do you consume nuts (including 
peanuts), potato chips, French fries or commercial snacks? 
≤ 1  
*0 points if these criteria are not met 
1.2.2.3. GROUP SESSIONS 
Every three months participants attended to group sessions, with no more than 20 
individuals, which were run by PREDIMED dietitians. These sessions were scheduled 
separated for each of the 3 intervention arms including: 
 A reminder of the 14-item MedDiet score to those participants enrolled in 
the two MedDiet groups and a reminder of the 9-item low-fat diet score for 
those randomized to the low-fat control group 
 Resolution of intervention-related problems about face-to-face counseling 
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 Delivery of written material, adapted to the season of the year, with 
description of 4-5 foods typical of the MedDiet or the low-fat diet; a 
quantitative shopping list of foods for 1-week along with a weekly plan of 
meals and cooking recipes according to the suggested menus. 
 Delivery for free of either extra virgin olive oil (15L) or nuts (1.350g) for the 
MedDiet groups or gifts such as books, dispensers of olive oil, etc, for 
participants in the control group. 
1.2.3. VARIABLES: DATA COLLECTION 
At baseline, 6 months and yearly during the follow-up, participants of all intervention 
arms attended to a face-to-face visit in their primary care centers in which different 
questionnaires were administered and several anthropometric and biochemical 
measurements were collected (see Table 5). 
Table 5. Overview of measurement scheduled in the PREDIMED study 
 Baseline 1 
year 
2 
years 
3 
years 
4 
years 
5 
years 
6 
years 
Eligibility questionnaire X       
General questionnaire X       
FFQ X X X X X X X 
Physical activity 
questionnaire 
X X X X X X X 
Follow-up questionnaire*  X X X X X X 
Tolerance questionnaire  X X X X X X 
Abandonment 
questionnaire** 
 X X X X X X 
Electrocardiogram X X X X X X X 
Blood sample X X  X  X X 
Urine Sample X X  X  X X 
Toenail Sample X       
*Includes measurements of weight, height, waist circumference, blood pressure and 
ankle-brachial blood pressure index. 
** Only if applicable. 
Abbreviations: FFQ, food frequency questionnaire 
UNIVERSITAT ROVIRA I VIRGILI 
DIETARY FACTORS ASSOCIATED WITH METABOLIC SYNDROME AND TYPE 2 DIABETES RISK 
Nerea Becerra Tomás 
1.2.3.1. QUESTIONNAIRES 
General and follow-up questionnaire: These questionnaires included different items 
related to CVD risk factors, drug treatment, medical history; family history of disease; 
smoking status; alcohol consumption (type and frequency); data on employment and 
socio-economic status; new onset of cardiovascular events; other medical conditions. 
14-item questionnaire of adherence to the MedDiet: as explained before a validated 
short questionnaire was used to assess the adherence to the MedDiet diet342.  
9-item questionnaire of adherence to the low-fat diet: as stated before a specific 
questionnaire to assess the adherence to the low-fat diet was administered to those 
participants in the control group. 
Leisure time physical activity questionnaire: a validated Spanish version of the 
Minnesota Leisure-time Physical Activity Questionnaire was administered to each 
participant. This questionnaire included information about the type and frequency 
of several physical activities during the previous month and year343.  
Food frequency questionnaire: a validated semi-quantitative FFQ of 137-items was 
administered in order to assess the dietary intake344. Participants were asked to 
report their frequency consumption, on an incremental scale (from never or almost 
never to more than six times per day) during the previous year, in a face-to-face 
interview with experimented dietitians. Nutrient and energy consumption were 
derived from these responses using Spanish food composition tables345,346. 
Tolerance and side effects questionnaire: In order to assess the side effects derived 
from the three interventions, participants completed a specific questionnaire at the 
first year of intervention and thereafter yearly.  
1.2.3.2. ANTHROPOMETRIC AND BLOOD PRESSURE MEASUREMENTS 
PREDIMED nurses were the responsible to measure blood pressure, body weight, 
height and waist circumference. 
 Blood pressure: was measured in triplicate with participants in seated 
position and after 5min rest using a validated oscillometer (Omron 
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HEM705CP, Hoofddorp, The Netherlans). The average of the three 
measurements was written in the data collection form. 
 Body weight: was measured using a calibrated balance beam scale with 
participants wearing light clothes and no shoes.  
 Height: was measured using a wall-mounted calibrated stadiometer. 
 Waist circumference: was measured using an anthropometric measuring 
tape in the midway between the lowest rib and the iliac crest. 
1.2.3.3. BIOLOGICAL SAMPLES AND BIOCHEMICAL DETERMINATIONS 
PREDIMED nurses were the responsible for the collection, processing and storage of 
all the biological samples. As indicated in Table 5, blood samples were collected at 
baseline and at years 1, 3, 5 and 6, following a standardized protocol and after an 
overnight fast. All biochemical measurements were performed blindly and in the 
same batch for consecutive samples of each participant. In the PREDIMED study 
urine sample was also collected at the time of blood extraction and stored at -80ºC.  
Moreover, in the primary care centers, a complete blood count and routine 
biochemical measurements were also performed, which included: fasting blood 
glucose, uric acid, alanine aminotransferase, aspartate aminotransferase, gamma-
glutamyltranspeptidase, total cholesterol, HDL-cholesterol and LDL-cholesterol, 
triglycerides, total protein and albumin. 
1.2.4. ASCERTAINMENT OF METABOLIC SYNDROME AND TYPE 2 DIABETES 
T2D and MetS were considered as secondary end-points in the PREDIMED study. In 
the following section, a description of the criteria used for its diagnosis is presented.  
1.2.4.1. METABOLIC SYNDROME 
For the present doctoral thesis, MetS was defined in accordance with the updated 
harmonized IDF and AHA/NHLBI criteria6. Participants were considered to have 
MetS if they had at least three of the following risk factors: a) abdominal obesity 
(≥88cm in men and ≥ 102cm in women), b) hypertriglyceridemia (≥150mg/dL) or 
drug treatment, c) low HDL-cholesterol levels (<40mg/dL in men and <50mg/dL in 
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women) or drug treatment, d) high blood pressure ( systolic blood pressure 
≥130mmHg and/or diastolic blood pressure ≥85mmHg) or drug treatment, e) high 
fasting glucose levels (≥100mg/dL) or drug treatment for diabetes. 
This criteria was used to identify both prevalent and incidence cases during the 
follow-up. 
1.2.4.2. TYPE 2 DIABETES 
Prevalent cases of T2D were determined when clinical diagnosis was reported at the 
beginning of the study and/or when participants were taking oral hypoglycemic 
drugs or insulin.   
New cases of T2D during the follow-up were diagnosed according to the criteria 
stablished by the American Diabetes Association88, namely fasting plasma glucose 
≥126mg/dL (7.0 mmol/L) in fasting conditions or ≥200mg/dL (11.1 mmol/L) after 
a 75g oral glucose load.   
Physician investigators affiliated to each recruitment center, who were blinded to 
the intervention group, reviewed yearly all medical records of the participants. When 
a new-onset T2D was identified, the information was sent to the PREDIMED Clinical 
Events Committee who was also blinded to treatment allocation. The adjudication 
committee confirmed definitely the end-point only when a second test, repeated 
within the following 3 months, verify the new T2D case. Only those cases of T2D 
confirmed between 1 October 2003 and 1 December 2010 were included in the 
analyses.  
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2. Study population for the analyses 
For the present doctoral thesis, data from the PREDIMED study was used as if it was 
an observational prospective cohort study. 
Sample for analyses considering MetS as an outcome: From all the participants 
randomized to the PREDIMED study, we selected 5801 individuals with 
biochemical determinations available for a follow-up of ≥2 years. Due to MetS 
incidence was considered as an outcome, we excluded 3707 participants with the 
syndrome at baseline. Moreover, 226 participants with lack of information 
regarding FFQ at baseline or because they reported implausible total energy 
intake (≤500 and ≥3500 kcal/d in women and ≤800 and ≥4000 kcal/d in men) 
and individuals with missing data to determine the incidence of MetS, were also 
excluded. Therefore, the final sample for these analyses included 1868 
individuals. 
Sample for analyses considering T2D as an outcome: For these analyses, 3614 
participants who had T2D at baseline, 292 with lack measures of blood glucose 
control, 98 individuals who had total energy consumption outside the pre-
specified limits described before or with missing information regarding baseline 
FFQ and 94 individuals who were not followed up, were excluded from the 
original sample enrolled to the PREDIMED study (n=7447). The final available 
biological sample for these analyses consisted in 3349 participants. 
3. Statistical analyses 
A detailed description of the statistical analyses used for this doctoral thesis is 
explained in each publication presented in the results section. Briefly, all the analyses 
were performed using the statistical software SPSS versions 19.0 and 22.0 (SPSS Inc, 
Chicago, Illinois) or Stata versions 12.1 and 14.0 (StataCorp LP). The level of 
significance for all statistical tests was set at P < 0.05 for bilateral contrast. 
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All dietetic variables (exposures and co-variables) were energy-adjusted using the 
residual method described by Walter Willet. This approach allows us to represent 
nutrient and food consumption uncorrelated with total energy intake347. An 
exception was made in the analyses of fat intake, where all macronutrients 
consumption was expressed as percentage of total energy intake. 
In order to compare baseline differences between categories of exposures, an 
ANOVA or Pearson chi-squared tests were used for continuous and categorical 
variables, respectively. 
To assess the risk (Hazard Ratio) of the different outcomes according to categories 
of exposures, a Cox regression model adjusted for several potential confounders, was 
fitted. The follow-up time was calculated as the interval between the randomization 
and the date of the diagnosis of the outcome of interest or the date of the last visit or 
death for those participants who did not develop the disease. The linear trend was 
assessed through the assignment of the median intake within each category of 
exposure and modeled it as a continuous variable.   
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Table 6 presents the list of the 3 publications included in the present doctoral 
thesis.  
Table 6. Reference, impact factor, category and journal rank of the 
publications presented in this thesis1 
Reference 
Impact 
factor 
Category 
Journal 
rank 
Babio N, Becerra-Tomás N, Martínez-
González MÁ, et al. Consumption of Yogurt, 
Low-Fat Milk, and Other Low-Fat Dairy 
Products Is Associated with Lower Risk of 
Metabolic Syndrome Incidence in an Elderly 
Mediterranean Population. J Nutr. 
2015;145(10):2308-16.  
doi:10.3945/jn.115.214593 
4.145 
Nutrition 
& 
dietetics 
Q1 
16/81 
Becerra-Tomás N, Babio N, Martínez-
González MÁ, et al. Replacing red meat and 
processed red meat for white meat, fish, 
legumes or eggs is associated with lower risk 
of incidence of metabolic syndrome. Clin 
Nutr.  
2016;35(6):1442-1449.  
doi:10.1016/j.clnu.2016.03.017 
4.548 
Nutrition 
& 
dietetics 
Q1 
9/81 
Becerra-Tomás N, Díaz-López A, Rosique-
Esteban N et al. Legume consumption is 
inversely associated with type 2 diabetes 
incidence in adults: A prospective assessment 
from the PREDIMED study. Clin Nutr. 2017.   
doi: 10.1016/j.clnu.2017.03.015. [Epub 
ahead of print] 
4.548 
Nutrition 
& 
dietetics 
Q1 
9/81 
Q, Quartile 
1Accessed date: July 05, 2017 (Journal Citation Reports of the ISI web of Knowledge, 
Thompson Reuters). 
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1. Consumption of yogurt, low-fat milk, and other low-fat dairy products is 
associated with lower risk of metabolic syndrome incidence in an elderly 
Mediterranean population. 
Babio N, Becerra-Tomás N, Martínez-González MÁ, Corella D, Estruch R, Ros E, 
Sayón-Orea C, Fitó M, Serra-Majem L, Arós F, Lamuela-Raventós RM, Lapetra J, 
Gómez-Gracia E, Fiol M, Díaz-López A, Sorlí JV, Martínez JA, Salas-Salvadó J; 
PREDIMED Investigators. 
 
Key teaching points: 
 Little it is known about the association between dairy products consumption 
and MetS risk. 
 For the first time, the present study analyzed the association between the 
consumption of dairy products and its different subtypes and the risk of 
MetS and its components in a Mediterranean population at high CVD risk. 
 A prospective assessment with 1868 elderly individuals at high CVD risk was 
conducted in the framework of the PREDIMED study. 
 Results revealed an inverse association between low-fat dairy products, 
yogurt (total, low-fat and whole-fat yogurt) and low-fat milk consumption 
and the incidence of MetS. Cheese consumption was positively associated 
with the risk of MetS incidence. 
 Whole-fat yogurt was associated with a lower risk of all MetS components, 
whereas low-fat yogurt related inversely to high triglycerides, low HDL-
cholesterol and elevated fasting glucose. 
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Abstract
Background: The association between consumption of dairy products and the risk of developing metabolic syndrome
(MetS) is unclear.
Objective: The purpose of this study was to evaluate the associations between consumption of dairy products (total and
different subtypes) and incident MetS in a Mediterranean population at high cardiovascular disease risk.
Methods: We prospectively analyzed 1868 men and women (55–80 y old) without MetS at baseline, recruited from
different PREDIMED (Prevencio´n con DietaMediterra´nea) centers betweenOctober 2003 and June 2009 and followed up
until December 2010. MetS was deﬁned according to updated, harmonized criteria. At baseline and yearly thereafter, we
determined anthropometric variables, dietary habits by a 137-item validated food-frequency questionnaire, and blood
biochemistry. Multivariable-adjusted HRs of MetS or its components were estimated for each of the 2 upper tertiles (vs.
the lowest one) of mean consumption of dairy products during the follow-up.
Results: During a median follow-up of 3.2 y, we documented 930 incident MetS cases. In the multivariable-adjusted
model, HRs (95%CIs) of MetS for the comparison of extreme tertiles of dairy product consumption were 0.72 (0.61, 0.86)
for low-fat dairy, 0.73 (0.62, 0.86) for low-fat yogurt, 0.78 (0.66, 0.92) for whole-fat yogurt, and 0.80 (0.67, 0.95) for low-fat
milk. The respective HR for cheese was 1.31 (1.10, 1.56).
Conclusions: Higher consumption of low-fat dairy products, yogurt (total, low-fat, and whole-fat yogurt) and low-fat milk
was associated with a reduced risk of MetS in individuals at high cardiovascular disease risk from a Mediterranean
population. Conversely, higher consumption of cheese was related to a higher risk of MetS. This trial was registered at
controlled-trials.com as ISRCTN35739639. J Nutr 2015;145:2308–16.
Keywords: dairy products, metabolic syndrome, milk, yogurt, metabolic syndrome components, PREDIMED study
Introduction
Metabolic syndrome (MetS)19 comprises a cluster of risk factors,
including abnormal obesity, dyslipidemia, increased blood pres-
sure, and high fasting plasma glucose, which markedly increase
the risk of type 2 diabetes (T2D) and cardiovascular disease
(CVD) (1).
ã 2015 American Society for Nutrition.
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Diet and lifestyle are recognized as key elements in the
prevention (2) and treatment of MetS (3). In recent years, a
growing body of evidence has shown that the consumption of
dairy products may have beneﬁcial effects on risk factors deﬁning
MetS, including atherogenic dyslipidemia (4), hyperglycemia (5),
insulin resistance (6) or T2D (7–9), blood pressure (10), and
abdominal obesity (11).
In epidemiologic studies, the association between the total
consumption of dairy products and the risk of MetS has been
controversial. Some cross-sectional (4, 12–15) and prospective
studies (5, 16, 17) have shown an inverse association, whereas
others (18–20) have shown no association. Results by sex have
also been inconsistent (18, 19).
Although most studies suggest that total dairy consumption
could provide protection against the development of MetS,
methodologic biases or multiple combinations of different types
of dairy product with varying nutrient content may have
contributed to the controversial results reported. Few studies
have analyzed these associations across different dairy product
subtypes. Some cross-sectional studies have reported an inverse
association (15, 19) that was not found when data were analyzed
prospectively (5). For example, in the case of cheese consumption,
cross-sectional studies showed a positive association with MetS
prevalence (19), whereas prospective studies showed a negative
one (5, 17). Pereira et al. (5) showed an inverse association
with total consumption of dairy products regardless of their fat
content, whereas Louie et al. (20) found this inverse association
only for whole-fat dairy products.
To the best of our knowledge, of the 4 prospective studies
published to date on the relation between dairy product consump-
tion and MetS incidence, 3 were conducted in healthy adult
populations (5, 17, 20) and only 1 in older individuals (21), in
whom MetS is more prevalent and potentially has more reper-
cussions on health (22). In addition, only one study explored the
associations for different dairy subtype products (5). Therefore,
the aim of the present study was to examine the relation between
the consumptionof dairy products (whole or low-fat options) and
risk ofMetS in an olderMediterranean population in the frame of
the PREDIMED (Prevencio´n con Dieta Mediterra´nea) study.
Methods
Study design, participants, and outcome. The present study was
conducted within the framework of the PREDIMED trial, the design of
which has been described in detail elsewhere (23, 24). The PREDIMED
study is a large, parallel-group, multicenter, randomized, controlled
ﬁeld trial aimed at assessing the effects of the Mediterranean diet on the
primary prevention of CVD (25). The main results of the trial with re-
spect to the primary endpoint have been published recently (26).
Brieﬂy, 7447 community-dwelling men (aged 55–80 y) and women
(aged 60–80 y) with no previously documented CVD were recruited. They
were eligible if they had either T2D or$3 of the following CVD risk factors:
hypertension (systolic blood pressure $140 mm Hg or diastolic blood
pressure$90mmHgoronantihypertensivemedication),highplasmaLDL
cholesterol ($160mg/dL), lowplasmaHDLcholesterol (<40mg/dL inmen;
<50mg/dL in women), overweight or obesity (BMI $25 kg/m2), current
smoking, or a familyhistoryofpremature coronaryheartdisease (23).From
October 2003 to June 2009, participants were randomly assigned to 3
intervention groups (2 of which were advised to follow a Mediterranean
diet supplemented with either 1 L/wk extra-virgin olive oil or 30 g/d
mixed nuts, and were compared with the third group, which was advised
to follow a control low-fat diet). The study follow-up ended in December
2010. All participants provided their informed consent and the protocol
was approved by the institutional review boards of each recruitment center.
In the present report, the datawere analyzed assuming the design of an
observational prospective cohort whose members were selected from all
the PREDIMED recruiting centers with biochemical determinations
available for a follow-up of $2 y (n = 5801). Because our aim was to
explore the associations between the consumption of dairy foods and
incident MetS, we excluded participants who had diagnoses of MetS at
baseline (63.9%; n = 3707). We also excluded participants who had not
completed the baseline FFQ or who reported an extreme total energy
intake with values outside the prespeciﬁed limits (500–3500 kcal/d in
women and 800–4000 kcal/d in men). A total of 2094 individuals were
assessed. Of these, a total of 226 were excluded because of missing data
that prevented the presence of MetS incidence from being determined.
Thus, a total of 1868 participants were included in our longitudinal
assessment for MetS incidence. The individual components of MetS—
abdominal obesity, hypertriglyceridemia, low HDL cholesterol, high
blood pressure, and high fasting glucose concentration—were analyzed
for a total of 1386, 3539, 3745, 337, and 1844 participants (from 5801
participants initially considered with biochemical determinations avail-
able for a follow-up of$2 y), respectively.
The primary endpoint of the PREDIMED trial was a combination of
several major cardiovascular clinical events (myocardial infarction,
stroke, or CVD death). In the present analysis, incident MetS and its
components were considered as the outcome.
MetSwas deﬁned in accordancewith the updated harmonized criteria
of the International Diabetes Federation and the AHA/National Heart,
Lung, and Blood Institute (1). Individuals were diagnosed with MetS
if they had $3 of the following components: hypertriglyceridemia
1 This study was funded in part by the Spanish Ministry of Health (PI1001407,
PI13/00462, PI052584, and PI071138), Thematic Network G03/140, RD06/0045,
the European Regional Development Fund, and the Catalan Nutrition Center of
the Institute of Catalan Studies. None of the funding sources played a role in the
design, collection, analysis, or interpretation of the data or in the decision to
submit the manuscript for publication. The Center of Biomedical Research in
Physiopathology of Obesity and Nutrition (CIBEROBN) is an initiative of Health
Institute Carlos III (ISCIII), Spain.
2 Author disclosures: N Babio received consulting fees from Danone. R Estruch
served on the board of, and received lecture fees from, the Research Foundation
on Wine and Nutrition; served on the boards of the Beer and Health Foundation
and the European Foundation for Alcohol Research; received lecture fees from
Cerveceros de Espan˜a and Sanoﬁ-Aventis; and received grant support through
his institution from Novartis. E Ros served on the board of, and received travel
support and grant support through his institution from the California Walnut
Commission; served on the board of the Flora Foundation (Unilever); served on the
board of, and received lecture fees from, Roche; served on the board of, and
received grant support through his institution from Amgen; received consulting
fees from Damm and Abbott Laboratories; received consulting fees, lecture fees,
and grant support through his institution from Merck; received lecture fees from
Danone, Pace, AstraZeneca, and Rottapharm; received lecture fees and payment
for the development of educational presentations and grant support through his
institution from Ferrer; received payment for the development of educational
presentations from Recordati; and received grant support through his institution
from Sanoﬁ-Aventis, Takeda, Daiichi Sankyo, Nutrexpa, Feiraco, Unilever, and Karo
Bio. L Serra-Majem is a member of the Scientiﬁc Advisory Board and received
consulting fees and grant support from the European Hydratation Institute,
received lecture fees from the International Nut Council, and received travel
support fromNestle. F Aro´s received payment for the development of educational
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on the board of, and received grant support through his institution from the
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[$150 mg/dL ($1.7 mmol/L)] or drug treatment for elevated TGs; low
concentrations of HDL cholesterol [<50 mg/dL (<1.3 mmol/L) and
<40mg/dL (<1.03 mmol/L) in women and men, respectively] or drug
treatment for low HDL cholesterol; elevated blood pressure (systolic
$130 mmHg and/or diastolic$85mmHg) or being treated for hyperten-
sion; high fasting plasma glucose [$100 mg/dL ($5.5 mmol/L)] or drug
treatment for hyperglycemia; and elevated waist circumference for Euro-
pean individuals ($88 cm in women and$102 cm in men.
Dietary assessment. At baseline and yearly during follow-up, dietary
intake was quantiﬁed by trained dietitians with a 137-item semi-quantitative
FFQ validated for the PREDIMED study (27). In the validation study, the
FFQwas administered twice to explore reproducibility at 1 y; 4 3-d dietary
records for the different seasons of the yearwere used as gold standard. The
reproducibility of the FFQ used in PREDIMED for food groups and energy
and nutrient intake, explored by the Pearson correlation coefﬁcient, ranged
from 0.50 to 0.82, and the intraclass correlation coefﬁcient (ICC) ranged
from 0.63 to 0.90. The validity indexes of the FFQ in relation to the dietary
records for food groups and energy and nutrient intake ranged from 0.24
to 0.72, whereas the range of the ICC was between 0.40 and 0.84.
Regarding dairy product consumption, the reproducibility and validity
of FFQs were 0.81 (ICC 0.89), and 0.72 (ICC 0.84), respectively.
Dairy product consumption was assessed yearly with the use of 15
items from the FFQ. In order to assess habitual dietary intake over the
previous year, frequencies of consumption were measured in 9 categories
(ranging from never/almost never to >6 servings/d) for each food item.
These responses to individual dairy items were then converted into mean
daily consumption (grams per day) during the follow-up by multiplying
the typical portion sizes (grams) by the consumption frequency for each
food andmaking the appropriate division for the periodassessed toobtain
daily consumption. The total dairy foods category included low-fat/skim
milkand skimyogurt,wholemilk, condensedmilk,whole yogurt, custard,
and all types of cheeses, including petit Swiss, ricotta, cottage, and
semicured/cured cheeses such as cheddar, Manchego, and Emmentaler).
Low-fat dairy foods included low-fat/skim milk and skim yogurt, whole-
fat dairy foods (whole milk and whole yogurt), and total dairy foods,
including all of the above. Consumption of dairy products was also
categorizedby subtype, includingmilk (including total, low-fat andwhole
milk), yogurt (including total, low-fat and whole-fat yogurt), and cheese.
Energy and nutrient intake and food groups were calculated from
Spanish food composition tables (28, 29). We adjusted dairy consumption
for total energy intake with the use of the nutrient residual method (30).
Measurements. Participants completed the following at baseline and
yearly: 1) a questionnaire about lifestyle variables, medical history, and
medication use; 2) a 14-item validated questionnaire (31) designed to
assess adherence to the Mediterranean diet; 3) a validated 137-item
semiquantitativeFFQ(27); and4) thevalidatedSpanishversion (32)of the
Minnesota Leisure-Time Physical Activity Questionnaire. In addition,
anthropometric variables and blood pressure were determined by trained
staff. Blood pressure was measured in triplicate with the use of a
validated semiautomatic oscillometer with a 5 min interval between
measurements and the subject in a sitting position (OmronHEM-705CP).
Blood sampleswere collectedafter anovernight fast, coded, shipped to
a central laboratory, and stored at 280C until analysis. Biochemical
analysiswasperformedin local laboratories.Glucosewasmeasuredby the
glucose-oxidasemethod, cholesterolby esterase-oxidase-peroxidase,TGs
by glycerol-phosphate oxidase-peroxidase, and HDL cholesterol by
direct measurement. All local laboratories satisﬁed external quality-
control requirements.When TGswere <300mg/dL, LDL cholesterol was
calculated with the use of the Friedewald formula so that the LDL
cholesterol was not underestimated. A concordance study of 9 laborato-
ries was conducted. From each study, a mean of 200 samples were
analyzed for total cholesterol, HDL cholesterol, and TGs with the use of
the Medical Research Institute of del Mar laboratory as reference. The
Medical Research Institute of del Mar laboratory used ABX-Horiba
commercial kits in a PENTRA-400 autoanalyzer (ABX-Horiba). One
center was unable to provide samples for the concordance study.
The analysis of concordance of lipid measurements showed an r2 and
an ICC (95% CI) between 0.85 and 0.97, and 0.85 (0.77, 0.90) and 0.97
(0.95, 0.98) for total cholesterol, respectively; between 0.819 and 0.92,
and 0.81 (0.78, 0.83) and 0.92 (0.89, 0.95) for HDL cholesterol,
respectively; between 0.81 and 0.99, and 0.81 (0.73, 0.87) and 0.99
(0.99,0.99) for triglycerides, respectively; andbetween0.82and0.96, and
0.82 (0.74, 0.88) and 0.99 (0.99, 0.99) for glucose, respectively.
Statistical analysis. We averaged the intake reported during the baseline
interview and the yearly consumption during the follow-up. Then, partici-
pants were categorized into tertiles of the mean consumption of total dairy
products and different subtypes during the follow-up. To better represent the
long-term consumption of dairy products and to minimize within-person
variation, we used the mean energy-adjusted dairy consumption for all
analyses based on assessments of items from all FFQs, whichwere admin-
istered at baseline and yearly during the follow-up for those participants
who did not developMetS. For those who did developMetS, and given that
participantscanaltertheirdietarypatternafterdevelopingMetS,weonlyused
data from all the available FFQs until the year before MetS was diagnosed.
Thebaseline characteristics of theparticipants are expressedasmean6 SDor
median (IQR) for continuous variables and number and percentages for
categorical variables. Chi-square and 1-factor ANOVA tests were used to
assess differences in the baseline characteristics of the study population.
Multivariable time-dependentCoxproportional regressionmodelswere
ﬁtted to assess the HRs of developing MetS and its components during
follow-up according to tertiles of consumption of total, low-fat, andwhole-
fat dairy products;milk, low-fatmilk, andwholemilk; total yogurt, low-fat
yogurt, and whole-fat yogurt; and cheese. Both upper tertiles were com-
paredwith the lowest tertile (reference). The assumption of proportional
hazards was tested with the use of time-dependent covariates.
The timevariablewas the intervalbetweenrandomassignmentand the
date of the last follow-up, or the last recorded clinical event (MetS
incidence) of participants who were still alive, whichever occurred ﬁrst.
Participants who were free of MetS or who were lost during follow-up
were censored at the date of the last visit.
ThreedifferentCox regressionmodelswere adjusted forpotential con-
founding factors. Model 1 was adjusted for intervention group; sex; age
(years); leisure time physical activity (metabolic equivalent task  d); BMI
(kilograms per meter squared); current smoker (yes/no); former smoker
(yes/no); and hypoglycemic, hypolipidemic, antihypertensive, and insulin
treatment at baseline. Model 2 was additionally adjusted for mean
consumption during follow-up of vegetables, fruit, legumes, cereals, ﬁsh,
redmeat, cookies, olive oil, and nuts (all grams per day), aswell as alcohol
(gramsperdayandquadratic term).Model3wasadjusted formodel2plus
the prevalence of MetS components at baseline, including abdominal
obesity (yes/no), hypertriglyceridemia (yes/no), lowHDLcholesterol (yes/
no), hypertension (yes/no), and high fasting plasma glucose (yes/no).
Statistical interaction between tertiles of total dairy consumptionand its
different subtypes, and potential effect-modifying variables, such as sex and
intervention group, was assessed by including product terms in themodels.
To assess the linear trend, the median value of each tertile of dairy product
and the different dairy subtypes was assigned and used as a continuous
variable in the Cox regression models. The level of signiﬁcance for all
statistical testswasP<0.05 for bilateral contrast.TheBenjamini-Hochberg
method was used to correct P values for multiple comparisons (33).
WealsoconductedasensitivityanalysisofanumberofMetScomponents
at baseline to test the robustness of our results. The main analysis was
stratiﬁed by those individuals who did not have any components ofMetS or
had one, or who had 2 components. This was done to prevent possible bias
effects, because it is easier for those who already have 2 criteria to meet the
diagnostic deﬁnition than those with one or none.
All analyses were performed with SPSS software, version 19.0.
Results
After a median of 3.2 y of follow-up (IQR: 1.9, 5.8), 930
participantswithoutMetS at baseline (53.8%women) developed
new-onset MetS. Of those not showing the speciﬁc MetS
components at baseline, 43.4% of 1040 participants developed
abdominal obesity during follow-up, 27.7% of 1770 developed
hypertriglyceridemia, 24.5% of 1810 developed low HDL
2310 Babio et al.
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TABLE 1 Baseline characteristics of study individuals at high cardiovascular disease risk by tertiles of
total dairy consumption1
Total dairy consumption,2 g/d
P
2T1 (#287; n = 622) T2 (287–449; n = 623) T3 ($450; n = 623)
Total dairy consumption, median (P25, P75) 207 (142, 250) 354 (322, 393) 577 (518, 661)
Age, y 66.0 (6.0) 67.0 (5.9) 67.7 (6.2) ,0.001
Women, % (n) 38.7 (241) 52.6 (328) 66.0 (411) ,0.001
Waist circumference, cm
Women 92.3 6 10.6 92.43 6 10.3 92.5 6 10.8 0.84
Men 98.8 6 7.9 97.4 6 7.6 97.5 6 7.3 0.042
BMI, kg/m2 28.2 6 3.4 28.3 6 3.4 28.6 6 3.7 0.08
Leisure time physical activity, MET  min/d 297 6 260 273 6 258 253 6 242 0.010
Former smokers, % (n) 33.6 (209) 24.7 (154) 19.3 (120) ,0.001
Current smokers, % (n) 19.3 (120) 14.6 (91) 13.2 (82) 0.008
Blood pressure, mm Hg
Systolic 147.6 6 20.3 145.7 6 19.6 145.7 6 21.5 0.18
Diastolic 82.6 6 10.9 81.9 (10.5) 81.6 6 10.9 0.25
Biochemistry, mg/dL
Plasma fasting blood glucose 101.7 6 27.9 102.5 6 32.1 107.5 6 39.0 0.004
Serum HDL cholesterol 56.0 (49.0, 66.0) 58.0 (51.0, 68.0) 60.0 (53.0, 68.2) 0.001
Serum TGs 99.9 (77.0, 122) 95.0 (75.0, 118) 94.0 (73.0, 118) 0.022
Current medication use, % (n)
Use of hypoglycemic agents 12.3 (76) 14.5 (90) 16.4 (102) 0.12
Use hypolipidemic agents 45.0 (280) 46.7 (291) 46.5 (290) 0.66
Use of antihypertensive agents 65.6 (408) 66.6 (415) 63.4 (395) 0.46
Insulin treatment 3.2 (20) 2.7 (17) 7.1 (44) ,0.001
MetS components, % (n)
Abdominal obesity 41.2 (255) 41.4 (256) 49.1 (303) 0.006
Hypertriglyceridemia 6.9 (43) 5.3 (33) 3.4 (21) 0.019
Low HDL cholesterol 2.6 (16) 3.4 (21) 3.1 (19) 0.71
High blood pressure 88.9 (552) 87.3 (543) 85.1 (530) 0.13
High fasting plasma glucose 29.7 (184) 29.7 (183) 35.7 (222) 0.032
Intervention groups, % (n) 0.44
Mediterranean diet + EVOO 32.6 (203) 35.0 (218) 36.1 (225)
Mediterrandean diet + nuts 36.8 (229) 34.5 (215) 31.8 (198)
Control low-fat diet 30.5 (190) 30.5 (190) 32.1 (200)
Energy intake, kcal/d 2368 (541) 2264 (527) 2336 (522) 0.002
Food consumption,3 g/d
Vegetables 336 6 122 348 6 120 343 6 126 0.23
Fruits 383 6 154 391 6 135 397 6 160 0.24
Legumes 22 6 9 22 6 10 23 6 11 0.40
Meat 128 6 43 125 6 40 118 6 42 ,0.001
Fish 111 6 39 105 6 35 101 6 37 ,0.001
Cereals 238 6 71 223 6 60 210 6 60 ,0.001
Cookies 21 6 24 21 6 20 21 6 22 0.94
Nuts 16 6 14 16 6 13 14 6 13 0.015
Olive oil 46 6 13 45 6 13 43 6 14 ,0.001
Alcohol 14 6 15 9 6 10 6 6 9 ,0.001
Low-fat dairy 125 6 88 270 6 96 485 6 191 ,0.001
Whole-fat dairy 32 6 58 51 6 85 79 6 161 ,0.001
Total yogurt 41 6 44 92 6 61 122 6 89 ,0.001
Low-fat yogurt 29 6 40 67 6 60 95 6 88 ,0.001
Whole-fat yogurt 12 6 25 25 6 44 26 6 51 ,0.001
Cheese 27 6 22 33 6 23 37 6 32 ,0.001
Total milk 117 6 82 229 6 73 442 6 131 ,0.001
Low-fat milk 97 6 85 203 6 90 389 6 176 ,0.001
Whole milk 25 6 68 30 6 85 61 6 170 ,0.001
1 Values are means 6 SDs or medians (IQRs) unless otherwise indicated. Tertile cutoffs are based on the energy-adjusted mean of total dairy
consumption during the follow-up. EVOO, extra virgin olive oil; MET, metabolic equivalent task; MetS, metabolic syndrome; P, percentile; T, tertile.
2
P values for differences between tertiles were calculated by chi-square tests for categorical variables and ANOVA tests for continuous variables.
3 All dietary variables were adjusted for energy.
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cholesterol, 82.2% of 240 developed high blood pressure, and
41.4% of 1268 developed high fasting glucose concentration.
The median consumption during the follow-up of total dairy
products in the whole study population was 363 g/d (IQR: 257,
525 g/d), low-fat dairy products being the largest contributors to
total dairy consumption (72.5%). The median of consumption of
milk,yogurt,andcheesewas207g/d,70g/d,and30g/d, respectively.
Thegeneral characteristics of the studyparticipants according to
their mean consumption categories of total dairy products (tertiles)
during the follow-up are shown in Table 1. Compared with those
in the lowest tertile, participants in the top tertile were more likely
tobeolderwomenand less likely to smoke,bephysically active, and
have lower serum concentrations of TGs and higher concentrations
of HDL cholesterol. Participants in the highest tertile of dairy
consumption also had lower total energy intake and consumed less
red meat, ﬁsh, cereals, nuts, olive oil, and alcohol.
Consumption of total dairy products and incidence of
MetS. The multivariable-adjusted HRs (95% CIs) for MetS
incidence across tertiles of consumption of total dairy products
are shown in Table 2. After adjusting for several potential
confounders, subjects in the top tertile of low-fat dairy consump-
tion, but not total dairy or high-fat dairy, had a lower risk of
incident MetS [HR: 0.72; 95% CI: 0.61,0.86; P-trend = 0.001]
compared with those in the bottom tertile.
Consumption of dairy product subtypes and incidence of
MetS. The HRs of incident MetS across tertiles of consumption of
speciﬁc subtypes of dairy products (yogurt, cheese, and milk) also
adjusted for potential confounders are shown in Table 3. Among the
subtypes of dairy products, consumers in tertile 3 of low-fat yogurt
[HR: 0.73; 95% CI: 0.62, 0.86; P-trend = 0.004], whole-fat yogurt
[HR: 0.78; 95% CI: 0.66, 0.92; P-trend = 0.003], and low-fat milk
[HR: 0.80; 95% CI: 0.67, 0.95); P-trend = 0.007] had a lower risk
of developing MetS than did participants in the lowest tertile
of consumption. Compared with participants in the lowest tertile of
consumption of cheese, those in the highest tertile had an increased
risk of incident MetS [HR: 1.31; 95% CI: 1.10, 1.56; P-trend <
0.001]. No statistical interactions were found between the consump-
tion of total dairy products or subtypes and sex or intervention group.
Yogurt consumption and MetS and its components. The
multivariable-adjusted HR of each MetS component in subjects
who were initially free of MetS in extreme categories of total,
whole-fat, and low-fat yogurt consumption (tertile 3 vs. tertile 1)
are shown in Figure 1. With the exception of high blood pressure,
participants in the highest tertile of total yogurt consumption had a
signiﬁcantly lower risk of developing each of the MetS components
than those in the lowest tertile. However, the linear trend was
signiﬁcant only for high fasting glucose (P-trend = 0.004).
Compared with participants in the lowest tertile, participants in
the highest tertile of whole-fat yogurt consumption had a lower
risk of several components of MetS, including abdominal obesity
[HR: 0.80; 95% CI: 0.65, 0.98; P-trend = 0.048], hypertriglycer-
idemia [HR:0.74; 95%CI: 0.64, 0.86;P-trend<0.001], lowHDL
cholesterol [HR: 0.73; 95%CI: 0.63, 0.85; P-trend < 0.001], high
blood pressure [HR: 0.62; 95% CI: 0.44, 0.86; P-trend = 0.001],
and high fasting plasma glucose [HR: 0.80; 95% CI: 0.66, 0.94;
P-trend = 0.005]. The associations with low-fat yogurt were in
the same direction as those with total and whole-fat yogurt, but
inverse associations were limited to hypertriglyceridemia [HR:
0.73; 95% CI: 0.63, 0.85; P-trend = 0.18], low HDL cholesterol
[HR: 0.76; 95% CI: 0.66, 0.88; P-trend = 0.35], and high fasting
plasma glucose [HR: 0.81; 95%CI: 0.68, 0.96; P-trend = 0.004].
TABLE 2 HRs (95% CIs) of MetS incidence across energy-adjusted tertiles of consumption of total,
low-fat, and whole-fat dairy products in elderly individuals at high cardiovascular disease risk1
Total dairy consumption, g/d
P-trendT1 T2 T3
Total dairy consumption, median (P25, P75) 207 (142, 250) 354 (322, 393) 577 (518, 661)
MetS incidence, n (%) 319 (51.3) 293 (47.0) 318 (51.0) 0.24
Crude model 1.00 (ref.) 0.84 (0.72, 0.99) 1.02 (0.87, 1.20) 0.60
Multivariate model 1 1.00 (ref.) 0.82 (0.70, 0.97) 0.93 (0.78, 1.10) 0.54
Multivariate model 2 1.00 (ref.) 0.83 (0.70, 0.98) 0.89 (0.73, 1.07) 0.30
Multivariate model 3 1.00 (ref.) 0.80 (0.68, 0.95) 0.83 (0.69, 1.01) 0.11
Whole-fat dairy, median (P25, P75) 0 18 (12, 25) 94 (53, 179)
MetS incidence, n (%) 327 (47.4) 289 (46.4) 314 (50.4) 0.09
Crude model 1.00 (ref.) 0.88 (0.75, 1.03) 0.95 (0.81, 1.11) 0.85
Multivariate model 1 1.00 (ref.) 0.82 (0.69, 0.96) 0.93 (0.80, 1.09) 0.88
Multivariate model 2 1.00 (ref.) 0.90 (0.76, 1.06) 0.96 (0.81, 1.13) 0.87
Multivariate model 3 1.00 (ref.) 0.92 (0.78, 1.10) 0.99 (0.84, 1.16) 0.92
Low-fat dairy, median (P25, P75) 87 (7, 163) 263 (227, 316) 503 (429, 587)
MetS incidence, n (%) 325 (52.3) 310 (49.8) 295 (47.4) 0.22
Crude model 1.00 (ref.) 0.90 (0.77, 1.06) 0.87 (0.74, 1.02) 0.18
Multivariate model 1 1.00 (ref.) 0.87 (0.74, 1.02) 0.79 (0.67, 0.93) 0.005
Multivariate model 2 1.00 (ref.) 0.90 (0.76, 1.05) 0.78 (0.66, 0.93) 0.005
Multivariate model 3 1.00 (ref.) 0.88 (0.75, 1.03) 0.72 (0.61, 0.86) 0.001
1 Tertile cutoffs are based on energy-adjusted mean total, low-fat, or whole-fat dairy consumption during the follow-up. Cox regression
model 1 adjusted for intervention group; sex; age (year); leisure time physical activity (metabolic equivalent task  day); BMI (kilograms per
meter squared); current smoker (yes/no); former smoker (yes/no); and use of hypoglycemic, hypolipidemic, antihypertensive, and insulin
treatment at baseline. Cox regression model 2 additionally adjusted for mean consumption during the follow-up of vegetables, fruit,
legumes, cereals, ﬁsh, red meat, cookies, olive oil, and nuts (all grams per day), as well as alcohol (grams per day and quadratic term). Cox
regression model 3 additionally adjusted for prevalence of MetS components at baseline, including abdominal obesity (yes/no),
hypertriglyceridemia (yes/no), low HDL cholesterol (yes/no), hypertension (yes/no), and high fasting plasma glucose (yes/no). All models
were stratiﬁed by recruitment center. MetS, metabolic syndrome; P, percentile; ref., reference; T, tertile.
2312 Babio et al.
 at U
N
IV
E
R
S
ITA
T R
O
V
IR
A
 I V
IR
G
ILI | D
'E
N
G
IN
Y
E
R
IA
 Q
U
IM
IC
A
 on July 9, 2017
jn.nutrition.org
D
ow
nloaded from
 
UNIVERSITAT ROVIRA I VIRGILI 
DIETARY FACTORS ASSOCIATED WITH METABOLIC SYNDROME AND TYPE 2 DIABETES RISK 
Nerea Becerra Tomás 
Consumption of dairy products, dairy product subtypes,
and MetS components. HRs for the components of incident
MetS across tertiles of consumption of total dairy products and
subtypes are shown in Supplemental Table 1. An increased
consumption of total milk and low-fat milk was signiﬁcantly
associated with a lower incidence of low HDL cholesterol and
high fasting glucose. Low-fat dairy consumption was inversely
associated with high fasting glucose, hypertriglyceridemia, and
low HDL cholesterol (Supplemental Table 1).
Consumption of dairy products, subtypes of dairy pro-
ducts, and incidence of MetS based on the number of
MetS components at baseline. A sensitivity analysis based on
the number of MetS components at baseline found that in those
TABLE 3 HRs (95% CIs) of MetS incidence across energy-adjusted tertiles of consumption of speciﬁc
dairy products (yogurt, cheese, and milk) in elderly individuals at high cardiovascular disease risk1
Tertiles of specific dairy consumption
P-trendT1 T2 T3
Total yogurt,2 g/d 7 (1, 24) 70 (54,94) 127 (125, 189)
MetS incidence, n (%) 318 (51.1) 283 (45.4) 329 (52.8)
Crude model 1.00 (ref.) 0.82 (0.69, 0.97) 1.10 (0.95, 1.29) 0.26
Multivariate model 1 1.00 (ref.) 0.81 (0.69, 0.96) 1.10 (0.93, 1.29) 0.31
Multivariate model 2 1.00 (ref.) 0.88 (0.74, 1.03) 0.75 (0.64, 0.89) 0.15
Multivariate model 3 1.00 (ref.) 0.88 (0.74, 1.04) 0.77 (0.65, 0.91) 0.14
Low-fat yogurt,2 g/d 1 (0, 5) 46 (27, 60) 124 (107, 159)
MetS incidence, n (%) 366 (58.8) 260 (41.7) 304 (48.8) ,0.001
Crude model 1.00 (ref.) 0.56 (0.47, 0.65) 0.74 (0.64, 0.87) 0.004
Multivariate model 1 1.00 (ref.) 0.53 (0.47, 0.64) 0.72 (0.62, 0.85) 0.002
Multivariate model 2 1.00 (ref.) 0.57 (0.49, 0.67) 0.76 (0.65, 0.90) 0.016
Multivariate model 3 1.00 (ref.) 0.56 (0.47, 0.66) 0.73 (0.62, 0.86) 0.004
Whole-fat yogurt,2 g/d 0 6 (4, 9) 46 (24, 78)
MetS incidence, n (%) 346 (55.6) 310 (49.8) 274 (44.0) ,0.001
Crude model 1.00 (ref.) 0.88 (0.75, 1.03) 0.71 (0.61, 0.84) ,0.001
Multivariate model 1 1.00 (ref.) 0.83 (0.71, 0.98) 0.71 (0.60, 0.83) ,0.001
Multivariate model 2 1.00 (ref.) 0.91 (0.77, 1.07) 0.74 (0.63, 0.87) ,0.001
Multivariate model 3 1.00 (ref.) 0.93 (0.79, 1.10) 0.78 (0.66, 0.92) 0.003
Cheese,2 g/d 11 (6, 15) 28 (23, 33) 51 (44, 66)
MetS incidence, n (%) 293 (47.1) 280 (44.9) 357 (57.3)
Crude model 1.00 (ref.) 0.94 (0.79, 1.11) 1.41 (1.20, 1.66) ,0.001
Multivariate model 1 1.00 (ref.) 0.90 (0.76, 1.07) 1.29 (1.10, 1.52) 0.001
Multivariate model 2 1.00 (ref.) 0.94 (0.79, 1.12) 1.34 (1.13, 1.58) ,0.001
Multivariate model 3 1.00 (ref.) 0.93 (0.79, 1.11) 1.31 (1.10, 1.56) ,0.001
Total milk,2 g/d 120 (35, 162) 222 (205, 250) 462 (380, 504)
MetS incidence, n (%) 313 (50.3) 303 (48.6) 314 (50.4) 0.78
Crude model 1.00 (ref.) 0.97 (0.83, 1.14) 1.04 (0.88, 1.22) 0.57
Multivariate model 1 1.00 (ref.) 0.90 (0.76, 1.06) 0.93 (0.78, 1.10) 0.58
Multivariate model 2 1.00 (ref.) 0.93 (0.79, 1.10) 0.90 (0.75, 1.78) 0.29
Multivariate model 3 1.00 (ref.) 0.90 (0.77, 1.07) 0.85 (0.70, 1.02) 0.11
Low-fat milk,2 g/d 28 (0, 107) 204 (193, 216) 433 (345, 499)
MetS incidence, n (%) 306 (49.2) 331 (53.1) 293 (47.0) 0.09
Crude model 1.00 (ref.) 1.17 (1.00, 1.37) 0.94 (0.80, 1.11) 0.38
Multivariate model 1 1.00 (ref.) 1.14 (0.98, 1.34) 0.86 (0.73, 1.02) 0.06
Multivariate model 2 1.00 (ref.) 1.16 (0.99, 1.37) 0.85 (0.71, 1.01) 0.040
Multivariate model 3 1.00 (ref.) 1.16 (0.98, 1.36) 0.80 (0.67, 0.95) 0.007
Whole-fat milk,2 g/d 0 5 (2, 8) 31 (18, 136)
MetS incidence, n (%) 314 (50.5) 288 (462) 328 (52.6) 0.07
Crude model 1.00 (ref.) 0.92 (0.78, 1.08) 1.12 (0.96, 1.31) 0.08
Multivariate model 1 1.00 (ref.) 0.89 (0.75, 1.05) 1.02 (0.87, 1.21) 0.50
Multivariate model 2 1.00 (ref.) 1.00 (0.85, 1.19) 1.10 (0.93, 1.30) 0.21
Multivariate model 3 1.00 (ref.) 1.02 (0.86, 1.21) 1.12 (0.95, 1.33) 0.16
1 The MetS components were deﬁned with updated harmonizing criteria. Tertile cutoffs are based on energy-adjusted mean dairy product
consumption during the follow-up. Cox regression model 1 adjusted for intervention group; sex; age (year); leisure time physical activity
(metabolic equivalent task  day); BMI (kilograms per meter squared); current smoker (yes/no); former smoker (yes/no); and use of
hypoglycemic, hypolipidemic, antihypertensive, and insulin treatment at baseline. Cox regression model 2 additionally adjusted for mean
consumption during the follow-up of vegetables, fruit, legumes, cereals, ﬁsh, red meat, cookies, olive oil, and nuts (all grams per day), as
well as alcohol (grams per day and quadratic term). Cox regression model 3 additionally adjusted for prevalence of MetS components at
baseline, including abdominal obesity (yes/no), hypertriglyceridemia (yes/no), low HDL cholesterol (yes/no), hypertension (yes/no), and high
fasting plasma glucose (yes/no). All models were stratiﬁed by recruitment center. MetS, metabolic syndrome; ref., reference; T, tertile.
2 Values are medians; 25th, 75th percentiles in parentheses.
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individualswhohad only one component or none at all, therewas
no signiﬁcant association between total dairy or its subtypes and
MetS incidence, except for cheese (P-trend < 0.05). In those
individuals with 2 MetS components at baseline, there were still
signiﬁcant inverse associations between low-fat dairy, low-fat
yogurt, andwhole-fat yogurt consumptionandMetS incidence.A
positive association was observed between cheese consumption
andMetS development (Supplemental Table 2).
Discussion
In this longitudinal assessment of the PREDIMED cohort, an
older Mediterranean population at high CVD risk, we evaluated
the consumption of total and speciﬁc dairy products in relation to
the risk of developing MetS. The results show that the consump-
tion of low-fat dairy products, yogurt (total, low-fat, and whole
yogurt), and low-fat milk is associated with a lower incidence of
MetS. These results remained even after we used the Benjamini-
Hochberg method to correct P values for multiple comparisons.
The association between total dairy consumption and MetS
remained in the same direction, although it was not signiﬁcant
(P = 0.11). In contrast, increased consumption of total cheese
was directly associated with a higher risk of MetS. Likewise,
increased consumption of whole yogurt was also inversely associated
with all MetS components, whereas consumption of low-fat
yogurt related inversely to high TGs, low HDL cholesterol, and
elevated fasting glucose.
Our results are in line with those of other prospective studies
showing an inverse association between total dairy product
consumption and MetS (5, 16, 17). The results of other cross-
sectional (19, 34) and prospective studies (20, 21), however, are
not fully consistent.Thesemixed results canbepartially explained
by the heterogeneity of dairy products included in the total dairy
category. Further reasons for discordant results could relate to the
design of the studies, because, unlike in the present study, most
previous studies did not use repeated measurements of consump-
tion, and to inherent differences in the characteristics of the
population studied.
Our results for the type of product and fat content are
discordant with those reported by the prospective CARDIA
(Coronary Artery Risk Development in Young Adults) study (5),
in which an inverse association between the consumption of
whole-fat dairy products and cheese and MetS was observed in
individuals above 18 y of age. We observed a direct association
between the consumption of cheese and incident MetS. Unlike in
our ﬁndings, individuals in the Blue Mountain Eyes Study (20)
who consumed more whole-fat dairy or low-fat dairy products
showed a decreased or an increased risk of developing MetS,
respectively. The population in our study consisted of older
individuals at high CVD risk, whereas the study subjects were
younger in both the CARDIA and the Blue Mountain Eyes
Studies. This may partly explain the contradictory results. It
should be pointed out that only the CARDIA study analyzed the
associations betweenMetS and dairy product subtypes, although
FIGURE 1 HRs (95% CIs) of meta-
bolic syndrome and its components
[abdominal obesity (n = 1386), hyper-
triglyceridemia (n = 3539), low HDL
cholesterol (n = 3745), high blood
pressure (n = 337), and high fasting
plasma glucose (n = 1844)], comparing
tertile 3 and tertile 1 of yogurt con-
sumption in elderly individuals at high
cardiovascular disease risk. Tertile
cutoffs are based on energy-adjusted
mean yogurt consumption during the
follow-up. Cox regression models ad-
justed for intervention group; sex; age
(years); leisure time physical activity
(metabolic equivalent task  day); BMI
(kilograms per meter squared); current
smoker (yes/no); former smoker (yes/
no); and use of hypoglycemic, hypo-
lipidemic, antihypertensive, and insulin
treatment at baseline plus mean con-
sumption during follow-up of vegeta-
bles, fruit, legumes, cereals, fish, red
meat, cookies, olive oil, and nuts (all
grams per day), as well as alcohol
(grams per day and quadratic term).
All models were stratified by recruit-
ment center.
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they were classiﬁed differently from in our study. This may help
explain the divergent results.
In support of our ﬁndings, the protective role of yogurt
consumption on MetS has been noted previously in cross-
sectional studies (15, 19), but the prospective CARDIA study
(5) found no association between yogurt consumption andMetS
development.
Numerous biological mechanisms may mediate the relation
between dairy consumption and risk of MetS.
Dairy products are an important source of calcium. The
calcium in milk products interacts with SFAs to form calcium–
FA soaps, thereby increasing fecal fat excretion (35) and, thus,
improving the HDL-to-LDL cholesterol ratio. Lorenzen et al.
(36) also showed that, unlike calcium from supplements,
calcium from milk and low-fat yogurt reduced the TG content
of chylomicrons postprandially (36). Intervention studies have
also shown that calcium intake decreases blood pressure (37,
38), and that milk-derived bioactive peptides have antihy-
pertensive properties (39). Milk-derived bioactive peptides
increasingly have been shown to play an important role in
preventing MetS by regulating insulinemia, blood pressure,
dyslipidemia, and central fat accumulation (39–41). Nutrients
from dairy products may act synergistically on metabolic
pathways that have a beneﬁcial impact on MetS. It has been
reported that insulin concentrations are lower in those subjects
consuming diets high in dairy products than in subjects
consuming diets low in dairy products (41), which suggests
that calciumor other nutrients thatmake updairy products have
beneﬁcial effects on glucosemetabolism. Although some studies
(40) have suggested that there are beneﬁcial associations
between dairy consumption and body weight or body compo-
sition, clinical trials data are not supportive (42). Recently,
however, a high consumption of total andwhole-fat yogurt was
associated with a lower risk of being overweight/obese (43). It
has also been suggested that probiotics from yogurt beneﬁcially
inﬂuence the inﬂammatory/anti-inﬂammatory balance of the
microbiota, which might mediate the lower risk of presenting
overweight/obesity (44).
In our study, whole-milk yogurt protected against all MetS
components. Although nutritionally yogurt is comparable to
milk, added ingredients and fermentation may improve its
nutritional value (45) and provide it with unique properties that
enhance thebioavailability of somenutrients (46, 47).As far as fat
is concerned, dairy products contain mostly SFAs, in addition to
high proportions of oleic, stearic, rumenic and trans-palmitoleic
acids.The results of recentmeta-analyses havequestioned the role
of SFAs on CVD risk (48). Likewise, there is meta-analytical
evidence that a high intake of total dairy products andmost dairy
subtypes donot increase the risk ofCVD (49). In our study, cheese
was directly associated with an increased risk of MetS, which
may be partly explained by the fact that it is rich in sodium and
has a higher energy density and phosphorus content than other
dairy products (19).
In elderly individuals, MetS is an important health problem
with potentially greater repercussions on health than in other
population groups (22). According to our results, dairy products
are a food group with a high nutritional value that could prevent
MetS development. Consequently, the consumption of this food
group may be promoted in elderly individuals in order to try to
attempt to reduce the incidence of this disease.
Our study has several strengths, including the use of yearly
measurements of diet, a relatively long follow-up period, the
analysis of dairy subtypes with different fat contents, and
adjustment for a large number of potential confounders forwhich
multiple testing corrections minimized small differences among
individuals and potential confounders.
The study also has limitations. First, incident MetS was a
secondary endpoint of the PREDIMED trial, which make our
analyses exploratory in nature. Second, our cohortwasmadeup
of elderly participants at high risk of CVD; thus, our ﬁndings
cannot be generalized to other populations. Third, although
diet was assessed by a validated FFQ, potential measurement
errors are unavoidable. Nevertheless, to minimize the random
measurement error caused by within-person variation and
dietary changes during follow-up, we calculated the mean of
consumption during the follow-up for dietary variables to
better represent long-term habitual dietary consumption when
these associations were explored (50). The present study
suggests that consumption of low-fat dairy products, all types
of yogurt, and low-fat milk is associated with a lower incidence
of MetS in older individuals at high CVD risk. Furthermore,
increased consumption of whole-fat yogurt is associated with a
lower incidence of all MetS components. Conversely, cheese
consumption is associated with an increased risk of MetS
development.
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Supplemental Table 1. Hazard ratios (95% CI)1 of MetS components2 across energy-adjusted tertiles of specific dairy 
consumption3 in elderly individuals at high cardiovascular risk
T1 T2 T3 P-trend
Total dairy  
Abdominal obesity 1.00 ref. 0.98 (0.79-1.21) 1.06 (0.83-1.36) 0.55 
Hypertriglyceridemia 1.00 ref. 0.70 (0-60-0.81) 0.92 (0.78-1.08) 0.60
Low HDL-cholesterol 1.00 ref. 0.79 (0.68 -0.91) 0.87 (0.74-1.03) 0.19 
High blood pressure 1.00 ref. 0.86 (0.62-1.19) 0.93 (0.65-1.33) 0.71 
High fasting plasma glucose 1.00 ref. 0.88 (0.73-1.04) 0.97 (0.80-1.18) 0.94 
Low-fat dairy 
Abdominal obesity 1.00 ref. 1.26 (1.04-1.56) 1.01 (0.81-1.26) 0.92 
Hypertriglyceridemia 1.00 ref. 0.78 (0.68-0.91) 0.84 (0.73-0.98) 0.034 
Low HDL-cholesterol 1.00 ref. 0.98 (0.85-1.13) 0.85 (0.73-0.99) 0.029 
Hypertension 1.00 ref. 0.90 (0.65-1.25) 0.87 (0.63-1.20) 0.41 
High fasting plasma glucose 1.00 ref. 0.88 (0.74-1.04) 0.82 (0.69-0.98) 0.033 
Whole-fat dairy 
Abdominal obesity 1.00 ref. 0.90 (0.70-1.06) 0.90 (0.73-1.11) 0.59 
Hypertriglyceridemia 1.00 ref. 0.81 (0.70-0.94) 0.85 (0.74-0.99) 0.16 
Low HDL-cholesterol 1.00 ref. 0.88 (0.77-1.02) 0.87 (0.75-1.01) 0.14 
High blood pressure 1.00 ref. 0.94 (0.68-1.32) 0.85 (0.61-1.19) 0.34 
High fasting plasma glucose 1.00 ref. 0.89 (0.74-1.07) 1.05 (0.89-1.25) 0.28 
Cheese  
Abdominal obesity 1.00 ref. 0.77 (0.62-0.95) 0.95 (0.77-1.18) 0.97 
Hypertriglyceridemia 1.00 ref. 0.81 (0.70-0.94) 0.88 (0.76-1.03) 0.16 
Low HDL-cholesterol 1.00 ref. 0.86 (0.74-1.00) 0.92 (0.79-1.07) 0.36 
High blood pressure 1.00 ref. 0.76 (0.56-1.04) 0.95 (0.68-1.34) 0.86 
High fasting plasma glucose 1.00 ref. 0.95 (0.80-1.14) 1.04 (0.87-1.25) 0.61 
Total milk 
Abdominal obesity 1.00 ref. 1.02 (0.83-1.26) 1.08 (0.86-1.36) 0.49 
Hypertriglyceridemia 1.00 ref. 0.79 (0.68-0.92) 0.92 (0.79-1.08) 0.77 
Low HDL-cholesterol 1.00 ref. 0.92 (0.79-1.06) 0.84 (0.72-0.98) 0.035 
High blood pressure 1.00 ref. 0.84 (0.60-1.18)  0.81 (0.57-1.15) 0.30
High fasting plasma glucose 1.00 ref. 1.01 (0.85-1.20) 0.84 (0.69-1.01) 0.039 
Low-fat milk 
Abdominal obesity 1.00 ref. 1.11 (0.89-1.33) 0.96 (0.78-1.18) 0.66 
Hypertriglyceridemia 1.00 ref. 1.00 (0.86-1.15) 0.91 (0.79-1.06) 0.22 
Low HDL-cholesterol 1.00 ref. 1.14 (0.99-1.31) 0.81 (0.70-0.95) 0.007 
High blood pressure 1.00 ref. 1.20 (0.87-1.65) 0.78 (0.56-1.08) 0.08 
High fasting plasma glucose 1.00 ref. 1.13 (0.96-1.33) 0.79 (0.66-0.94) 0.009 
Whole-fat milk 
Abdominal obesity 1.00 ref. 0.87 (0.71-1.08) 0.97 (0.78-1.19) 0.91 
Hypertriglyceridemia 1.00 ref. 0.78 (0.67-0.90) 0.91 (0.79-1.06) 0.95 
Low HDL-cholesterol 1.00 ref. 0.81 (0.69-.93) 0.90 (0.78-1.05) 0.66 
High blood pressure 1.00 ref. 0.92 (0.66-1.30) 1.01 (0.72-1.42) 0.16 
High fasting plasma glucose 1.00 ref. 0.88 (0.73-1.05) 1.16 (0.97-1.38) 0.028 
Abbreviations: CI, confidence interval, MetS, metabolic syndrome; T, tertile. 
1 Cox regression models adjusted for intervention group, sex, age (year), leisure time physical activity (MET-day), BMI (kg/m2), current 
smoker (yes/no), former smoker (yes/no) and use of hypoglycemic, hypolipidemic, antihypertensive and insulin treatment at baseline, and 
mean consumption of vegetables (g/d), fruit (g/d), legumes (g/d), cereals (g/d), fish (g/d), red meat (g/d), alcohol (g/d and quadratic term), 
biscuits (g/d), olive oil (g/d) and nuts (g/d) during the follow-up. All models were stratified by recruitment center.
2 The MetS components (abdominal obesity, hypertriglyceridemia, low HDL-cholesterol, high blood pressure and high fasting plasma 
glucose) were defined according to updated harmonizing criteria.  
3 Tertile cut-offs are based on mean energy-adjusted dairy product consumption during the follow-up.
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Supplemental table 2. Hazard ratios1 (95%CI) of metabolic syndrome incidence across energy-adjusted 
tertiles of total dairy consumption and its different subtypes, based on the number of metabolic syndrome 
components at baseline, in individuals at high cardiovascular risk. 
T3 vs T12
0-1 MetS components 
n=512 
2 MetS components 
n=1356 
Total dairy 0.78 (0.48,1.27) 0.96 (0.78,1.18) 
Low-fat dairy 0.77 (0.50,1.20) 0.77 (0.64,0.93)
Whole-fat dairy 0.84 (0.61,1.45) 0.99 (0.83,1.18) 
Total yogurt 0.89 (0.59,1.35) 0.77 (0.64,0.92) 
Low-fat yogurt 0.79 (0.53,1.19) 0.73 (0.61,0.87)
Whole-fat yogurt 0.77 (0.49,1.20) 0.77 (0.65,0.93)
Cheese 1.79 (0.13,2.85)* 1.31 (1.09,1.57)* 
Total milk 0.99 (0.63,1.54) 0.91 (0.74,1.10) 
Low-fat milk 0.92 (0.60,1.43) 0.86 (0.71,1.04) 
Whole-fat milk 1.06 (0.69,1.61) 1.12 (0.93,1.34) 
1Cox regression model adjusted for intervention group, sex, age (year), leisure time physical activity (MET-
day), BMI (kg/m2), current smoker (yes/no), former smoker (yes/no), use of hypoglycemic, hypolipidemic, 
antihypertensive and insulin treatment at baseline, mean consumption during the follow-up of vegetables 
(g/d), fruit (g/d), legumes (g/d), cereals (g/d), fish (g/d), red meat (g/d), alcohol (g/d and quadratic term), 
biscuits (g/d), olive oil (g/d) and nuts (g/d). Stratified by recruitment center. 
2Tertile cut-offs are based on energy-adjusted mean during the follow-up.
Abbreviations: T, Tertile 
*P-trend <0.05 
P-trend <0.01 
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PREDIMED investigators: University of Navarra and Osasunbidea (Servicio Navarro 
de Salud), Primary Care Centres, Pamplona, Spain: E Toledo, B. Sanjulian, A. Marti, P. 
Buil-Cosiales, M. Serrano-Martínez,J. Diez-Espino, A. García-Arellano, J. Basterra-
Gortari, E.H. Martínez-Lapiscina, N. Ortuno, N. Berrade, V. Extremera-Urabayen, C. 
Arroyo-Azpa, L. García -Perez, J. Villanueva Telleria, F. Cortes Ugalde, T. Sagredo 
Arce, M. D.García  de la Noceda Montoy, M. D. Vigata López, M. T. Arceiz Campo, A. 
Urtasun Samper, M. V. Gueto Rubio, and B. Churio Beraza. 
Hospital Clinic, IDIBAPS, Barcelona, Spain: M. Serra, A. Perez-Heras, C. Vinas, R. 
Casas, L. de Santamaria, S. Romero, J.M. Baena, M. García , M. Oller, J. Amat, I. 
Duaso, Y. García , C. Iglesias, C. Simon, Ll. Quinzavos, Ll. Parra, M. Liroz, J. 
Benavent, J. Clos, I. Pla, M. Amoros, M.T. Bonet, M.T. Martin, M.S. Sanchez, J. 
Altirruba, E. Manzano, A. Altes, M. Cofan, C. Valls-Pedret, A. Sala-Vila, and M. 
Domenech. 
University Rovira i Virgili, Reus, Spain: J. Basora, R. González, C. Molina, F. 
Marquez, P. Martínez, N. Ibarrola, M. Sorli, J. García  Roselló, A, Castro, F. Martin, N, 
Tort, A. Isach, M. Guasch-Ferre, M. Baldrich, J.J. Cabre, G. Mestres, F. Paris, M. 
Llauradó, R. Pedret, J. Basells, J. Vizcaino, and J. Fernández-Ballart.  
Institute de Recerca Hospital del Mar, Barcelona, Spain: M.I. Covas, S. Tello, J. Vila, 
R. de la Torre, D. Munoz-Aguayo, R. Elosua, J. Marrugat, and M. Ferrer. 
University of Valencia, Valencia, Spain: P. Carrasco, R. Osma, M. Guillen, P. Guillem-
Saiz, O. Portoles, V. Pascual, C. Riera, J. Valderrama, A. Serrano, E. Lazaro, A. 
Sanmartin, A. Girbes, V. Santamaria, C. Sanchez, Z. Pla.  
University Hospital of Alava, Vitoria, Spain: F. Arós, I. Salaverria, T. del Hierro, J. 
Algorta, S. Francisco, A. Alonso-Gómez, E. Sanz, J. Rekondo, MC Belló and A. 
Loma-Osorio. 
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University of Malaga, Malaga, Spain: E. Gómez-Gracia, J. Wärnberg, R. Benitez Pont, 
M. Bianchi Alba, R. Gomez-Huelgas, J. Martínez-González, V. Velasco García, J. de 
Diego Salas, A. Baca Osorio, J. Gil Zarzosa, J.J. Sánchez Luque, and E. Vargas López. 
Instituto de la Grasa, Consejo Superior de Investigaciones Científicas, Sevilla, Spain: J. 
Sánchez Perona, E. Montero Romero, M. García -García  and E. Jurado-Ruiz. 
Institute of Health Sciences IUNICS, University of Balearic Islands, and Hospital Son 
Espases, Palma de Mallorca, Spain: M. García-Valdueza, M. Moñino, A. Proenza, R. 
Prieto, G. Frontera, M. Ginard, F. Fiol, A. Jover, D. Romaguera, and J. García. 
Department of Family Medicine, Primary Care Division of Sevilla, Sevilla, Spain: JM. 
Santos-Lozano, M. Leal, E. Martínez, M. Ortega-Calvo, P. Roman, F. Jose García , P. 
Iglesias, Y. Corchado, E. Mayoral, L. Mellado, L. Miró, JM. Lozano and C. Lama. 
School of Pharmacy, University of Barcelona, Barcelona, Spain: M.C. López- Sabater, 
A.I. Castellote-Bargallo, A. Medina-Remon, and A. Tresserra-Rimbau. 
University of Las Palmas de Gran Canaria, Las Palmas, Spain: J. Alvarez-Perez, E. 
Diez Benitez, I. Bautista Castaño, I. Maldonado Diaz, A. Sanchez-Villegas, M.J. 
Férnandez-Rodríguez, F. Sarmiendo de la Fe, C. Simon García, I. Falcon Sanabria, B. 
Macias Gutierrez, and A.J. Santana Santana. 
Hospital Universitario de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain: E. de la 
Cruz, A. Galera, Y. Soler, F. Trias, I. Sarasa, E. Padres, and E. Corbella. 
Primary Care Division, Catalan Institute of Health, Barcelona, Spain: C. Cabezas, E. 
Vinyoles, M.A. Rovira, L. García , G. Flores, J.M. Verdu, P. Baby, A. Ramos, L. 
Mengual, P. Roura, M.C. Yuste, A. Guarner, A. Rovira, M.I. Santamaria, M. Mata, C. 
de Juan, and A. Brau. 
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Other investigators of the PREDIMED network: J.A. Tur (University of Balearic 
Islands), M.P. Portillo (University of Basque Country) and G. Saez (University of 
Valencia). 
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2. Replacing red meat and processed red meat for white meat, fish, legumes 
or eggs is associated with lower risk of incidence of metabolic syndrome. 
Becerra-Tomás N, Babio N, Martínez-González MÁ, Corella D, Estruch R, Ros E, 
Fitó M, Serra-Majem L, Salaverria I, Lamuela-Raventós RM, Lapetra J, Gómez-
Gracia E, Fiol M, Toledo E, Sorlí JV, Pedret-Llaberia MR, Salas-Salvadó J. 
Key teaching points: 
 Few prospective cohort studies have analyzed the association between red 
meat and processed red meat consumption and the risk of MetS showing 
inconsistent results. 
 Previous results from the PREDIMED Reus-Tarragona center showed an 
increased risk of MetS with high consumption of red meat and processed red 
meat. 
 The present study has gone beyond and has analyzed the association 
between meat (total meat, red meat, processed red meat and poultry) 
consumption and the risk of MetS incidence in the full PREDIMED cohort. 
Besides, the replacement effect of red meat and processed meat with other 
protein-rich foods on MetS risk was also analyzed. 
 Total meat, red meat and processed red meat consumption was positively 
associated with a higher risk of MetS incidence, whereas poultry 
consumption was inversely associated. 
 The replacement or red meat and processed red meat with other protein-
rich foods were associated with a lower risk of MetS incidence. 
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Background & aims: Few studies have assessed the association between consumption of red meat (RM)
and processed red meats (PRM) and the incidence of metabolic syndrome (MetS) and results have been
inconsistent. We investigated associations between total consumption of meat and its subtypes and
incident MetS and estimated the effect of substituting RM or PRM for alternative protein-rich foods.
Methods: We analyzed 1868 participants (55e80 years-old) recruited into the PREDIMED study who had
no MetS at baseline and were followed for a median of 3.2 years. MetS was deﬁned using updated
harmonized criteria. Anthropometric variables, dietary habits, and blood biochemistry were determined
at baseline and yearly thereafter. Multivariable-adjusted hazard ratios (HRs) of MetS were estimated for
the two upper tertiles (versus the lowest one) of mean consumption of meat and its subtypes during the
follow-up as exposure.
Results: Comparing the highest vs the lowest tertile of consumption, we observed an increased risk of
MetS incidence, with HRs of 1.23 (95% conﬁdence interval [CI]: 1.03e1.45) and 1.46 (CI: 1.22e1.74) for
total meat and pooled RM and PRM, respectively. Compared with participants in the lowest tertile, those
in the highest tertile of poultry and rabbit consumption had a lower risk of MetS incidence. The risk of
MetS was lower when one-serving/day of RM or PRM was replaced by legumes, poultry and rabbit, ﬁsh
or eggs.
Abbreviations: CVD, cardiovascular disease; ICC, intra-class correlation coefﬁcient; FFQ, food frequency questionnaire; HR, hazards ratios; MedDiet, Mediterranean diet;
MetS, metabolic syndrome; PRM, processed red meat; RM, red meat; RM&PRM, red meat and processed red meat; SFAs, saturated fatty acids.
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Conclusion: RM and PRM consumption was associated with higher risk of MetS. Replacing RM or PRM
with other protein-rich foods related to a lower risk of MetS and should, therefore, be encouraged.
This trial was registered at controlled-trials.com as ISRCTN35739639.
© 2016 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
1. Introduction
Metabolic syndrome (MetS) is a cluster of metabolic disorders
associated with abdominal obesity that is associated with an
increased risk of cardiovascular disease (CVD) and diabetes [1]. It
has been suggested that adherence to the Mediterranean diet
(MedDiet) and a healthy lifestyle are cornerstones in the preven-
tion and treatment of MetS [2]. On the other hand, a Western di-
etary pattern, characterized by a high consumption of red meat,
processed meat, butter and margarine and reﬁned grain has been
associated with an increased prevalence and incidence [3] of MetS.
Some studies have reported a positive association betweenmeat
consumption e mainly red meat and processed meat e and hy-
pertension [4], abdominal obesity [5], and type 2 diabetes [6,7], all
of which are MetS components. Cross-sectional [8e12] and pro-
spective studies [3,9,13] have examined the association between
red meat consumption and MetS, with controversial results. To our
knowledge only three prospective studies have analyzed the as-
sociation between red meat consumption and MetS [3,9,13]. In the
Atherosclerosis Risk in Communities study, a direct associationwas
observed between meat consumption (hamburger, hot dogs, pro-
cessed meats, bacon, meat sandwiches or mixed dishes, meat as a
main dish) and MetS incidence in middle-aged women and men
[3]. Along the same lines, in a study limited to one of the centers of
the PREDIMED trial we found an increased risk of MetS develop-
ment in those individuals in the highest baseline quartile of red
meat and processed red meat consumption compared to those in
the ﬁrst quartile after one year of follow-up [9]. Finally, in a cohort
of Japanese ancestry a 4.7-fold increased risk of developing MetS
was observed in those individuals in the top tertile of red meat
consumption compared to those in the lower tertile, although the
relationship was lost after adjustment for saturated fatty acid
intake [13]. As far as we know, only two previous studies related
exposure to poultry consumption with MetS prevalence [12] or
incidence [13] and reported no associations.
In the present analysis we provide the results obtained in the
full cohort of the PREDIMED study, a nutritional intervention trial
for the primary prevention of cardiovascular disease [14] for the
associations between total meat and speciﬁc types of meat con-
sumption (especially red meat and processed red meat) and the
incidence of MetS during the total study follow-up. We also esti-
mated the effects on MetS incidence of replacing red meat and
processed red meat with alternative protein-rich foods.
2. Material and methods
2.1. Study design and participants
This study is a secondary analysis of a previously published
randomized clinical trial, the PREDIMED (PREvencion con DIeta-
MEDiterranea, www.predimed.es) study. Brieﬂy, PREDIMED is a
randomized, multicentre, parallel-group ﬁeld trial that was con-
ducted in Spain between October 2003 and December 2010 to
assess the effectiveness of the MedDiet on the primary prevention
of CVD. The protocol and design have been described elsewhere
[14]. The trial was registered at http://www.controlledtrials.com/
ISRCTN35739639 and included 7444 men and women (aged
55e80 and 60e80 years, respectively), without previously docu-
mented cardiovascular disease. Participants were eligible if they
had either type 2 diabetes or at least three of the following car-
diovascular risk factors: hypertension (systolic blood pressure
140 mmHg or diastolic blood pressure 90 mmHg or on antihy-
pertensive medication), high plasma LDL-cholesterol (160 mg/
dL), low plasma HDL-cholesterol (<40 mg/dL in men; <50 mg/dLin
women), overweight or obesity (BMI 25 kg/m2), current smoking,
or a family history of premature coronary heart disease. Partici-
pants were randomized to one of three intervention groups: a
MedDiet supplemented with 1 L/week of extra-virgin olive oil, a
MedDiet supplemented with 30 g/day of mixed nuts, or a control
diet (advice to follow a low fat-diet). The main results in relation to
cardiovascular events have been published [15].
In the present report, data were analyzed considering the PRE-
DIMED study as a observational cohort. We selected participants
from all the PREDIMED recruiting centers with biochemical de-
terminations available for at least 2 years of follow-up (n ¼ 5081).
Because our main aim was to explore the associations between
different types of meat consumption and the risk of MetS devel-
opment, we excluded participants with MetSat baseline (n¼ 3707).
We also excluded participants who had not completed a baseline
food frequency questionnaire (FFQ) and those who reported total
energy intake values outside the pre-speciﬁed limits
(500e3500 kcal/d inwomen and 800e4000 kcal/d in men). Finally,
2094 individuals were available for evaluation. The protocol was
approved by the institutional review boards of each recruitment
center and all participants provided written informed consent.
2.2. Dietary assessment
Dietary intake was evaluated at baseline and yearly during
follow-up using a previously validated FFQ [16]. The reproducibility
of the FFQ used in the PREDIMED study for food groups, and energy
and nutrient intake, explored by the Pearson correlation coefﬁcient
(r), ranged from 0.50 to 0.82, and the intra-class correlation coef-
ﬁcient (ICC) ranged from 0.63 to 0.90. The validity indices of the FFQ
in relation to the dietary records for food groups, nutrient and
energy intake ranged (r) from 0.24 to 0.72, while the ICC ranged
from 0.40 to 0.84. The ICC was 0.75 for total meat/meat products,
0.59 for ﬁsh or seafood, 0.40 for legumes, and 0.58 for eggs. Infor-
mation about meat consumption was assessed using 13 items
included in the FFQ. Energy and nutrient intake were estimated
using Spanish food composition tables [15].
Trained dieticians asked the participants about the frequency
with which they consumed red meat, poultry or rabbit, processed
meat products, ﬁsh, eggs and legumes: never, one to three times
per month, once per week, two to four times per week, ﬁve to six
times per week, once per day, two to three times per day, four to six
times per day or more than six times per day. The responses were
transformed to grams per day and then categorized into red meat
(RM) including pork, veal, beef and lamb; processed red meat
(PRM) including offal, ham, sausages, pa^te, hamburgers and bacon.
Red meat and processed red meat were merged into one category
(RM&PRM) and poultry and rabbit, into another category, including
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chicken, turkey and rabbit, while total meat included all of the
above categories. All dietary variables at baseline and yearly during
the follow-up were adjusted for total energy intake using the re-
siduals method [17].
2.3. Ascertainment of metabolic syndrome
The primary endpoint of the PREDIMED trial was a composite of
major cardiovascular clinical events (non-fatal myocardial infarc-
tion, non-fatal stroke or cardiovascular death). For the present
study, we considered MetS incidence and its components to be the
outcome. The deﬁnition of MetS we used was in accordance with
the updated harmonized criteria of the International Diabetes
Federation and the American Heart Association/National Heart,
Lung, and Blood Institute [1]. Individuals were diagnosed with
MetS if they had three or more of the following components:
elevated waist circumference for European individuals (88 cm in
women and 102 cm in men), hypertriglyceridemia (>150 mg/dl)
or drug treatment for elevated triglycerides, low concentrations of
HDL-cholesterol (<50 mg/dl and <40 mg/dL in women and men,
respectively) or drug treatment for low HDL-cholesterol, elevated
blood pressure (systolic 130 mmHg and/or diastolic  85 mmHg)
or taking antihypertensive medication; and high fasting plasma
glucose (100 mg/dl) or drug treatment for hyperglycemia.
2.4. Assessment of covariates
At baseline and yearly during follow-up, participants completed
a 47-item questionnaire about lifestyle variables, medical history
and medication use; a validated Spanish version of the Minnesota
Leisure Time Physical Activity Questionnaire [18]; a 14-item vali-
dated questionnaire designed to assess adherence to the MedDiet
[19]; and a validated semi-quantitative FFQ with 137items [16].
Trained personnel measured height in centimeters, weight in
kilograms, and waist circumference by standard methods and
blood pressure in triplicate with a 5-min interval between each
measurement by using a validated oscillometer (Omron
HEM705CP, Hoofddorp, The Netherlands). BMI was calculated by
dividing weight in kilograms by the square of height in meters.
Fasting blood samples were collected from all participants. Total
cholesterol, triglycerides and glucose concentrations were
measured using standard methods. HDL-cholesterol was deter-
mined after precipitation with phosphotungstic acid and magne-
sium chloride. The laboratory technicians were blinded to the
intervention group.
2.5. Statistical analyses
To take advantage of the yearly dietary assessments, we aver-
aged the meat consumption from baseline to the end of the follow-
up or from baseline to the last follow-up FFQ before the occurrence
of MetS (if it ever occurred) as the relevant exposure. Because
participants who developed MetS during follow-up might have
changed their dietary habits after the diagnosis of MetS, their
average consumption was calculated from baseline to the year
before MetS diagnosis. Then, participants were categorized into
tertiles of average daily consumption of total meat and its different
subtypes during follow-up. The baseline characteristics of the study
population are expressed as percentages and numbers for cate-
gorical variables and mean ± SD or median (IQR) for continuous
variables. The Chi-square and one-way ANOVA tests were used to
appraise differences in the baseline characteristics according to
tertiles of the average energy-adjusted daily consumption of total
meat. Multivariable Cox regression models were ﬁtted to assess the
hazards ratios (HR) of incident MetS and its components during
follow-up for tertiles of total meat, RM, RM&PRM, PRM, and poultry
and rabbit. The Cox regression models were adjusted for several
potential confounders. Model 1 was adjusted for intervention
group, sex, age, leisure time physical activity (METs/min-day), BMI
(kg/m2), smoking (current, former or never) at baseline; model 2
was additionally adjusted for quintiles of daily average consump-
tion (g/d) during follow-up of vegetables, fruit, legumes, cereals,
ﬁsh, dairy products, biscuits, olive oil, nuts and alcohol(continuous
and adding the quadratic term); and model 3 was additionally
adjusted for the prevalence of MetS components at baseline:
abdominal obesity (yes/no), hypertriglyceridemia (yes/no), low
HDL-cholesterol (yes/no), high blood pressure (yes/no), and high
fasting plasma glucose (yes/no). The ﬁrst tertile was used as the
reference category in all models. The time variable was calculated
as the difference between the date of death or end of follow-up (the
date of the last visit or the last recorded clinical event [MetS inci-
dence] of participants who were still alive) and the date of
recruitment.
Statistical interaction between tertiles of total meat or its
different subtypes and potential confounding variables such as sex,
diabetes status and BMI were checked including product terms in
the multivariable model. Because no signiﬁcant interactions were
observed with sex, age or BMI, the product terms were removed.
To assess the linear trend, the median value of each tertile of
total meat and different subtypes of meat consumption was
included in the Cox regression models as a continuous variable. We
conducted subsequent multivariable analyses to examine the HRs
for MetS of substituting RM and PRMwith one portion/day of other
protein-rich foods such as ﬁsh, poultry and rabbit, legumes and
eggs. These dietary variables were included in the same fully
adjustedmodel as continuous variables, and the differences in their
b-coefﬁcients, variances and covariance were used to calculate the
b-coefﬁcient ± SE for the substitution effect. Thereafter, these pa-
rameters were used to estimate the HR and 95% CI. The level of
signiﬁcance for all statistical tests was set at P < 0.05 for bilateral
contrast. All analyses were performed with the SPSS software
(version 22.0).
3. Results
A total of 1868 individuals free of MetS at baseline and without
extreme total energy values in FFQ were included in the ﬁnal lon-
gitudinal analyses after 226 individuals had been excluded because
data on some of the MetS components during follow-up were
missing. The mean daily consumption of total meat was 124 g, for
which RM&PRM were the major contributors (55%).
After a median follow-up of 3.2 years (interquartile range
1.9e5.8), 980 participants without MetS at baseline (53.8% women)
developed new-onset MetS. Table 1 depicts the baseline charac-
teristics of the study subjects by tertiles of average daily con-
sumption of total meat. Participants, in the top tertile were more
likely than those in the bottom tertile to have abdominal obesity
and use oral antidiabetic agents or insulin; they also consumed less
fruit, legumes, dairy products, nuts, and olive oil.
The risk of MetS development across tertiles of total meat
consumption and its different subtypes is presented in Table 2.
Participants in the top tertile of total meat and RM&PRM con-
sumption had a greater risk of incident MetS than those in the
bottom tertile, with HRs of 1.23 (95%CI: 1.03e1.45) for total meat
and 1.46 (95%CI: 1.22e1.74) for RM&PRM.When RM and PRMwere
analyzed separately, similar direct associationswere observed, with
HRs of 1.27 (95%CI: 1.06e1.52) and 1.37 (95%CI; 1.15e1.62),
respectively. On the other hand, the consumption of poultry and
rabbit was inversely associated with the risk of MetS [HR: 0.83 (95%
CI: 0.70e0.99) for the upper tertile compared to the lowest tertile].
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Table 3 shows HR and 95% CI of the MetS components for the
daily average tertiles of energy-adjusted total meat consumption
and its different subtypes. An increased intake of total meat was
associated with an increased risk in the incidence of all MetS
components, except high blood pressure. Results were similar
when RM and PRM were merged and when PRM was analyzed
alone.
Individuals in the top tertile of RM consumption showed a 40%,
25% and 36% higher risk of abdominal obesity, hypertriglyceridemia
and low HDL-cholesterol, respectively, compared to those in the
bottom tertile. Conversely, compared with participants in the bot-
tom tertile of poultry and rabbit consumption, those in the top
tertile had a lower risk of all MetS components, except for
abdominal obesity.
The risk of MetS was lower when one serving/day of legumes
(150 g boiled), poultry and rabbit (150 g), ﬁsh (150 g) or eggs (60 g)
were substituted for RM (150 g). The corresponding HR and 95%CI
were 0.32 (0.09e0.60), 0.34 (0.20e0.66), 0.40 (0.24e0.87), 0.37
(0.19e0.76), respectively. Results were similar when one-serving/
day of PRM (150 g) was replaced (Fig. 1).The replacement of one
serving/day of RM for one serving/day of PRMwas non-signiﬁcantly
associated with a lower risk of MetS development [HR:0.72 (95%CI;
0.34e2.92)].
4. Discussion
To the best of our knowledge, this is the ﬁrst epidemiologic
study that has evaluated the association between total meat and
different subtypes of meat and the risk of MetS development in
older individuals at high cardiovascular risk. The results showed
that a high consumption of total meat (around more than one
serving/day), especially RM&PRM, was associated with increased
risk of MetS after adjusting for several potential confounders. In
contrast, poultry and rabbit consumption was associated with a
reduced risk of MetS and all its components except abdominal
obesity. The consumption of total meat, RM&PRM and PRM was
Table 1
Baseline characteristics of the study population according to tertiles of energy-adjusted average daily consumption of total meat.a
Total meat consumption (g/day)
T1  106.92 n ¼ 622 T2 106.94e137.80 n ¼ 623 T3  137.82 n ¼ 623 P-valueb
Age, years 67.3 ± 6.0 66.9 ± 6.0 66.5 ± 6.2 0.06
Women, % (n) 54.0 (336) 52.5 (327) 50.9 (317) 0.54
Waist circumference, cm 95.5 ± 9.8 94.00 ± 9.5 95.7 ± 9.9 0.05
Women 93.2 ± 10.5 91.0 ± 10.9 92.8 ± 10.2 0.02
Men 98.1 ± 8.1 97.3 ± 6.1 98.6 ± 8.5 0.11
BMI, kg/m2 28.4 ± 3.4 28.1 ± 3.5 28.5 ± 3.6 0.15
Leisure time physical activity, METs-min/d 272 ± 270 269 ± 244 282 ± 248 0.66
Former smokers, % (n) 24.8 (154) 25.7 (160) 27.1 (169) 0.63
Current smokers, % (n) 17.4 (108) 14.6 (91) 15.1 (94) 0.36
Blood pressure, mmHg
Systolic 145.9 ± 20.0 147.3 ± 21.0 146.3 ± 20.5 0.35
Diastolic 81.4 ± 10.9 82.3 ± 10.7 82.3 ± 10.7 0.27
Biochemistry, mg/dL
Fasting blood glucose 101.2 ± 37.1 99.0 ± 34.5 99.1 ± 34.6 0.01
HDL-cholesterol, median [IRQ] 59.0 [51.0e68.0] 58.7 [51.0e68.0] 57.0 [50.0e66.5] 0.41
Triglycerides, median [IRQ] 97.0 [75.0e120.0] 94.0 [76.0e116.0] 96.0 [73.0e121.0] 0.56
Current medication use, % (n)
Use of hypoglycemic agents 13.2 (82) 12.7 (79) 17.2 (107) 0.04
Use hypolipidemic agents 46.9 (292) 47.2 (294) 44.1 (275) 0.31
Use of antihypertensive agents 65.3 (406) 66.5 (414) 63.9 (398) 0.59
Insulin treatment 2.3 (14) 4.7 (29) 6.1 (38) <0.01
Metabolic syndrome components, % (n)
Abdominal obesity 47.0 (289) 38.1 (237) 46.6 (288) <0.01
Hypertriglyceridemia 5.6 (35) 5.1 (32) 4.8 (30) 0.81
Low HDL-cholesterol 2.6 (16) 4.2 (26) 2.2 (14) 0.10
High blood pressure 87.8 (545) 86.8 (541) 86.7 (539) 0.82
High fasting plasma glucose 28.6 (177) 31.7 (196) 34.8 (216) 0.07
Intervention group, % (n)
MedDiet þ EVOO 37.1 (231) 34.3 (214) 32.3 (201) 0.32
MedDiet þ nuts 33.8 (210) 35.3 (220) 34.0 (212)
Low-fat control diet 29.1 (181) 30.3 (189) 33.7 (210)
Energy intake, kcal/day 2358 ± 534 2279 ± 521 2332 ± 538 0.03
Food consumption, g/dayc
Vegetables 335 ± 145 330 ± 133 348 ± 151 0.09
Fruits 392 ± 211 388 ± 202 366 ± 194 0.05
Eggs 19 ± 11 20 ± 10 21 ± 12 <0.01
Legumes 23 ± 17 21 ± 11 20 ± 10 <0.01
Dairy 421 ± 241 384 ± 216 360 ± 212 <0.01
Fish 100 ± 47 102 ± 43 105 ± 45 0.10
Cereals 232 ± 92 234 ± 82 225 ± 79 0.11
Biscuits 25 ± 30 24 ± 29 21 ± 24 0.07
Nuts 13 ± 16 12 ± 13 11 ± 14 0.01
Olive oil 43 ± 18 42 ± 16 40 ± 16 0.03
Alcohol 10 ± 16 10 ± 13 10 ± 14 0.61
Data are expressed as means (standard deviation) or medians [IRQ, interquartile range] for continuous variables and percentages and numbers (n) for categorical variables.
Abbreviations: T, tertile; BMI, body mass index; MedDiet, Mediterranean diet, EVOO, extra-virgin olive oil.
a Tertile cut-offs are based on energy-adjusted daily average of total meat intake.
b P values for differences between tertiles were calculated by chi-square or ANOVA tests for categorical and continuous variables, respectively.
c All dietary variables were adjusted for total energy intake.
N. Becerra-Tomas et al. / Clinical Nutrition 35 (2016) 1442e1449 1445
UNIVERSITAT ROVIRA I VIRGILI 
DIETARY FACTORS ASSOCIATED WITH METABOLIC SYNDROME AND TYPE 2 DIABETES RISK 
Nerea Becerra Tomás 
also associated with components of the MetS such as abdominal
obesity, hypertriglyceridemia, low HDL-cholesterol and high fast-
ing glucose. In addition, the substitution of one serving/day of
poultry and rabbit, legumes, ﬁsh or eggs for one serving/day of RM
or PRM was associated with a signiﬁcant lower risk of developing
MetS.
Our results regarding RM, PRM and RM&PRM are in line with
most of the previous cross-sectional [8e10,12] and prospective
studies [3,9]. Although Dami~ao and co-workers showed that in-
dividuals with a higher red meat consumption in a Japanesee-
Brazilian population had an increased risk of developing MetS, this
association disappeared after adjustment for saturated fatty acid
(SFA) intake [13]. This discrepancy may be due to over-adjustment,
because SFA may be mediators of the association rather than
confounders.
Contrary to our results, two previous studies found no associa-
tion between consumption of poultry and the risk of MetS [12,13].
This discrepancy may be due to differences in the meat subtypes
included in the poultry category of these studies. Cocate et al.,
grouped poultry and ﬁsh in the same category [12], while Dami~ao
et al. did notmentionwhichmeats were included in their deﬁnition
of poultry [13]. In our study, chicken, turkey and rabbit were
included in the same category.
Various mechanisms can explain the associations observed
between meat consumption and MetS incidence. For instance, red
meat is a food group rich in compounds harmful for car-
diometabolic risk, such as cholesterol, SFA and heme iron There is
compelling evidence suggesting that SFA have a lower thermo-
genic effect and are more prone to oxidation than unsaturated
fatty acids from plant sources [20], and this type of fat has been
associated with a higher likelihood of weight gain in animals [21].
Indeed, in a recent meta-analysis [5], consumption of RM and PRM
has been associated with higher waist circumference and BMI.
Moreover, consumption of SFA from RM, but not fromwhite meat,
has also been associated with MetS, which suggests that this
nutrient has an important role in the pathogenesis of metabolic
disorders [12]. Heme iron from red meat, but not from other food
sources, has also been associated with MetS [22]. Iron is
Table 2
Hazard ratios (95% conﬁdence intervals) of metabolic syndrome incidence across average energy-adjusted tertiles of total meat, red meat and processed red meat, red meat,
processed red meat and poultry and rabbit consumption during the follow-up.a
Meat consumption (g/day)
T1a T2 T3 P-trend
Total meat, median g/dayb 87.0 120.6 158.9
Metabolic syndrome incidence, % (n) 49.2 (306) 42.1 (262) 58.1 (362) <0.01
Crude model 1.00 ref. 0.82 (0.69e0.97) 1.31 (1.12e1.54) <0.01
Multivariable model 1 1.00 ref. 0.83 (0.70e0.98) 1.32 (1.12e1.55) <0.01
Multivariable model 2 1.00 ref. 0.95 (0.80e1.13) 1.29 (1.09e1.53) 0.01
Multivariable model 3 1.00 ref. 0.93 (0.78e1.11) 1.23 (1.03e1.45) 0.02
Red meat and processed red meat, median g/dayc 38.4 62.9 96.4
Metabolic syndrome incidence, % (n) 45.5 (283) 44.3 (276) 59.6 (371)
Crude model 1.00 ref. 0.96 (0.81e1.14) 1.61 (1.37e1.89) <0.01
Multivariable model 1 1.00 ref. 0.97 (0.82e1.15) 1.67 (1.41e1.97) <0.01
Multivariable model 2 1.00 ref. 1.03 (0.87e1.23) 1.57 (1.32e1.86) <0.01
Multivariable model 3 1.00 ref. 0.98 (0.82e1.17) 1.46 (1.22e1.74) <0.01
Red meat, median g/dayd 19.5 39.3 67.5
Metabolic syndrome incidence, % (n) 47.9 (298) 44.1 (275) 57.3 (357) <0.01
Crude model 1.00 ref. 0.89 (0.75e1.05) 1.38 (1.17e1.63) <0.01
Multivariable model 1 1.00 ref. 0.89 (0.75e1.05) 1.43 (1.21e1.68) <0.01
Multivariable model 2 1.00 ref. 0.91 (0.77e1.09) 1.32 (1.10e1.57) <0.01
Multivariable model 3 1.00 ref. 0.86 (0.72e1.02) 1.27 (1.06e1.52) <0.01
Processed red meat, median g/daye 12.3 22.4 35.3
Metabolic syndrome incidence, % (n) 46.0 (286) 45.1 (281) 58.3 (363) <0.01
Crude model 1.00 ref. 0.96 (0.81e1.14) 1.44 (1.22e1.69) <0.01
Multivariable model 1 1.00 ref. 0.97 (0.82e1.14) 1.46 (1.24e1.72) <0.01
Multivariable model 2 1.00 ref. 1.06 (0.89e1.26) 1.42 (1.20e1.68) <0.01
Multivariable model 3 1.00 ref. 1.06 (0.89e1.26) 1.37 (1.15e1.62) <0.01
Poultry and rabbit, median g/dayf 28.9 58.6 79.4
Metabolic syndrome incidence, % (n) 56.4 (351) 43.2 (269) 49.8 (310) <0.01
Crude model 1.00 ref. 0.67 (0.57e0.79) 0.79 (0.67e0.93) <0.01
Multivariable model 1 1.00 ref. 0.67 (0.57e0.78) 0.78 (0.66e0.92) <0.01
Multivariable model 2 1.00 ref. 0.76 (0.64e0.90) 0.85 (0.72e1.01) 0.03
Multivariable model 3 1.00 ref. 0.74 (0.63e0.88) 0.83 (0.70e0.99) 0.02
Abbreviations: T, tertile.
Multivariable model 1 adjusted for intervention group, sex, age (years), leisure time physical activity (METs-min/day), BMI (kg/m2), current smoker (yes/no), former smoker
(yes/no). Multivariable model 2 additionally adjusted for average consumption quintiles of vegetables (g/d), fruit (g/d), legumes (g/d), cereals (g/d), ﬁsh (g/d), dairy products (g/
d), alcohol (g/d and quadratic term), biscuits (g/d), olive oil (g/d) and nuts (g/d). Multivariable model 3 additionally adjusted for the prevalence of metabolic syndrome
components at baseline: abdominal obesity (yes/no), hypertriglyceridemia (yes/no), lowHDL-cholesterol (yes/no), hypertension (yes/no) and high fasting plasma glucose (yes/
no). All models were stratiﬁed by recruitment center.
a Tertile cut-offs are based on energy-adjusted daily average of total meat, red meat and processed red meat, red meat, processed red meat and poultry and rabbit.
b Includes all meat products: chicken, turkey, rabbit, pork, beef, veal, lamb, several types of sausages and processed red meat.
c Includes pork, veal, lamb, several types of sausages and processed red meat.
d Includes pork, beef, veal and lamb.
e Includes several types of sausages and processed red meat.
f Includes chicken, turkey and rabbit.
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potentially harmful because it catalyses cellular reactions and
produces reactive oxygen species that increase the oxidative
stress. This has a particular effect on pancreatic beta cells, which
can lead to insulin resistance [23].
Processed meat products are treated by salting, curing, or
smoking, thus having high sodium content, besides harmful addi-
tives such as nitrites and nitrates, aromatic polycyclic hydrocar-
bons, and heterocyclic amines. Nitrites and nitrates can be
converted into nitrosamines that have been associated with an
increased risk of diabetes in experimental animal models [24].
Moreover, blood nitrites have been associated with endothelial
dysfunction and impaired insulin response in adults [25], thus
increasing the risk of MetS development. Finally, excessive sodium
intake is clearly related to high blood pressure.
The mechanism by which poultry consumption may decrease
MetS risk remains unclear. The substitution of poultry for RM and
PRM entails a lower intake of SFA, heme iron, glycotoxins and
sodium, which may be involved in the development of MetS
through the aforementionedmechanisms. In fact, in observational
studies the risk of type 2 diabetes was reduced when one serving
of poultry/day was substituted for one serving of total red meat/
day [6]. Our results also show that substituting a serving of
poultry, ﬁsh, legumes or eggs for RM and PRM can protect against
MetS development. A recent meta-analysis of prospective studies
showed an inverse association between ﬁsh consumption and the
risk of MetS incidence [26]. The mechanisms explaining this in-
verse association may be the high ﬁsh content of n-3 fatty acids,
which have anti-inﬂammatory effects and may help reduce in-
sulin resistance in muscle, improve the plasma lipoprotein proﬁle
and endothelial function, and control blood pressure [27]. In
epidemiologic studies legume consumption has been associated
with a reduced risk of MetS components such as increased waist
circumference and high blood pressure [28]. Legumes have a high
ﬁber and magnesium content, which has been associated with a
better lipid proﬁle and improved glucose and inﬂammatory re-
sponses [29] that may be responsible in part for these beneﬁcial
effects. The inverse association found with MetS when
substituting eggs for RM and PRM may be explained in part
because eggs are a good source of folate, B vitamins, and carot-
enoids and promote the absorption of other antioxidants present
in vegetables [30]. Robust observational evidence suggests that
high egg consumption is not associated with an increased risk of
coronary heart disease or stroke, with the probable exception of
high consumption levels among diabetic persons [31].
Table 3
Hazard ratios (95% CI) of metabolic syndrome components (abdominal obesity, hypertriglyceridemia, low HDL-cholesterol, high blood pressure and high fasting plasma
glucose) across energy-adjusted tertiles of speciﬁc meat consumption.a
T1 T2 T3 P-trend
Total meatb
Abdominal obesity 1.00 ref. 0.87 (0.69e1.09) 1.34 (1.07e1.68) 0.01
Hypertriglyceridemia 1.00 ref. 0.94 (0.80e1.09) 1.21 (1.03e1.41) 0.01
Low HDL-cholesterol 1.00 ref. 0.90 (0.77e1.06) 1.29 (1.10e1.50) <0.01
High blood pressure 1.00 ref. 0.76 (0.52e1.12) 0.88 (0.59e1.31) 0.64
High fasting plasma glucose 1.00 ref. 0.87 (0.72e1.05) 1.21 (1.00e1.46) 0.04
Red and processed red meatc
Abdominal obesity 1.00 ref. 1.19 (0.96e1.49) 1.73 (1.36e2.18) <0.01
Hypertriglyceridemia 1.00 ref. 1.02 (0.87e1.19) 1.47 (1.26e1.72) <0.01
Low HDL-cholesterol 1.00 ref. 1.08 (0.92e1.26) 1.45 (1.24e1.70) <0.01
High blood pressure 1.00 ref. 0.95 (0.66e1.37) 1.25 (0.84e1.88) 0.28
High fasting plasma glucose 1.00 ref. 0.99 (0.82e1.19) 1.28 (1.05e1.56) 0.01
Red meatd
Abdominal obesity 1.00 ref. 1.07 (0.86e1.33) 1.4 (1.19e1.88) <0.01
Hypertriglyceridemia 1.00 ref. 0.88 (0.76e1.03) 1.25 (1.08e1.46) <0.01
Low HDL-cholesterol 1.00 ref. 0.99 (0.86e1.16) 1.36 (1.17e1.59) <0.01
High blood pressure 1.00 ref. 0.78 (0.55e1.12) 1.05 (0.71e1.54) 0.69
High fasting plasma glucose 1.00 ref. 1.07 (0.89e1.29) 1.18 (0.97e1.43) 0.09
Processed red meate
Abdominal obesity 1.00 ref. 0.83 (0.66e1.03) 1.50 (1.21e1.86) <0.01
Hypertriglyceridemia 1.00 ref. 0.89 (0.77e1.04) 1.26 (1.09e1.46) <0.01
Low HDL-cholesterol 1.00 ref. 0.90 (0.77e1.04) 1.25 (1.08e1.45) <0.01
High blood pressure 1.00 ref. 0.94 (0.66e1.34) 0.97 (0.66e1.41) 0.88
High fasting plasma glucose 1.00 ref. 0.96 (0.80e1.15) 1.23 (1.02e1.48) 0.02
Poultry and rabbitf
Abdominal obesity 1.00 ref. 0.72 (0.59e0.89) 0.81 (0.65e1.01) 0.03
Hypertriglyceridemia 1.00 ref. 0.69 (0.59e0.80) 0.78 (0.67e0.91) <0.01
Low HDL-cholesterol 1.00 ref. 0.70 (0.61e0.82) 0.83 (0.71e0.96) <0.01
High blood pressure 1.00 ref. 0.69(0.48e0.99) 0.68 (0.47e0.97) 0.02
High fasting plasma glucose 1.00 ref. 0.74 (0.62e0.88) 0.83 (0.69e0.99) 0.01
Abbreviations: CI, conﬁdence interval, T, tertile.
a Tertile cut-offs are based on energy-adjusted daily average meat intake. The metabolic syndrome components were deﬁned according to updated harmonizing criteria.
Cox regression models adjusted for intervention group, sex, age (year), leisure time physical activity (METs-min/day), BMI (kg/m2), current smoker (yes/no), former smoker
(yes/no), quintiles of average consumption of vegetables (g/d), fruit (g/d), legumes (g/d), cereals (g/d), ﬁsh (g/d) dairy (g/d), biscuits (g/d), olive oil (g/d) and nuts (g/d), and
alcohol (g/d) (continuous and quadratic term). All models were stratiﬁed by recruitment center.
b Includes all meat products: chicken, turkey, rabbit, pork, beef, veal, lamb, several types of sausages and processed red meat.
c Includes pork, beef, veal, lamb, several types of sausages and processed red meat.
d Includes pork, beef, veal and lamb.
e Includes several types of sausages and processed red meat.
f Includes chicken, turkey and rabbit.
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Although our study focuses on the risk of MetS attributable to
exposure to a speciﬁc food group (meat and processed meat), it
should be considered that the effect of the overall dietary pattern is
likely to have a considerably greater effect than those of individual
food groups or nutrients. For example, there is consistent evidence
that some dietary patterns, such us the MedDiet, DASH and Nordic
diet, have beneﬁcial effects on MetS [32]. Probably, the joint effect
of the whole dietary pattern is larger than the sum of its parts.
Nevertheless, the associations we found remained signiﬁcant after
adjusting for other food groups within the background diet.
Our study has some limitations. First, the results cannot be
generalized to other populations because study subjects are older
individuals at high cardiovascular risk. Second, MetS was a sec-
ondary outcome of the PREDIMED study, hence the results are
exploratory in nature. Third, our study has been conducted in the
frame of a nutritional ﬁeld trial with dietary patterns that might
have a differential effect on the incidence of MetS or its compo-
nents. However, this confounding effect was minimized by adjust-
ing analyses for the intervention group. Fourth, as in any
prospective study, there can be unknown or unmeasured con-
founding factors, such as the amounts of nitrates, nitrites and het-
erocyclic amines consumed, all of which have been related to the
occurrence and progress of MetS and its components. This possi-
bility may have introduced some degree of residual confounding.
Our study also has strengths, such as the relatively long follow-
up, the control for a large number of potential confounders, the
analysis of different meat subtypes and yearly repeated dietary
assessments during follow-up, which allows updating the con-
sumption of the foods under consideration and is rarely undertaken
in large observational studies.
In conclusion, the present study suggests that total meat (when
consumed to a level of around more than one serving/day), RM and
PRM promote MetS development. In contrast, poultry consumption
is associated with a lower risk of MetS. The substitution of other
protein-rich foods for RM or PRM is also associated with a lower
risk of MetS. Therefore, replacing RM and PRM by other healthy
foods should be recommended to decrease the risk of MetS in in-
dividuals at high cardiovascular risk. Further studies are warranted
to conﬁrm these ﬁndings and elucidate the possible mechanisms
involved.
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3. Legume consumption is inversely associated with type 2 diabetes 
incidence in adults: A prospective assessment from the PREDIMED study. 
Becerra-Tomás N, Díaz-López A, Rosique-Esteban N, Ros E, Buil-Cosiales P, 
Corella D, Estruch R, Fitó M, Serra-Majem L, Arós F, Lamuela-Raventós RM, Fiol 
M, Santos-Lozano JM, Díez-Espino J, Portoles O, Salas-Salvadó J; PREDIMED Study 
Investigators. 
Key teaching points: 
 Legumes consumption is widely recommended for its healthy effects, but its 
association with T2D is scarce. 
 Most of the previous studies have been focused on soy-legumes 
consumption and only few of them have analyzed the association between 
non-soy legumes and T2D risk. 
 The present study analyzed for the first time the association between total 
non-soy legume and its different subtype consumption and the risk of T2D 
incidence in a Mediterranean population. Moreover, the theoretical 
substitution effect of legumes for other protein- or carbohydrate-rich foods 
on the risk of T2D was also assessed.  
 Results suggest a beneficial effect of total legume, and particularly lentils, 
consumption on T2D risk incidence.  
 The theoretically substitution of legumes for eggs, bread, rice and potato 
was associated with a lower risk of incidence of T2D. 
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Background & aims: Legumes, a low-energy, nutrient-dense and low glycemic index food, have shown
beneﬁcial effects on glycemic control and adiposity. As such, legumes are widely recommended in
diabetic diets, even though there is little evidence that their consumption protects against type 2 dia-
betes. Therefore the aim of the present study was to examine the associations between consumption of
total legumes and speciﬁc subtypes, and type 2 diabetes risk. We also investigated the effect of theo-
retically substituting legumes for other protein- or carbohydrate-rich foods.
Methods: Prospective assessment of 3349 participants in the PREvencion con DIeta MEDiterranea
(PREDIMED) study without type 2 diabetes at baseline. Dietary information was assessed at baseline and
yearly during follow-up. We used Cox regression models to estimate hazard ratios (HRs) and 95% con-
ﬁdence intervals (95% CIs) for type-2 diabetes incidence according to quartiles of cumulative average
consumption of total legumes, lentils, chickpeas, dry beans and fresh peas.
Results: During a median follow-up of 4.3 years, 266 new cases of type 2 diabetes occurred. Individuals in
the highest quartile of total legume and lentil consumption had a lower risk of diabetes than those in the
lowest quartile (HR: 0.65; 95% CI: 0.43, 0.96; P-trend ¼ 0.04; and HR: 0.67; 95% CI: 0.46e0.98; P-
trend ¼ 0.05, respectively). A borderline signiﬁcant association was also observed for chickpeas con-
sumption (HR 0.68; 95% CI: 0.46, 1.00; P-trend ¼ 0.06). Substitutions of half a serving/day of legumes for
similar servings of eggs, bread, rice or baked potato was associated with lower risk of diabetes incidence.
Abbreviations used: IDF, International Diabetes Federation; CVD, cardiovascular disease; MedDiet, Mediterranean diet; PREDIMED, PREvencion con DIeta MEDiterranea;
FFQ, Food Frequency Questionnaire; ICC, intraclass correlation coefﬁcient; HRs, hazard ratios; Cis, Conﬁdence intervals; METs, metabolic equivalent task.
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Conclusions: A frequent consumption of legumes, particularly lentils, in the context of a Mediterranean
diet, may provide beneﬁts on type 2 diabetes prevention in older adults at high cardiovascular risk.
Trial registration: The trial is registered at http://www.controlled-trials.com (ISRCTN35739639). Regis-
tration date: 5th October 2005.
© 2017 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
Background
Type 2 diabetes is recognised as a major public health issue
worldwide. According to the International Diabetes Federation
(IDF), type 2 diabetes affected 415 million adults in 2015 and it is
estimated that this ﬁgure will increase to 642 million in 2040 [1].
Type 2 diabetes is associated with signiﬁcant systemic conse-
quences, including microvascular andmacrovascular complications
affecting the quality of life and decreasing the life expectancy [2].
Therefore, it is imperative to identify strategies to prevent and
manage this condition.
In recent years, accumulating evidence from prospective studies
and randomized controlled trials indicates that changes in diet and
lifestyle are critical for the prevention of type 2 diabetes [3]. Le-
gumes have been proposed as one of the dietary factors that may
offer protection against type 2 diabetes. However, the independent
association between non-soy legume intake and type 2 diabetes
has scarcely been studied.
Legumes, including green beans and peas, peanuts, soybeans,
lupine, alfalfa, clover, dry beans, broad beans, dry peas, chickpeas
and lentils [4], are protein- and ﬁbre-rich foods, and have a low
glycemic index [5]. In addition, legumes contain sizeable amounts
of B vitamins, particularly folate, as well as beneﬁcial minerals such
as, calcium, magnesium and potassium [6]. As a consequence of this
unique nutritional value, several diabetes guidelines recommend
them [7,8]. Furthermore, legumes are importantly present in
healthy plant-based dietary patterns as the Mediterranean diet
(MedDiet), vegetarian diets and prudent diets, which have consis-
tently been associated with a lower risk of chronic diseases and
type 2 diabetes [9,10]. Legumes consumption has also demon-
strated beneﬁcial effects on obesity, abdominal adiposity and
metabolic syndrome [11e14] which are well recognized risk factors
for type 2 diabetes. In addition, the replacement of red meat by
legume consumption decreased peripheral inﬂammation, glycae-
mia and insulinemia in diabetic individuals [15,16].
To date, the few epidemiological studies evaluating these asso-
ciations show inconsistent results. According to India's Third Na-
tional Family Health Survey, compared to non-consumers, women
who consumed legumes daily or weekly, but not men, showed a
signiﬁcant reduced prevalence of type 2 diabetes [17]. In contrast,
this association was not observed in the Indian Migration Study
[18]. Results from prospective studies are also controversial and
highlight the paucity of studies on legumes and diabetes. Whereas
several studies did not show any signiﬁcant association between
legume consumption and type 2 diabetes development [19e21], in
the Shanghai Women's Health Study [22] consumption of total le-
gumes (including soybeans) was associated with a reduced risk of
type 2 diabetes incidence. Contrary, in the Nurse's health study a
higher risk of type 2 diabetes was observed in the highest cate-
gories of total legume consumption [23].
However, to the best of our knowledge, no previous prospective
studies have been conducted in Mediterranean populations who
customarily consume sizeable amounts of non-soy legumes, or in
individuals at high cardiovascular risk. Moreover, the effect of
substituting legumes for other food sources rich in proteins or
carbohydrates, has not been previously assessed. Therefore, the aim
of the current study was to examine the association between the
consumption of total non-soy legumes and its different subtypes
(dry beans, chickpeas, lentils, and fresh peas), and the risk of type 2
diabetes development in a Mediterranean population at high car-
diovascular risk. We also investigated the effect of substituting le-
gumes for other protein- and carbohydrate-rich foods.
Research design and methods
Study population
The present data was analysed using an observational pro-
spective design conducted within the frame of the PREDIMED
(PREvencion con DIeta MEDiterranea) trial (PREDIMED website:
http://www.predimed.es) [24]. The PREDIMED study (registered at
http://www.controlled-trials.com as ISRCTN35739639) was a ran-
domized, multi center, parallel-group clinical trial conducted in
Spain between October 2003 and December 2010. The main aim of
the trial was to evaluate the effectiveness of the MedDiet on the
primary prevention of CVD; the principal results have been pub-
lished elsewhere [25]. Brieﬂy, the study included 7447 men (aged
55e80 years) and women (aged 60e80 years) without CVD at
enrolment but who were at high cardiovascular risk. They were
eligible if they had either type 2 diabetes or at least three of the
following cardiovascular risk factors: hypertension (systolic blood
pressure 140 mmHg or diastolic blood pressure 90 mmHg or
taking antihypertensive drugs), hypercholesterolemia (high LDL
cholesterol 160 mg/dL or taking hypolipidemic medication), low
high-density lipoprotein (50 mg/dL in women or 40 mg/dL in
men), overweight/obesity (BMI  25 kg/m2), current smoking or
family history of premature coronary heart disease. Exclusion
criteria included alcohol or drug abuse, severe chronic illness,
presence of BMI40 kg/m2 and allergy or intolerance to olive oil or
nuts. For the current analysis, we excluded participants with type 2
diabetes at baseline (n ¼ 3614), and those who lacked measures of
blood glucose control (n ¼ 292), who had implausible daily energy
intake (<500 or >3500 kcal/d for women and <800 or >4000 kcal/
d for men [26]) or who had not completed the baseline Food Fre-
quency Questionnaire (FFQ) (n¼ 98). We also excluded participants
without follow-up (n ¼ 94). The ﬁnal analysis included 3349 non-
diabetic individuals. The protocol was approved by the institu-
tional review boards of the respective recruiting centers, and
written informed consent was provided by all participants included
in the study.
Dietary assessment
Trained dietitians quantiﬁed dietary intake using a validated
semi-quantitative FFQ at baseline and yearly during the follow-up
[27]. The Pearson correlation coefﬁcient and the intraclass corre-
lation coefﬁcient (ICC) were used to explore the reproducibility of
the FFQ for food groups and energy and nutrient intake. The
reproducibility and validity of the FFQ for legumes were 0.47 (ICC
0.63), and 0.29 (ICC 0.40), respectively [27]. Legumes consumption
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was assessed using four items from the FFQ (lentils, chickpeas, dry
beans and fresh peas). The consumption frequency was measured
in nine categories (ranging from never or almost never to >6
servings/day) for each food item. The responses to each item were
transformed to daily frequency and then multiplied by the portion
size (in grams) in order to obtain grams per day consumed during
the follow-up. The consumption of energy, nutrients and food
groups was calculated using Spanish food composition tables
[28,29].
Assessment of other covariates
At baseline and yearly during the follow-up, participants
completed a 47-item questionnaire about lifestyle, medical history
and medication use and a validated Spanish version of the Min-
nesota Leisure Time Physical Activity Questionnaire [30]. To assess
adherence to the MedDiet, a 14-item validated questionnaire was
ﬁlled in for each participant [31]. One question was about legume
consumption, two questions about meat and one about ﬁsh [31]. In
order to control for the overall dietary pattern, we used this Med-
Diet questionnaire score but removed the variable related to
legume consumption for the main analysis. Therefore, a 13-point
score was used as a covariate in the models. For the substitution
analysis of meat and ﬁsh, we used an 11-point score after addi-
tionally removing the variables related to meat intake and a 12-
point score after removing the variable related to ﬁsh intake as
covariates in the models.
Fasting blood samples, and anthropometric and blood pressure
measurements were collected from all participants by trained
personnel. Blood pressure was measured in triplicate (recording
the mean of the three values), with an interval of 5 min between
each measurement, using a validated oscillometer (Omron
HEM705CP, Hoofddorp, The Netherlands), Weight and height were
measured with participants in lightweight clothing and no shoes
using calibrated scales and a wall-mounted stadiometer.
Ascertainment of type 2 diabetes mellitus
Type 2 diabetes was a prespeciﬁed secondary outcome in the
PREDIMED trial. New-onset type 2 diabetes was identiﬁed
following the American Diabetes Association criteria [32]; namely,
fasting plasma glucose levels of7.0 mmol/L (126.1 mg/dL) or 2-h
plasma glucose levels of11.1 mmol/L (200.0 mg/dL) after an oral
dose of 75 g of glucose. Yearly, physicians-investigators of each
center, who were blinded to the intervention, completed a review
of all the participants' medical records. When new cases of type 2
diabetes were identiﬁed based on a diagnosis reported in the
medical charts or on a fasting blood glucose values during routine
biochemical analyses (done at least once per year), these reports
were sent to the PREDIMED Clinical Events Committee, whose
members were also blinded to treatment allocation. Only when the
new onset type 2 diabetes case was veriﬁed within the next 3
months, using the same criteria, the adjudication committee
deﬁnitively conﬁrmed the end point [10]. Only conﬁrmed diabetes
events that occurred between 1 October 2003 and 1 December
2010 were included in the analyses.
Statistical analyses
To take advantage of the yearly dietary assessment and to
better represent the long term diet [33], we used the cumulative
average from baseline to the last FFQ before the new-onset of type
2 diabetes or to the last available FFQ (in those individuals
without type 2 diabetes incidence). Participants were categorized
into quartiles of consumption of total legumes, lentils, chickpeas,
dry beans and fresh peas adjusted for energy intake using the
residuals method [26].
The baseline characteristics of the study population were pre-
sented as means ± SD for quantitative variables, and percentages
and numbers for categorical variables. One way ANOVA and Chi-
square tests were used to assess differences in baseline character-
istics according to quartiles of energy-adjusted cumulative average
consumption of total legumes and the different subtypes. Cox
regression models were ﬁtted to assess the hazard ratios (HRs) and
95% conﬁdence intervals (CIs) of type 2 diabetes according to
quartiles of consumption of total legumes, lentils, chickpeas, dry
beans and fresh peas. To appraise the linear trend, the median
consumption within each quartile was included in the Cox
regression models as a continuous variable. Model 1 was adjusted
for sex, age (continuous), intervention group, baseline leisure time
physical activity (METs-min/day), smoking status (never, current or
former), educational level (primary education, secondary education
or academic/graduate), fasting plasma glucose (<100 mg/dL or
100 mg/dL), prevalence of hypertension (yes/no), prevalence of
hypercholesterolemia (yes/no), use of antihypertensive medication
(yes/no), use of hypolipidaemic medication (yes/no) and cumula-
tive average alcohol consumption in grams per day (continuous and
adding a quadratic term). Model 2 was additionally adjusted for
cumulative average of the 13-point screener (excluding legumes) of
MedDiet adherence as a continuous variable. Model 3 was further
adjusted for BMI (kg/m2). All models were stratiﬁed by recruitment
center. The ﬁrst quartile was used as a reference category in all
models. For each participant, we calculated the time variable as the
interval between the randomization and the date of type 2 diabetes
diagnosis, death from any cause or the last visit, whichever came
ﬁrst. To test the statistical interaction between quartiles of total
legumes, lentils, chickpeas, dry beans, fresh peas and potential
confounding variables such as sex, intervention group and BMI, the
product terms were included in the multivariable model. Because
no signiﬁcant interactions were observed, the product terms were
removed. We conducted subsequent multivariate analyses to
examine the HRs of substituting half a serving/day of legumes (30 g
in raw) for half a serving/day of another protein-rich food, such as
meat (75 g), ﬁsh (75 g) and eggs (30 g), and another carbohydrate-
rich food, such as bread (38 g), rice (30 g raw), baked potato (100 g)
and pasta (30 g raw). These dietary variables were included as
continuous variables in the samemodel, adjusted for the covariates
listed above. The differences in their b-coefﬁcients, variance and
covariance were used to calculate the b-coefﬁcient ± SE for the
substitution effect, and the HRs and 95% CI were calculated from
these parameters.
To test the robustness of our results, we conducted two sensi-
tivity analyses: a) adjusting for updated BMI instead of baseline BMI
to evaluate the impact of changes in body weight; and b) censoring
participants at the time of diagnosis of cancer or CVD (myocardial
infarction, stroke) because these diseases may lead to changes in
diet [34].
Data were analysed using a commercially available software
program Stata 14 (StataCorp) and statistical signiﬁcancewas set at a
2-tailed P value <0.05.
Results
During a median follow-up of 4.3 years, 266 incident cases of
type 2 diabetes were documented. Baseline characteristics of the
study population according to energy-adjusted quartiles of total
legume intake are presented in Table 1. Participants in the highest
quartile of total legume consumption were less likely to have
higher education and had higher BMI and fasting plasma glucose
levels than those in the bottom quartile. They also had a lower
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intake of total energy, dietary fat and alcohol but a higher intake of
carbohydrates, protein and dietary ﬁbre. Baseline characteristics
according to quartiles of different type of legume consumption are
described in Supplemental Table 1.
During follow-up, the median cumulative average intake was
19.76 g/d for total legumes, 6.58 g/d for lentils, 4.98 g/d for chick-
peas, 4.69 g/d for dry beans and 2.76 g/d for fresh peas (Table 2).
In multivariable analyses (Table 3), participants in the highest
quartile of consumption of total legumes had a lower risk of
developing type 2 diabetes even after adjusting for the overall di-
etary pattern score and BMI (HRs: 0.65; 95% CI: 0.43, 0.96; P
trend ¼ 0.04) than those in the lowest quartile. Likewise, those in
the highest quartile of lentil intake had a 33% lower risk of type 2
diabetes incidence (HRs 0.67; 95% CI: 0.46e0.98; P trend ¼ 0.05)
than those in the bottom quartile. Comparing the 4th vs the 1st
quartile of chickpeas consumption a borderline signiﬁcant inverse
association with type 2 diabetes development was observed (HRs
0.68; 95% CI: 0.46e1.00; P trend¼ 0.06). No signiﬁcant associations
were observed between fresh peas and dry beans, and the risk of
type 2 diabetes. The results were similar when the consumption of
total legumes, lentils, chickpeas, dry beans and fresh peas was
modelled as a continuous variable per 30 g/day increase
(Supplemental Table 2). We observed an inverse association be-
tween total legumes (HR: 0.55; 95% CI: 0.32, 0.93; P-value ¼ 0.03)
and lentil consumption (HR: 0.18; 95% CI: 0.05, 0.65; P-
value ¼ 0.01) with incident type 2 diabetes, while consumption of
chickpeas, dry beans and fresh peas was unrelated.
Results were similar when model 3 was adjusted by quintiles of
cumulative consumption of nuts, olive oil, ﬁsh and fruits and veg-
etables instead of using the MedDiet score (data not shown).
Figure 1 shows the potential impact on type 2 diabetes devel-
opment of theoretically substituting half a serving/day of total le-
gumes for half a serving/day of food rich in protein or
carbohydrates. For foods rich in protein, the risk of type 2 diabetes
was 50% lower when half a serving/day of legumes was substituted
for half a serving/day of eggs. However, although there was a trend
toward lower risk of type 2 diabetes, the association was non-
signiﬁcant when ﬁsh or meat were replaced with legumes [(HR:
0.58; 95% CI: 0.32, 1.05; P-value ¼ 0.07) and (HR: 0.59; 95% CI 0.34,
Table 1
Baseline characteristics of the study population according to cumulative average quartiles of energy-adjusted total legume consumption.a
Quartile of total legume consumption P-valueb
Q1 (lowest)
n ¼ 838
Q2
n ¼ 837
Q3
n ¼ 837
Q4 (highest)
n ¼ 837
Total legume consumption, (g/day) 9.64 ± 3.55 16.09 ± 1.41 21.57 ± 1.89 34.60 ± 17.24
Lentils, g/day 3.58 ± 2.31 5.26 ± 2.13 7.28 ± 2.34 9.97 ± 6.06
Chickpeas, g/day 2.71 ± 2.02 4.31 ± 1.70 6.06 ± 2.051 9.17 ± 5.53
Fresh peas, g/day 1.14 ± 1.92 2.57 ± 2.15 2.90 ± 2.84 6.24 ± 14.70
Dry beans, g/day 2.20 ± 1.97 3.95 ± 1.85 5.32 ± 2.67 9.22 ± 6.22
Age, years 66 ± 6 67 ± 6 67 ± 6 67 ± 6 0.31
Women, % (n) 59.90 (502) 62.37 (522) 63.80 (534) 62.60 (524) 0.42
Smoking habit, % (n) 0.31
Never 60.74 (509) 60.81 (509) 64.40 (539) 63.92 (535)
Former 21.72 (182) 22.82 (191) 22.10 (185) 20.79 (174)
Current 17.54 (147) 16.37 (137) 13.50 (113) 15.29 (128)
Education, % (n) 0.01
Primary 72.43 (607) 75.87 (635) 76.58 (641) 78.49 (657)
Secondary 16.59 (139) 16.97 (142) 16.01 (134) 15.05 (126)
University/graduate 10.98 (92) 7.17 (60) 7.41 (62) 6.45 (54)
Intervention group, n (%) 0.13
MedDiet þ EVOO 32.22 (270) 33.09 (277) 34.65 (290) 33.09 (277)
MedDiet þ Nuts 35.20 (295) 35.72 (299) 36.56 (306) 31.66 (265)
Control group 32.58 (273) 31.18 (261) 28.79 (241) 35.24 (295)
BMI, kg/m2 29.95 ± 3.65 29.68 ± 3.48 30.16 ± 3.54 30.17 ± 3.65 0.02
Leisure time physical activity, METs.min/day 234.21 ± 236.78 228.65 ± 214.85 226.27 ± 215.75 237.12 ± 220.54 0.74
Hypertension, % (n) 90.57 (759) 92.11 (771) 91.52 (766) 92.95 (778) 0.34
Hypercholesterolemia, % (n) 84.25 (706) 83.27 (697) 85.19 (713) 85.90 (719) 0.47
Current medication use, % (n)
Use of antihypertensive agents 75.78 (635) 76.46 (640) 77.18 (646) 78.61 (658) 0.55
Use hypolipidemic agents 47.37 (397) 49.58 (415) 50.78 (425) 51.25 (429) 0.39
Fasting plasma glucose, mg/dL 97.57 ± 15.22 97.26 ± 12.93 98.81 ± 16.51 99.32 ± 14.79 0.01
Nutrient intakec
Total energy, kcal/day 2381 ± 564 2196 ± 469 2239 ± 533 2230 ± 504 <0.01
Total fat, % of total energy 38.68 ± 6.53 39.13 ± 6.11 38.02 ± 6.15 37.00 ± 6.56 <0.01
Carbohydrate, % of total energy 42.37 ± 7.23 42.09 ± 6.57 42.89 ± 6.43 44.11 ± 7.19 <0.01
Protein, % of total energy 15.75 ± 2.70 16.19 ± 2.64 16.59 ± 2.641 16.69 ± 2.81 <0.01
Alcohol, g/day 10.52 ± 16.71 9.10 ± 12.11 9.09 ± 14.10 7.74 ± 12.33 <0.01
Dietary ﬁbre, g/day 22.43 ± 7.02 24.02 ± 6.27 25.76 ± 6.93 28.98 ± 8.59 <0.01
Abbreviations: Q, quartile; MedDiet, Mediterranean diet; EVOO, extra virgin olive oil; METs, metabolic equivalent.
a Data are expressed as means ± SD for continuous variables and percentage and number (n) for categorical variables.
b P value for differences between quartiles were calculated by chi-square or ANOVA tests for categorical and continuous variables, respectively.
c All dietary variables were adjusted for total energy intake.
Table 2
Energy-adjusted cumulative average legume consumption during follow-up in the
study population.a
Means ± SD Median Interquartile range
Legumes 20.84 ± 9.60 19.76 15.42e24.75
Lentils 6.73 ± 3.51 6.58 4.37e8.46
Chickpeas 5.67 ± 3.25 4.98 3.90e7.37
Dry beans 5.33 ± 3.59 4.69 3.48e8.70
Fresh peas 3.12 ± 5.15 2.76 0.92e4.18
a Data are expressed in raw grams per day.
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1.03) (P-value ¼ 0.07), respectively]. For carbohydrate-rich food, a
44%, 47%, 52% and 51% lower risk of type 2 diabetes development
was observed when wholemeal bread, white bread, rice and baked
potato, respectively, were replaced with legumes.
Our results were signiﬁcant in two different sensitivity analyses.
When we examined the impact of changes in BMI on the associa-
tion of legume consumption and type 2 diabetes risk adjusting for
updated BMI instead of baseline BMI, total legumes lentils and
chickpeas consumption was associated with a lower risk of type 2
diabetes [HR: 0.65; 95% CI: 0.43, 0.96; P-trend ¼ 0.03 (fourth
quartile vs ﬁrst quartile of legumes consumption), HR: 0.68; 95% CI:
0.47, 0.98; P-trend ¼ 0.05 (fourth quartile vs ﬁrst quartile of lentils
consumption)] and HR: 0.67; 95% CI: 0.46, 0.99; P-value ¼ 0.05
(fourth quartile vs ﬁrst quartile of chickpeas consumption). The
associations were non-signiﬁcant for the intake of dry beans and
fresh peas. When study participants with cancer or CVD incidence
during follow-upwere censored after they were diagnosedeon the
assumption that their diet could have changed after the diagnosise
the results were similar. Individuals in the highest quartile of total
legumes and lentils consumption had a lower risk of type 2 dia-
betes development than those in the lowest quartile [(HR: 61; 95%
CI: 0.40, 0.93; P-trend ¼ 0.03) and (HR: 60; 95% CI: 0.41, 0.90; P-
trend ¼ 0.04), respectively]. Otherwise, chickpeas, dry-beans and
fresh-peas consumption was not associated with type 2 diabetes
incidence.
Discussion
To the best of our knowledge, this is the ﬁrst prospective study
conducted in senior Mediterranean individuals at high cardiovas-
cular risk evaluating the association between consumption of total
legumes and its different varieties, and type 2 diabetes. The present
study revealed that a higher consumption of total legumes, espe-
cially lentils, was associated with a lower risk of type 2 diabetes
development. The consumption of chickpeas was borderline
signiﬁcantly associated with a lower risk of type 2 diabetes inci-
dence. Nonetheless, the intake of dry beans and fresh peas was not
associated with type 2 diabetes risk. It should be underlined that
the theoretical effect of substituting half a serving/day of legumes
for half a serving/day of other foods rich in protein or carbohy-
drates, including eggs, wholemeal and white bread, rice or baked
potato, was associated with a signiﬁcant lower risk of type 2 dia-
betes incidence. These ﬁndings provide new insights into the role of
legume consumption in preventing type 2 diabetes.
To date there has been little evidence of the effect of legume
consumption on the risk of type 2 diabetes. In agreement with our
results, in the India's Third National Family Health Survey, total
legume consumption was associated with a reduced prevalence of
type 2 diabetes in adult women, but not in men [17]. In a similar
manner, in the prospective Shanghai Women's Health Study, total
legume consumption and the intake of three mutually exclusive
Table 3
HRs (95% CIs) of type 2 diabetes incidence according to energy-adjusted quartiles of cumulative average consumption of legumes and its speciﬁc subtypes.
Quartiles of legumes consumption
1 (lowest) 2 3 4 (highest) P-trend
Legumes
Cases/person-years 85/3479 72/3465 62/3456 47/3397
Median (P25, P75), g/day 12.73 (10.38, 14.29) 17.63 (16.59, 18.70) 21.97 (20.85, 23.23) 28.75 (26.45, 32.66)
Crude model 1 (ref.) 0.84 (0.61e1.15) 0.74 (0.54e1.03) 0.55 (0.37e0.81) <0.01
Multivariable model 1 1 (ref.) 0.84 (0.61e1.15) 0.81 (0.58e1.12) 0.59 (0.40e0.87) 0.01
Multivariable model 2 1 (ref.) 0.85 (0.62e1.17) 0.84 (0.60e1.17) 0.62 (0.42e0.93) 0.03
Multivariable model 3 1 (ref.) 0.87 (0.63e1.19) 0.86 (0.61e1.20) 0.65 (0.43e0.96) 0.04
Lentils
Cases/person-years 99/3465 60/3492 55/3465 52/3376
Median (P25, P75), g/day 3.77 (2.89, 4.17) 5.62 (4.71, 6.15) 7.66 (7.12, 8.23) 8.88 (8.66, 9.49)
Crude model 1 (ref.) 0.62 (0.45e0.86) 0.60 (0.43e0.85) 0.60 (0.42e0.87) 0.01
Multivariable model 1 1 (ref.) 0.67 (0.48e0.92) 0.61 (0.43e0.88) 0.63 (0.44e0.91) 0.02
Multivariable model 2 1 (ref.) 0.69 (0.50e0.96) 0.64 (0.45e0.92) 0.66 (0.45e0.96) 0.04
Multivariable model 3 1 (ref.) 0.69 (0.50e0.96) 0.66 (0.46e0.94) 0.67 (0.46e0.98) 0.05
Chickpeas
Cases/person-years 79/3470 80/3477 60/3461 47/3390
Median (P25, P75), g/day 3.05 (1.77, 3.57) 4.35 (4.14, 4.73) 6.15 (5.58, 6.71) 8.59 (7.99, 9.13)
Crude model 1 (ref.) 1.08 (0.79e1.47) 0.80 (0.57e1.13) 0.60 (0.42e0.88) 0.01
Multivariable model 1 1 (ref.) 1.10 (0.80e1.50) 0.89 (0.62e1.27) 0.65 (0.45e0.96) 0.03
Multivariable model 2 1 (ref.) 1.10 (0.80e1.51) 0.92 (0.64e1.31) 0.67 (0.46e0.99) 0.05
Multivariable model 3 1 (ref.) 1.08 (0.79e1.49) 0.91 (0.64e1.30) 0.68 (0.46e1.00) 0.06
Dry beans
Cases/person-years 77/3453 75/3480 56/3455 58/3410
Median (P25, P75), g/day 2.16 (0.68, 2.99) 4.16 (3.84, 4.46) 5.67 (5.08, 6.30) 8.45 (7.66, 9.22)
Crude model 1 (ref.) 1.02 (0.74e1.40) 0.77 (0.55e1.08) 0.83 (0.57e1.19) 0.31
Multivariable model 1 1 (ref.) 1.03 (0.75e1.41) 0.80 (0.56e1.12) 0.87 (0.61e1.26) 0.50
Multivariable model 2 1 (ref.) 1.05 (0.76e1.44) 0.83 (0.59e1.17) 0.91 (0.62e1.31) 0.65
Multivariable model 3 1 (ref.) 1.05 (0.77, 1.45) 0.84 (0.59, 1.18) 0.93 (0.65, 1.35) 0.75
Fresh peas
Cases/person-years 61/3418 76/3441 65/3487 64/3458
Median (P25, P75), g/day 0.22 (0, 0.61) 1.85 (1.33, 2.32) 3.53 (3.15, 3.87) 5.06 (4.52, 7.06)
Crude model 1 (ref.) 1.18 (0.84e1.66) 0.89 (0.62e1.28) 0.89 (0.61e1.29) 0.22
Multivariable model 1 1 (ref.) 1.26 (0.89e1.79) 1.03 (0.71e1.49) 0.97 (0.66e1.42) 0.51
Multivariable model 2 1 (ref.) 1.26 (0.89e1.79) 1.04 (0.72e1.50) 0.97 (0.66e1.41) 0.50
Multivariable model 3 1 (ref.) 1.27 (0.89e1.81) 1.04 (0.72e1.51) 0.97 (0.66e1.42) 0.49
Cox regression models were used to assess the risk of diabetes incidence by quartiles of cumulative average of intake of legumes and legume subtypes. Multivariable model 1
was adjusted for age (y), sex, intervention group, cumulative average consumption of alcohol (continuous and adding a quadratic term), smoking status (never, former, or
current smoker), educational level (primary education, secondary education, or academic/graduate), leisure-time physical activity (metabolic equivalent task minutes/day),
baseline hypertension (yes/no), hypercholesterolemia (yes/no), use of antihypertensive medication (yes/no), use of lipid-lowering drugs (yes/no) and fasting plasma glucose at
baseline (<100mg/dL or100mg/dL). Model 2 was further adjusted for cumulative average of the 13-point screener (excluding legumes) of MedDiet adherence (continuous).
Model 3 was additionally adjusted for BMI (kg/m2). Extremes of total energy intake (>4000 or <800 kcal/day in men and >3500 or <500 kcal/day in women) were excluded.
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legume groups (soybeans, peanuts and other legumes) were asso-
ciated with a protection against type 2 diabetes development [22].
Other epidemiological studies, however, have not supported
this protective role of total legume consumption on type 2 diabetes
risk [18e21,23]. For example, in the Indian Migration Study, no
cross-sectional association was observed between legume con-
sumption and type 2 diabetes prevalence [18]. Likewise, Meyer and
co-workers [19] found no association between legume consump-
tion and type 2 diabetes incidence in older women during six year
of follow-up. Similarly, no signiﬁcant association was observed in
the Malm€o Diet and Cancer study [21] and in the Women's Health
Study [20] after evaluating a large sample consisting of 27,140 men
and women, and 38,018 female health professionals, respectively.
Contrary to our results, in the Nurse's health Study [23], a higher
risk of type 2 diabetes was observed in those individuals in the 5th
quintile vs those in the 1st quintile of total legume consumption.
However, when they analysed the consumption as an increase of
one serving/day, non-signiﬁcant association was observed.
The discrepancies between our results and those of the afore-
mentioned studies, could be explained by differences in the study
design. For instance, in the present analysis we used cumulative
average consumption as exposure, while all the other prospective
studies, except the Nurse's Health study and the ShanghaiWomen's
Health Study [22,23], used a single measurement at baseline. Dis-
crepancies could also be due to the different characteristics of the
study population studied. Participants from the present study were
European Mediterranean individuals at high risk of CVD. However,
the other studies have been conducted in Asian [17,18,22], Amer-
ican [19,20,23] and Northern European populations [21]. Another
possible explanation is the way as the outcome was deﬁned. In the
present study, diabetes was deﬁned following the deﬁnition of the
American Diabetes Association, but in most of the studies
[17,19,20,22,23] diabetes was self-reported. Finally, subtypes of le-
gumes included in the analysis as well as the amount consumed
also could explain the heterogeneity in the results. In the present
study, we considered legumes as the sum of lentils, chickpeas, dry
beans and fresh peas, and the main contributors to total legumes
consumption were lentils and chickpeas (both subtypes inversely
associated with type 2 diabetes risk in the current analysis).
Nonetheless, of the 5 previous prospective published studies, only
two of them distinguished between the different subtypes of le-
gumes included [19,23], and contrary to us, they did not include
lentils and chickpeas in the analysis.
Various mechanisms could explain the protective role of legume
consumption against type 2 diabetes. Legumes are a low-energy
but nutrient-dense food group [6] and their consumption, like
that of other seeds, could improve cardiometabolic health due to
their unique composition in bioactive nutrients and phytochemi-
cals and the complex interplay among them [35]. Recently, the
intake of vegetable protein, of which legumes are a good source, has
been recently associated with a lower risk of type 2 diabetes in two
large US prospective cohorts [36]. Legumes also contain signiﬁcant
amounts of calcium, potassium and magnesium, minerals which
intake has been inversely related to type 2 diabetes risk [37e39].
Fig. 1. The impact of substituting half a serving/day of legumes for half a serving/day of foods rich in proteins or carbohydrates on risk of type 2 diabetes. All HRs were adjusted for
age (y), sex, intervention group, cumulative average of alcohol intake (continuous, adding a quadratic term), total energy intake (kcal/d), smoking status (never, former or current
smoker), educational level (primary education, secondary education or academic/graduate), leisure-time physical activity (metabolic equivalent task minutes/d), baseline hyper-
tension (yes/no), hypercholesterolemia (yes/no), use of lipid-lowering drugs (yes/no), use of antihypertensive drugs (yes/no), fasting plasma glucose at baseline (<100 mg/dL
or  100 mg/dL), MedDiet adherence (13-point score) except for meat (11-point score) and ﬁsh (12-point score) and BMI (kg/m2). Stratiﬁed by recruitment center. Extremes of total
energy intake (>4000 or <800 kcal/d in men and >3500 or <500 kcal/d in women) were excluded. Half a serving/day corresponds to 30 g of raw legumes, eggs, pasta and rice; 38 g
of bread; 75 g of ﬁsh and meat; 100 g of baked potato.
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Furthermore, legumes also contain high amounts of polyphenols
[40], predominantly phenolic acids and ﬂavonoids with antioxidant
and anti-inﬂammatory properties [6], which may also protect
against type 2 diabetes [41]. In addition, legumes are rich in ﬁbre
[6], which is associated with higher satiety [42] and improvements
in the control of body weight [43], glucose metabolism [44] as well
as lower risk of type 2 diabetes incidence [45]. Another explanation
for the beneﬁcial effect on type 2 diabetes risk may be the low
glycemic index of legumes, which might blunt glycemic excursions
and, therefore, pancreatic insulin secretion, both of which are
mechanisms involved in the development of type 2 diabetes. In this
context, a pooled analysis of randomized clinical trials demon-
strated that the consumption of pulses alone or combined with a
low glycemic index diet rich in ﬁbre improves markers of long term
glycemic control in individuals with or without type 2 diabetes
[46]. In addition, a higher risk of type 2 diabetes has been associ-
ated with high glycemic index diets, which highlights the biological
plausibility of these associations [47,48].
To date, no studies have evaluated the associations between the
consumption of lentils, dry beans, chickpeas, or fresh peas and type 2
diabetes incidence. In our study, lentil consumptionwas signiﬁcantly
associated with a lower risk of type 2 diabetes. The higher ﬂavonoid
content in cooked lentils compared to other cooked pulses may
explain this ﬁnding [49]. However, further studies are needed to
better understand theeffectof lentil consumptionon the incidenceof
type 2 diabetes and elucidate the underlying biological mechanisms.
We also examined the effect of substituting legumes for other
carbohydrate-or protein-rich foods on the risk of type 2 diabetes.
Our novel results suggest that replacing eggs, bread, rice or baked
potato with legumes has a beneﬁcial effect on type 2 diabetes.
These ﬁndings support our previous suggestions of legumes as a
good substitute for energy dense animal protein sources [6] and
other more rapidly digestible carbohydrates [50].
Our study has limitations. First, because type 2 diabetes was a
secondary outcome of the PREDIMED study, these analyses con-
ducted in a subgroup of participants without type 2 diabetes should
be considered exploratory in nature. Second, our sample popula-
tion was comprised of older elderly Caucasian individuals at high
cardiovascular risk, which limits the extrapolation of our results to
other populations. Third, although we used a validated FFQ to
assess diet, measurement errors are inevitable.
Our study also has strengths, such as the use of repeated dietary
measurements, which allows as to reduce the random measure-
ment error produced by within-person variation and dietary
changes during follow-up; the control for many potential con-
founding variables; the inclusion of sensitivity analyses; and the
accurate and blind assessment of incident cases of type 2 diabetes.
Conclusions
In summary, the current data suggests that a frequent con-
sumption of legumes and particularly lentils could provide beneﬁts
on type 2 diabetes development in senior adults at high cardiovas-
cular risk. The substitution of legumes for other protein- or
carbohydrate-rich foods is also associatedwith a lower risk of type 2
diabetes. The present study supports an increased consumption of
legumes for type 2 diabetes prevention. However, given the mixed
results from previous researches, further studies are needed to
conﬁrm our ﬁndings and elucidate which mechanisms are involved.
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Supplemental Table 2. HRs and 95% CIs of type 2 
diabetes associated with 30g/day increase consumption 
of energy-adjusted legumes and its different subtypes. 
HR 95% CI P-value 
Legumes 
Crude Model 0.42 (0.25-0.73) <0.01 
Model 1 0.48 (0.29-0.81) 0.01 
Model 2 0.52 (0.31-0.88) 0.02 
Model 3 0.55 (0.32, 0.93) 0.03 
Lentils 
Crude Model 0.12 (0.04-0.42) <0.01 
Model 1 0.14 (0.04-0.50) <0.01 
Model 2 0.17 (0.05-0.60) 0.01 
Model 3 0.18 (0.05, 0.65) 0.01 
Chickpeas 
Crude Model 0.32 (0.08-1.23) 0.10 
Model 1 0.42 (0.11-1.61) 0.21 
Model 2 0.48 (0.12-1.85) 0.29
Model 3 0.50 (0.13, 1.93) 0.32 
Fresh peas 
Crude Model 0.38 (0.10-1.48) 0.16 
Model 1 0.47 (0.14-1.57) 0.22
Model 2 0.47 (0.14-1.57) 0.22 
Model 3 0.48 (0.14, 1.64) 0.24 
Dry beans 
Crude Model 0.43 (0.13-1.41) 0.16 
Model 1 0.52 (0.17-1.57) 0.24 
Model 2 0.60 (0.20-1.78) 0.35 
Model 3 0.67 (0.22-2.02) 0.48 
Multivariable model 1 was adjusted for age (y), 
sex, intervention group, cumulative average of 
alcohol intake (continuous, adding a quadratic 
term), smoking status (never, former, or current 
smoker), educational level (primary education, 
secondary education, or academic/graduate), 
leisure-time physical activity (metabolic equivalent 
task minutes/d), baseline hypertension (yes/no), 
hypercholesterolemia (yes/no), use of 
antihypertensive medication (yes/no), use of lipid-
lowering drugs (yes/no) and fasting plasma glucose 
DW EDVHOLQH PJG/RUPJG/0RGHO 
was further adjusted for cumulative average of 
MedDiet adherence (13-point score). Model 3 was 
additionally adjusted for baseline BMI (kg/m2). All 
models were stratified by recruitment center. 
Extremes of total energy intake (>4000 or < 800 
kcal/d in men and >3500 or <500 kcal/d in women) 
were excluded.  
 
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The present doctoral thesis has sought to evaluate in deeper manner the association 
between the consumption of meat, dairy products and legumes in relation to MetS 
and T2D risk in Mediterranean elderly individuals at high CVD risk. 
The results derived from this thesis provide new insights to better understand the 
role that the abovementioned food groups could play in the observed differences in 
relation with T2D and MetS risk among dietary patterns, particularly between 
Western and Mediterranean diets. 
Each of the three articles presented in this dissertation included a discussion section. 
Nevertheless, other important aspects and additional considerations that were not 
commented in the articles are more extensively discussed below. 
1. General discussion 
The present prospective study conducted in elderly participants at high CVD risk 
showed: a) a beneficial association between the consumption of low-fat dairy 
products (milk and yogurt), low-fat milk and yogurt (total, low-fat and high-fat) and 
the risk of MetS development; and a positive association between cheese 
consumption and the incidence of MetS; b) a positive association between the 
consumption of total, red and processed red meat and the risk of MetS development, 
and an inverse association with poultry; c) a lower risk of T2D incidence with high 
total legume, and particularly lentils, consumption. 
As a consequence of the traditional belief that fat consumption exerted detrimental 
effects on health, the consumption of dairy products has been reduced. However, 
novel evidences have emerged suggesting that dairy products may protect against 
different chronic diseases348. Some studies have indicated that not all types of fat 
have the same health properties, suggesting that those from dairy products may have 
beneficial effects on T2D and MetS risk349. Despite this, most of the studies conducted 
so far did not distinguish between high-fat and low-fat options, probably because of 
limitations in methods used to collect dietary data. The FFQ used in the PREDIMED 
study provides with the opportunity to differentiate across different varieties of 
commonly-consumed dairy products. In our study, whole-fat dairy products 
consumption was not associated with the risk of MetS, whereas low-fat dairy options 
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showed an inverse association. Some controversies exist in this field. Some studies 
have observed a lower risk of MetS associated with high consumptions of whole-fat 
and cheese317, whereas others have observed a higher risk or lower risk of MetS 
incidence in individuals who consumed more whole-fat or low-fat dairy products, 
respectively318. These divergent results, apart from inherent differences in study 
populations, could be probably due to the nutrient composition of dairy products, 
which may vary across countries (i.e. inherent differences between breeds of dairy 
animals), and the use of different serving sizes. Moreover, technological innovations 
afforded the production of a wide variety of new dairy products, which nutritional 
composition has been altered by removing or adding several components, mainly 
minerals and vitamins. All of these new varieties have not been considered in any of 
the studies published up to date (including the present study), and could also 
contribute to the disparities in the observed results.  
Findings from the present study also showed an inverse association between total, 
low-fat and whole-fat yogurt and the risk of MetS incidence.  Although previous 
cross-sectional studies support a beneficial effect of yogurt on MetS risk350,351, 
prospective results from the CARDIA study did not find any significant association317. 
Yogurt results from the fermentation process driven by microorganisms, in which 
different metabolites with potential health properties may be also produced. 
Besides, these bacteria could interact with the host in a positive manner. Therefore, 
although the nutritional profile of yogurt is comparable with that of milk, the 
fermentation process of yogurt could enhance its nutritional value. Moreover, it has 
been recently reported that yogurt has a low-glycemic index352, and findings from 
prospective studies have shown a positive association between low-glycemic index 
diets and the risk of T2D and MetS180,192. One concern regarding yogurt is whether 
all types of yogurts have the same health effects. Whereas plain and artificially-
sweetened yogurts have a low-glycemic index (mean of 27), sugar-sweetened 
yogurts have higher glycemic index (mean of 41)352. Unfortunately, in the present 
study we could not evaluate the possible different effects of these yogurt varieties 
because our FFQ was limited to total, whole-fat and low-fat yogurt. Results derived 
from this dissertation also demonstrated that the MetS promoting effect of meats 
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differs by meat subtype. The consumption of total meat, and particularly red meat 
and processed meat, was associated with a higher risk of MetS incidence. These 
findings are in line with other previous prospective studies reporting a positive 
association between these subtypes of meat consumption and the risk of MetS 
development308,309. White meat consumption has not been extensively investigated 
in prospective studies. Previously, only one study specifically evaluated its 
consumption with the risk of MetS incidence, showing  no significant associations310. 
In our study, poultry intake per se, and the replacement of red meat and processed 
red meat with poultry has been inversely associated with the risk of MetS 
development. It is well known that red meat and processed red meat have higher 
amounts of heme iron and SFAs than poultry. Moreover, processed red meat contains 
other additives, such as nitrites, nitrates and salt, which have been associated with a 
higher risk of T2D and endothelial dysfunction353,354. The replacement of red meat 
and processed meat with poultry could displace the intake of these constituents, and 
therefore, reduce the risk of MetS. It is important to point out that studies published 
to date did not take into account the type of cooking methods used, which may 
represent another important aspect to consider when evaluating the effects of meat 
consumption on human health. A recent study conducted in the framework of the 
NHS demonstrated that high-temperature and/or open-flame cooking methods for 
red meat could be positively associated with the risk of T2D beyond red meat 
intake355. Therefore, it would be of great interest evaluating the effect of different 
cooking methods not only for red meat, but also for processed red meat and poultry. 
Another important aspect to take into consideration in observational 
epidemiological studies, is the difficulty in accurately estimating meat 
consumptions356 in view of the fact that usually meat is consumed as a part of 
composite meals, including other food components such as pasta, legumes or 
vegetables.   
Importantly, findings from the present doctoral thesis showed, on one hand, a 
beneficial association between total legumes consumption and the risk of T2D 
development. These observations reinforce the results derived from the theoretical 
replacement analyses of red meat and processed red meat, which showed a lower 
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risk of MetS incidence when its consumption was replaced with legumes. This food 
group has a unique nutritional composition value characterized by high amount of 
dietary fiber, minerals (calcium, potassium and magnesium), vitamins, bioactive 
components (mainly polyphenols) and plant proteins. Moreover, it is also considered 
a low-glycemic index food269. The synergy between all of these healthy components 
could be the responsible for the beneficial effects on T2D prevention associated to 
its consumption.  
On the other hand, findings from the substitution analyses suggest that legumes 
could be a good alternative for other protein- and carbohydrate rich foods such as, 
eggs, bread, rice and baked potato, highlighting the importance of choosing this food 
rather than others in the context of a healthy dietary pattern. 
Finally, we also reported, for the first time, the association between different non-
soy legumes subtypes and the risk of T2D incidence. Only lentils consumption was 
associated with a lower risk of T2D development. It is difficult to elucidate the 
possible mechanisms responsible for this protection. We speculate that it could be 
due to the flavonoid content of lentils because its amount is higher compared to the 
other type of legumes and the consumption of this polyphenol has been associated 
to a lower risk of T2D in a meta-analysis of prospective cohort studies357. Large well-
conducted randomized clinical trials are needed in order to clarify its effects on T2D 
risk and elucidate the possible mechanisms implicated in this association.  
The epidemiological studies derived from the present thesis suggest that a dietary 
pattern with high consumption of low-fat dairy products and yogurt (regardless the 
fat content), together with the preference for poultry rather than red meat or 
processed red meat, and high frequency consumption of legumes, would be 
beneficial for the prevention of MetS and T2D among individuals at high CVD risk.  
Balance and variety is essential to healthy eating. Therefore, dietary patterns, as the 
MedDiet, which also include high frequency consumption of whole grains, 
vegetables, fruits, nuts and vegetable oils, along with the aforementioned 
characteristics, should be encouraged for the reduction of MetS and T2D incidence 
in elderly Mediterranean individuals at high cardiovascular risk. 
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2. Strengths and limitations 
Several strengths and limitations derived from the present work deserve to be 
tackled. The first limitation is about sampling. Our study population included 
Mediterranean elderly individuals at high cardiovascular risk. Therefore, we cannot 
extrapolate our results to others and, consequently, further studies conducted in 
other populations are needed in order to confirm our findings.  
Second, we should be careful when drawing inference about causation, given the 
observational nature of the study design, which only allows us to claim associations.  
Third, also due to the observational design, results might be difficult to interpret 
because people often adopt other healthy or unhealthy behaviors (for instance 
increase or decrease physical exercise, reducing or increasing smoking, eating other 
healthy or unhealthy foods, etc.) associated to the consumption of the analyzed 
foods, which clearly affect their health status. Although we took into account these 
lifestyle factors adjusting all statistical models for it, residual confounding factors 
there may still be present.   
Fourth, we used a FFQ to estimate habitual dietary intake, which is susceptible for 
measurement error because participants are unable to exactly report their 
consumption of foods during the preceded year. However, FFQ is the method of 
dietary data collection that has been most widely used in large epidemiological 
studies. Moreover, the FFQ of the PREDIMED study was validated against a 3-day 
food record, which is an independent superior reference method. 
Fifth, MetS and T2D were secondary end-points in the PREDIMED study, making the 
results exploratory in nature. 
The present work also has some strengths that need to be highlighted. The relatively 
long follow-up; the control for a large number of potential confounders; the use of 
yearly updated FFQ that allows us to better represent the long-term diet and to 
reduce the random measurement error due to within person variation; the analyses 
of different subtypes of dairy products, meat and legumes consumption; the 
diagnosis of T2D was based on the criteria proposed by the ADA, and was confirmed 
UNIVERSITAT ROVIRA I VIRGILI 
DIETARY FACTORS ASSOCIATED WITH METABOLIC SYNDROME AND TYPE 2 DIABETES RISK 
Nerea Becerra Tomás 
with a second analytics conducted within the following 3 month; the End-point 
Adjudication Committee was blinded to the treatment allocation.  
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The conclusions derived from this prospective cohort study of Mediterranean elderly 
individuals at high cardiovascular risk are presented as a response of each 
hypothesis specified at the beginning of the present doctoral thesis: 
Hypothesis 1: A greater intake of dairy products is associated with a reduced risk of 
MetS or any of its components incidence.  
 Total dairy consumption was not associated with the risk of MetS incidence. 
Higher consumption of low-fat dairy products, yogurt (total, low-fat, and 
whole-fat yogurt) and low-fat milk was associated with a reduced risk of 
MetS incidence and some if its components. Contrary, higher consumption 
of cheese was related to a higher risk of MetS incidence. 
Hypothesis 2: Higher consumption of meat, and particularly red meat and processed 
red meat, is associated with an increased risk of MetS or any of its features 
development. 
 Total meat consumption was associated with a higher risk of MetS 
development and some of its components. The risk differs according to the 
subtype of meat consume. Whereas red meat and processed red meat 
consumption was associated with a higher risk, poultry consumption was 
associated with a lower risk. 
 The theoretically replacement effect of red meat and processed red meat for 
other protein-rich foods such as eggs, fish, poultry and legumes is associated 
with a lower risk of MetS incidence. 
Hypothesis 3: Higher consumption of legumes is inversely associated with the risk 
of T2D incidence. 
 Total legume consumption, particularly lentils, was associated with a lower 
risk of T2D incidence. The consumption of chickpeas, dry beans and fresh 
peas was not associated with T2D risk. 
The substitution effect of legumes for eggs, rice, bread and baked potato is 
associated with a lower risk of T2D incidence.  
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MetS and T2D are metabolic disturbances that can be prevented with changes in 
lifestyle. Results from the present research add further scientific evidence to 
understand the role that dairy products, meat and legumes consumption plays on the 
risk of MetS and T2D development. Importantly, it could help to form the basis for 
dietary guidelines recommendations for preventing both chronic diseases. 
Based on our findings, we could consider several important aspects regarding future 
research in the field of the aforementioned foods and the prevention of MetS and 
T2D:  
 It is important to conduct prospective studies in different populations from 
diverse geographic areas in order to confirm our results and could 
extrapolate it to the general population.  
 Dietary assessment tools used in epidemiological studies should be 
improved, in order to better represent the usual consumption: 
o Considering all new varieties of dairy products (i.e. plain, 
artificially-sweetened or sugar-sweetened yogurts)  
o Taking into consideration the type of cooking methods 
o Standardizing serving sizes  
This would help to compare findings from different studies and to translate 
the results to the general population in a clear, unambiguous and easily 
understandable manner.  
 Long-term randomized clinical trials with large number of participants, 
evaluating the effect of different varieties of dairy products, meat and 
legumes on the risk of MetS and T2D development are required in the future 
to stablish solid based-evidence recommendations. 
 Due to the fact that mechanisms implicated in the associations between 
dairy products, meat and legumes consumption and the risk of MetS and 
T2D are not fully understood, it is important to focus future investigations 
in this sense.The risk of T2D and MetS could vary according to the genetic 
background. Therefore, studies based on gene-diet interactions are also 
warranted in order to better understand the relation between specific 
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genetic loci, the consumption of the dairy products, meat and legumes and 
the risk of MetS and T2D incidence. 
 In the last decade special attention has been focused on microbiota. It has 
been reported that changes in its composition in response to both internal 
and external stimulus are associated with different diseases such as obesity, 
T2D and MetS. As consequence, evaluating the effect of diet-microbiota 
interactions and the risk of MetS and T2D would be of great interest to 
describe other new possible mechanisms regarding the observed 
associations in the present doctoral thesis. Moreover, a better 
understanding of the role of the diet-microbiota interaction in human health 
will allow the development of new preventive and therapeutic measures. 
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